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ABSTRACT 
Abigail Elizabeth Agoglia: Assessing the Adolescent and Adult Proteome for 
Mechanisms of Enhanced Vulnerability to Alcoholism 
(Under the Direction of Clyde W. Hodge) 
 
 Alcoholism is a debilitating neurobiological disorder affecting millions of 
people in the United States and around the globe. Treatment options for alcoholism 
are limited, due in part to incomplete understanding of the development and 
molecular mechanisms that lead to alcohol addiction. Age of drinking onset is one of 
the most significant predictors of lifetime alcoholism risk, with individuals initiating 
alcohol use during adolescence at substantially increased risk for developing 
alcoholism than those who initiate drinking during early adulthood. However, the 
specific neurobiological mechanisms responsible for this increased risk remain 
elusive.  Synaptic plasticity is a critical component of adolescent brain development, 
and evidence suggests that alcohol and other drugs of abuse may induce aberrant 
plasticity in the brain, leading to long-term changes in the response to these drugs.  
Thus, the goals of this dissertation were to characterize the development of the 
adolescent and adult prefrontal cortex, a region known to be involved in adolescent 
maturation and drug taking behavior, and assess the differences in how the 
adolescent and adult prefrontal cortex respond to the presence of alcohol at the 
protein-expression level. 
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Several of the proteins regulated by age and alcohol are involved in synaptic 
plasticity, including the protein phosphatase calcineurin (PPP3R1), which displays 
increased expression during adolescence and reduced expression following alcohol 
drinking in the adolescent but not adult prefrontal cortex.   Systemic inhibition of 
PPP3R1 withthe drug FK506 reduced alcohol drinking more potently in adolescent 
versus adult mice, suggesting that PPP3R1 may be functionally involved in age 
differences in alcohol consumption. Next, to evaluate the role of PPP3R1 in long-
term vulnerability to alcoholism following adolescent exposure to alcohol, a protocol 
for adolescent drinking and subsequent adult operant self-administration of alcohol 
was developed. Mice exposed to alcohol drinking during adolescence exhibited 
increased operant responding for alcohol during adulthood, and finding that was not 
evidenced in adult mice exposed to alcohol and subsequent operant self-
administration. The increased responding for alcohol in adolescent alcohol exposure 
was reduced by the PPP3R1 inhibitor FK506. In contrast, operant responding for 
alcohol was not affected by FK506 in mice exposed to water during adolescence or 
adult mice exposed to either alcohol or water, demonstrating relative selectivity for 
the unique pattern of increased intake exhibited by mice exposed to alcohol during 
adolescence. The role of PPP3R1 in the prefrontal cortex was assessed via site-
directed microinjection of FK506, which increased operant responding for alcohol in 
mice exposed to either alcohol or water during adolescence. Lastly, to examine brain 
regions known to be both regulated by input from the prefrontal cortex and involved 
in alcohol reinforcement, the amygdala, dorsal striatum and nucleus accumbens 
were all assessed for expression and phosphorylation of CaMKII, a protein critical 
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for synaptic plasticity. Adolescent mice displayed reduced phosphorylation of 
CaMKII in the amygdala following voluntary alcohol drinking, whereas adult mice 
exhibited no changes in expression or phosphorylation. Conversely, phosphorylation 
of the AMPA receptor subunit GluA1 was increased in adult mice following alcohol 
consumption but reduced in adolescent mice. Finally, systemic administration of 
tianeptine, an atypical antidepressant that upregulates pGluA1 in a CaMKII-
dependent manner, increased alcohol consumption in adolescent mice but 
decreased alcohol consumption in adult mice.  Collectively, these experiments 
demonstrate that the adolescent and adult brains have noticeably different 
responses to alcohol consumption. The findings provide evidence that long-lasting 
alterations in synaptic plasticity may be responsible for the increased alcohol intake 
observed after adolescent exposure to alcohol. 
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CHAPTER ONE: INTRODUCTION 
Alcoholism 
 Alcoholism is a chronic neuropsychiatric disorder involving excessive 
consumption of alcohol leading to deficits in the patient’s social, personal and 
professional life. The Diagnostic and Statistical Manual of Mental Disorders 
maintained by the American Psychiatric Association lists 11 criteria for Alcohol Use 
Disorder (AUD), focusing primarily on excessive consumption of alcohol (1-4), 
persistence of excessive drinking despite negative consequences (5-8), and 
physiological effects of alcohol including blackouts, tolerance and withdrawal (9-11) 
[1]. Patients exhibiting two to three of the 11 criteria are classified as having mild 
AUD, patients with four to five are considered moderate, and patients with six or 
more criteria are designated severe.  Individuals suffering from alcoholism face 
many negative health risks, including withdrawal, seizures, memory loss, anxiety, 
depression, brain damage and death [2]. A key feature of alcohol addiction is 
increased salience of alcohol and related cues over non-drug aspects of life, leading 
to the neglect of career, social life and health [3, 4].  The alterations in alcohol cue 
responsivity may represent a unique challenge of alcohol addiction treatment, since 
unlike most other drugs of abuse alcohol is freely available for purchase throughout 
the United States and indeed has an important cultural and social role in societies 
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throughout the world.  Completely removing oneself from the influence of alcohol is 
very difficult in a culture that readily promotes its use.        
The prevalence of AUD in the United States is relatively high, with recent 
estimates at 15.1 million adults (6% of total population) and an additional 600,000 
youths (3% of total population) meeting the criteria for an AUD diagnosis [SAMHSA, 
5]. Globally, alcohol consumption is the fifth leading risk factor for premature death 
and disability [6], and contributes to more than 3 million deaths worldwide each year 
[WHO, 7]. The economic burden on American society is also significant; in 2010, 
excessive alcohol consumption resulted in nearly $290 billion in expenses across 
the U.S., and in the state of North Carolina alone over $7 billion [8].   
Despite the pressing public health consequences of excessive drinking, 
treatment options for patients with AUD remain limited and often ineffective. 
Currently, only three medications are FDA-approved to treat alcoholism 
(disulfiram/Antabuse, naltrexone/Trexan, and acamprosate/Campral), and all three 
medications have suffered from inconsistent clinical outcomes [9] and under-
prescription by physicians [10].   Outpatient treatment options, including individual 
therapy, substance abuse counseling and 12-Step programs such as Alcoholics 
Anonymous, have shown variable success rates, with some studies reporting 1–year 
sobriety levels of 30-60% [11-14], but other reports finding sobriety at 1–year follow 
up to be as low as 16-20% [15, 16]. Inpatient treatment centers have generally been 
found to produce similar results to outpatient treatment [17, 18].  There is an urgent 
need for improved therapeutic interventions for alcoholism, including more effective 
pharmacotherapies, better targeting of treatments to individual patients, and 
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preventative strategies to identify at-risk individuals and provide intervention before 
problem drinking develops.  
Use of Animal Models in Alcoholism Research 
 The consumption of alcohol is an endogenous behavior for several disparate 
species in addition to humans. Non-human primates have been observed to eat 
fermented fruit containing significant alcohol content (up to 5% by volume) in the wild 
[19]. Indeed, genetic sequencing suggests that a common ancestor of human and 
non-human primates began to display a more efficient form of alcohol 
dehydrogenaze 4 (ADH4), an enzyme responsible for alcohol metabolism, about 10 
million years ago [20]. This finding suggests evolutionary pressure favoring better 
metabolism of alcohol, which may be indicative of increased alcohol intake among 
primates at that time. Fruit flies are attracted to fermented fruit in a similar fashion 
and can achieve doses of alcohol that induce intoxication-like behavior under normal 
conditions [21].  Animal models of alcohol intake and dependence are therefore not 
far removed from the behavior of wild animals in their natural habitat.  Non-human 
primates and fruit flies have been used to model alcoholism and provided important 
insight into the behavioral and genetic underpinnings of alcohol consumption, 
respectively [22, 23]. Work in rodent models of alcoholism, however, provides more 
behavioral complexity than invertebrate models combined with a more efficient 
means to evaluate genetic and molecular underpinnings of addiction than models 
using relatively long-lived primates. These features have made rodent models of 
alcoholism attractive to researchers for decades.     
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Rodent Models of Alcoholism 
 Both rats and mice readily consume alcohol, although the amount of intake 
and degree of preference can vary wildly by strain. Notably, several inbred strains of 
rodents have been selected for both high and low alcohol intake. In rats, selective 
breeding has created five lines with increased alcohol intake and preference: 
ALKO/Alcohol (AA), alcohol-preferring (P), high alcohol-drinking (HAD-1 and HAD-
2), and Sardinian alcohol-preferring (sP), all of which have been used to model 
alcoholism and related behaviors. [24]. In mice, intake and preference of alcohol 
varies markedly across strain [25]. Notably, the inbred C57BL/6 strain displays high 
alcohol intake and preference [26].  These behavioral characteristics have made P 
rats and C57 mice attractive as models for alcoholism due to their ready self-
administration of alcohol under normal conditions. In particular, C57 mice can 
achieve intoxicating doses of alcohol through simple home-cage self-administration, 
with intake in excess of 20 g/kg per day and blood alcohol levels in excess of 100 
mg/dL [27].  C57 mice show strong motivation to consume alcohol, as evidenced by 
their willingness to work for access to alcohol solutions in operant self-administration 
procedures [28].  Finally, direct assessment of brain reward via intracranial self-
administration has demonstrated that alcohol potentiates brain stimulation reward in 
C57 mice [29]. Together, these findings demonstrate the appropriateness of mouse 
models for the rewarding and consumatory aspects of alcohol drinking behavior.   
 In addition to the positive, rewarding effects of the drug, an important 
behavioral feature of alcohol addiction is the tendency to relapse, or begin drinking 
again following a period of sobriety. Rodent models for relapse-like behavior have 
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made use of operant self-administration procedures to evaluate the degree of 
alcohol-seeking a rat or mouse engages in following a period of forced abstinence 
[30]. After training to lever press for the delivery of an alcohol solution, the subject is 
put through a series of extinction sessions to reduce or eliminate the operant 
responding. Following extinction, when rats and mice are exposed to an alcohol-
related cue (such as the scent of alcohol, a brief period of alcohol access, or the 
presentation of a neutral stimulus previously paired with alcohol), operant 
responding for alcohol has been reliably shown to reinstate, even in the absence of 
alcohol delivery in response to lever pressing. The reinstatement of operant 
responding for alcohol has been used as a model for relapse, and can reliably be 
produced through mechanisms known to promote relapse in human alcoholics, such 
as exposure to alcohol or alcohol-related cues and stress [31]. C57 mice also exhibit 
cue-induced reinstatement of alcohol responding in a manner comparable to work 
done in rat models [32, 33]  
 Finally, human alcoholics display important behavioral and physiological 
changes as a result of the disease, including anxiety, depression, anhedonia, 
tolerance and withdrawal [34].  Rodents also readily display tolerance and 
withdrawal after repeated exposure to alcohol.  Indeed, over time rats and mice that 
freely self-administer alcohol to the point of tolerance/withdrawal become dependent 
upon it in much the same way as human alcoholics do [35, 36].  Mouse models of 
chronic alcohol consumption and exposure have also demonstrated increases in 
anxiety-like and depressive behavior when deprived of alcohol [37, 38]. Thus, the 
important behavioral characteristics and many of the clinical features of alcoholism 
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can be accurately reflected in rodent models of alcohol intake.  
 
Neurobiology of Alcoholism 
 
 The use of both animal models and human participants has elucidated a 
broad range of neurotransmitter systems impacted by alcohol.  A small, lipid-soluble 
molecule, ethanol readily crosses the blood-brain barrier and can interact with a host 
of receptors, subcellular targets, and genetic materials [39]. These diverse effects 
complicate the process of identifying a neurobiological substrate responsible for the 
physiological and behavioral effects of alcohol in patients with AUD and animal 
models of alcoholism. 
GABA 
 γ-aminobutyric acid (GABA) is an inhibitory neurotransmitter that is critical in 
regulating synaptic activity throughout the mammalian brain. Alcohol serves as a 
positive allosteric modulator of GABA A receptors (GABAARs), and has been shown 
to enhance GABAAR activity at physiologically relevant concentrations as low as 3 
mM [40]. Animal models have demonstrated the importance of GABAARs for several 
properties of alcohol intoxication, including subjective effects [41], locomotor 
stimulation [42], sedation/hypnosis [43], and reward [44]. In human studies, genetic 
variation at the GABAA α2 subunit has been associated with increased risk for 
alcoholism [45, 46]. Whereas acute alcohol enhances GABA signaling in vivo, 
chronic exposure to alcohol has been shown to suppress GABA activity, reducing 
normal inhibitory neurotransmission in the absence of alcohol [47]. This suppression 
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may be related to some of the serious symptoms of alcohol withdrawal, including 
anxiety/depression and seizures. Further, brain imaging studies have identified 
alcohol activation of GABAAR as a target of alcohol’s acute and chronic effects in 
humans [48]. 
Monoamines 
 A common feature of natural reinforcers and nearly all drugs of abuse is their 
ability to potentiate the release of dopamine into the nucleus accumbens [49]. 
Alcohol has been shown to acutely enhance accumbal dopamine in rodents, 
primates and humans [50]. Further, animal models have shown that dopamine 
activity in the nucleus accumbens is required for the rewarding effects of alcohol 
[51]. Pharmacological inhibition [52] or systemic knockout [53] of dopamine 
receptors have both been shown to reduce alcohol intake in rodent models. In 
human populations, variations in the gene for the monoamine transporter catechol-
O-methyl transferase (COMT) have been associated with increased risk for 
alcoholism and alterations in the behavioral response to alcohol [54].  
 The serotonin signaling systems have also been shown to respond to the 
presence of alcohol and mediate some of the effects of alcohol exposure. In rodent 
models, acute and chronic alcohol have both been shown to alter activity of 
serotonin neurons in the dorsal raphe nucleus [55], a region which projects to many 
brain areas critical to alcohol reward and consumption, including the prefrontal 
cortex, nucleus accumbens and amygdala [56]. Genetic variations in the serotonin 
transporter gene SERT have been associated with increased risk for alcoholism in 
human populations [57].  In preclinical models, selective serotonin reuptake 
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inhibitors (SSRIs) have been shown to reduce alcohol intake in rodents [58] and 
non-human primates [59], although human trials have had difficulty replicating this 
reduction even in populations of alcoholics with comorbid depression [60].   
Endocannabinoids 
 The endocannabinoid signaling systems serve as retrograde regulators of 
neuronal activity. Activation of pre-synaptic CB1 or CB2 receptors by the 
postsynaptic release of the endogenous ligands anandamide (AEA) or 2-
arachidonoylglycerol (2-AG) reduces firing of the presynaptic cell.  Activity at CB1 
receptors has been shown to be involved in the rewarding effects of natural 
reinforcers such as food as well as the euphoria accompanying marijuana use [61]. 
Endocannabinoid signaling is also involved in alcohol reward; inhibition of the CB1 
receptor blunts alcohol intake and reduces alcohol preference, whereas activation of 
CB1 has been generally shown to enhance alcohol consumption [62]. In terms of the 
effects of alcohol on endocannabinoid signaling, acute alcohol has been shown to 
promote the release of endocannabinoids and potentiate CB1 signaling [63], 
whereas chronic alcohol appears to decrease CB1 receptor expression [64] as well 
as increase synthesis of AEA and 2-AG [65]. In human populations, decreases in 
CB1 receptor availability has been demonstrated in alcoholics [66] and variations in 
the CNR1 gene have been associated with increased risk for alcoholism [67]. 
Glutamate   
 Glutamate is the primary excitatory neurotransmitter in the mammalian CNS 
and plays a critical role in driving neurotransmission throughout the brain.  
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Glutamate activates multiple receptors with specific synaptic functions. Ionotropic N-
methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) and kainite receptors are expressed at the postsynaptic membrane; 
glutamate stimulation of these receptors results in direct opening of ion channels, 
allowing ingress of cations and facilitating depolarization of the postsynaptic neuron 
[68].  Metabotropic glutamate receptors indirectly open ion channels through the 
action of the βγ subunit of the coupled G protein [69], and can also exert a 
modulatory effect on synaptic transmission via the activation of second messenger 
signaling systems, leading to a diverse array of alterations in cellular activity. Group I 
metabotropic receptors (mGluR1 and mGluR5) are localized to the postsynaptic 
membrane; both receptors are Gαq coupled and therefore stimulate increases in 
cyclic adenosine monophosphate (cAMP) and associated activity within the cell [70]. 
Common downstream effects of cAMP stimulation include the activation of 
phospholipase C (PLC) and the subsequent synthesis of inositol triphosphate (IP3) 
and diacylglycerol (DAG), which in turn can alter genetic material, protein 
expression, and protein trafficking to the cell surface [71]. In contrast, Group II 
metabotropic glutamate receptors (mGluR2 and mGluR3) are located at the 
presynaptic membrane. These inhibitory Gi coupled proteins serve as autoreceptors, 
regulating the release of glutamate from the presynaptic membrane [72]. Stimulation 
of mGluR2/3 receptors results in decreased glutamate release and thus reduces the 
likelihood of a postsynaptic depolarization. The role of Group III metabotropic 
glutamate receptors in the brain (mGluR4, mGluR7 and mGluR8) is less well 
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characterized, but these receptors are also Gi coupled and may serve to regulate 
glutamate release in a manner similar to the Group II receptors [73].   
 Alcohol has been shown to directly impact the mammalian glutamate 
systems. Generally speaking, acute alcohol appears to increase extracellular 
glutamate in the rodent brain [74-77]. Chronic alcohol exposure also appears to 
upregulate the release of glutamate in limbic brain regions; Griffin and colleagues 
[78] found that mice exposed to chronic ethanol vapor exhibited twice the enhanced 
glutamate release in the nucleus accumbens following voluntary alcohol 
consumption as compared with water vapor controls. This enhancement of 
glutamate release was observed up to a week following alcohol drinking. Evidence 
from human populations also suggests that alcohol consumption is associated with 
alterations in glutamate signaling and function. Increased glutamate activity has 
been linked to alcohol craving in detoxified alcoholic patients [79] and alcohol 
withdrawal [80], and postmortem studies in the brains of AUD patients have 
indicated changes in metabotropic [81] and ionotropic [82] glutamate receptor 
expression and binding activity.  In non-alcoholic participants, low dose alcohol has 
been shown to suppress excitability of the prefrontal cortex [83]. These findings 
illustrate that the interactions between alcohol and the glutamate systems vary 
depending upon population, alcohol dose and brain region. Lastly, one of the few 
FDA-approved treatments for AUD is acamprosate, a drug that has been shown to 
alter glutamatergic synaptic transmission (although the precise mechanism of action 
remains unclear) [84].    
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Acute alcohol has been shown to interact with the metabotropic glutamate 
receptors. Alcohol inhibits Group I metabotropic glutamate receptors through a 
protein kinase C (PKC) dependent mechanism [85], and may also inhibit the activity 
of Group 2 metabotropic glutamate receptors [86]. Exposure to alcohol also alters 
the expression of metabotropic glutamate receptors; acute alcohol has been shown 
to upregulate mGluR5 [87] and chronic alcohol has been found to reduce mGluR2/3 
expression [86]. Evidence indicates that glutamate receptors can functionally 
regulate alcohol-associated behaviors. The metabotropic glutamate receptors have 
been shown to regulate a variety of behavioral responses to alcohol, including 
subjective effects [88], locomotor sedation [89], reinforcement [90], intake [91], and 
relapse-like behavior [92]. In general, inhibition of Group I metabotropic glutamate 
receptors has been found to reduce alcohol intake, whereas Group II/III 
metabotropic glutamate receptor agonists reduce alcohol intake and block alcohol 
discrimination, suggesting opposing roles for these receptor groups in the regulation 
of alcohol-associated behaviors [93]. mGluR1 antagonists specifically inhibit the 
alcohol-induced potentiation of dopamine release in the nucleus accumbens [94], 
which may be a mechanism by which mGluR1 activity modulates alcohol reward and 
alcohol drinking. The specific mechanism by which alcohol interacts with 
metabotropic glutamate receptors remains unclear, but the lack of evidence for 
direct binding of alcohol to metabotropic glutamate receptors suggests that alcohol 
exerts these effects upstream of mGluR activity.  
The ionotropic glutamate receptors have also been shown to be involved in 
the brain response to alcohol. In mice, in vivo recording from hippocampal slices has 
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shown that acute alcohol inhibits NMDA-mediated excitatory synaptic transmission 
[95]. Chronic alcohol has been found to increase the expression of NMDA receptors 
over time [96], leading to a “hyperexited” state that may be associated with seizures 
during alcohol withdrawal [97]. Chronic alcohol has also been found to alter the 
subunit composition of NMDA receptors [98], which has been independently 
associated with alterations in the sensitivity of the NMDA receptor to alcohol [99]. 
Findings from the postmortem brain tissue of human alcoholics have been mixed, 
with some reports indicating an increase in NMDA receptor expression and 
glutamate binding sensitivity [100] whereas others report decreases in both 
measures [101]. A functional role for NMDA receptor activity in alcohol drinking has 
also been established, as inhibition of NMDAR has been shown to reduce alcohol 
intake in rodent models of alcohol drinking [102]. 
The AMPA receptors have also been shown to respond to and regulate 
alcohol drinking. The specific mechanism by which alcohol interacts with AMPA 
receptors has not been conclusively established, although evidence suggests that 
alcohol may interfere with AMPA receptor desensitization [103]. Acute alcohol 
appears to suppress the activity of AMPA receptors [104, 105], but chronic alcohol 
exposure leads to an upregulation in the expression and activity of AMPARs, 
particularly in brain regions known to be involved in alcohol reward such as the 
prefrontal cortex [106], nucleus accumbens [107], dorsal striatum [108], amygdala 
[109-111] and ventral tegmental area [112]. Systemic enhancement of AMPAR 
activity increases self-administration of alcohol in P-rats [111], as does intra-
amygdala AMPA activation [113], whereas AMPAR antagonists have been shown to 
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reduce alcohol intake in mice [110].  Primate models of chronic alcohol self-
administration have also revealed alterations in AMPA receptor mRNA [114]. Human 
research has also indicated that alcoholism may be associated with changes in 
AMPA receptor expression, with divergent effects across different brain regions 
[115].    
Taken together, these findings indicate that glutamate signaling is a critical 
component of alcohol consumption and a potential contributor to AUD. It has been 
suggested that the transition from alcohol use to alcohol dependence and abuse is 
characterized by an imbalance in inhibitory and excitatory signaling in the 
mesocorticolimbic regions of the brain, resulting in a hyper-excitatory state that 
enhances motivation to consume alcohol. A proposed consequence of this 
enhanced glutamatergic activity in the alcoholic brain is the activation of 
glutamatergic synaptic plasticity in addiction-associated brain regions. 
 
Synaptic Plasticity in Alcohol Addiction 
 
Synaptic plasticity refers to the phenomenon by which repeated stimulation of 
neurons can lead to long-lasting changes in the strength of synaptic connections. 
Synapses can be strengthened or weakened through plastic mechanisms depending 
upon the type of input received by the postsynaptic neuron. Generally, high-
frequency stimulation has been shown to increase synaptic strength between the 
presynaptic and postsynaptic neuron. This process, better known as long-term 
potentiation (LTP), has been thought to underlie the ability of the brain to learn and 
form memories and has been most thoroughly characterized in the glutamatergic 
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neurons of the hippocampus. Electrophysiology has identified a decrease in the ratio 
of NMDA/AMPA receptors (generally reflecting an increase in AMPA receptors 
accompanied by no change in NMDA receptors) in the postsynaptic neuron as a key 
identifying feature of LTP. Evidence for LTP has also been observed in additional 
brain regions, including the prefrontal cortex [116], amygdala [117], nucleus 
accumbens [118] and ventral tegmental area [119]. Although these key changes are 
driven by alterations in glutamatergic signaling, many other neurotransmitters also 
contribute to LTP in the brain. Specifically within the cortex, both monoamines [120] 
and GABAergic receptors [121] are sensitive to plastic adaptation and functionally 
regulate the alterations in cellular activity seen after LTP. 
Long-term depression (LTD) is a related phenomenon that typically translates 
low-frequency stimulation into a reduction of synaptic strength. At the postsynaptic 
membrane, LTD is accompanied by reductions in the AMPA/NMDA receptor ratio as 
AMPA receptors are removed from the synapse [122]. In addition to alterations in 
glutamate receptor expression, LTD has also been shown to require activity in the 
endocannabinoid systems, which act as retrograde facilitators of LTD from the 
postsynaptic membrane to the presynaptic terminal [123], and alterations in the 
inhibitory GABAergic signaling systems [124].    
Molecular Mechanisms of Glutamatergic Synaptic Plasticity 
 Although glutamatergic synaptic plasticity could be broadly described as an 
increase in AMPA receptors at the postsynaptic membrane, there are a number of 
key molecular mediators that translate an initial high-frequency stimulus train into 
long-lasting changes at the dendrite. Endogenously, the initial stimulus to the 
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postsynaptic membrane takes the form of glutamate release, which activates NMDA 
receptors already present at the postsynaptic membrane. The opening of ionotropic 
NMDA receptors triggers an influx of cations, most notably Ca2+. Ca2 is a critical 
regulator of a vast array of cellular functions, including metabolism, receptor 
trafficking, gene expression and cell death [125]. One of the distinct effects of Ca2 
influx is the activation of calmodulin, a Ca2-binding protein that facilitates many of 
the intracellular effects of Ca2 [126]. Once calmodulin binds Ca2 and thereby 
becomes active, the critical enzyme Ca2/calmodulin-dependent kinase II (CaMKII) 
can be activated by the complex.  
CaMKII is a heterodimer composed of 6 α and 6 β subunits which exhibits the 
ability to engage in autophosphorylation, phosphorylating its own subunits 
perpetually upon activation until the enzyme is inactivated [127]. The ability to 
maintain initial phosphorylation over extended periods of time has led many 
investigators to conclude that CaMKII may be a physical representation of memory 
in the brain [128]. One of the important downstream effects of CaMKII activation is 
the phosphorylation of the GluA1 subunit of the AMPA receptor at serine 831 on the 
C-terminus, which increases the conductance of the receptor and is associated with 
trafficking of cytoplasmic AMPARs to the cell surface [129].  Enhanced 
phosphorylation of GluA1 is therefore a key component of the increased AMPA 
expression and activity observed at postsynaptic neurons exhibiting LTP. Several 
lines of evidence from in vivo and in vitro studies have established that CaMKII 
activation is both necessary and sufficient for LTP induction. Mutant mice with 
autophosphorylation-deficient CaMKII do not display LTP under normal stimulation 
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procedures and exhibit memory deficits in learning tasks [130]. Conversely, the 
introduction of autophosphorylated CaMKII into the hippocampus triggers LTP [131].   
 GluA1 phosphorylation is dynamically regulated by phosphatases that 
dephosphorylate the subunit to reduce conductance and remove AMPARs from the 
synaptic membrane. A key phosphatase involved in this process is calcineurin, or 
protein phosphatase 3 (PPP3). Like CaMKII, PPP3 is a calcium-sensitive enzyme 
that is activated upon Ca2 influx to the postsynaptic neuron [132].  Upon activation, 
PPP3 dephosphorylates GluA1 at Ser845, a site phosphorylated by cAMP-
dependent protein kinase (PKA) and associated with increased single-channel 
conductance, open probability, and insertion into the synaptic membrane (much like 
Ser831, the CaMKII phosphorylation site). Whereas phosphorylation of these sites 
by CaMKII/PKA is associated with LTP, dephosphorylation by PPP3 is associated 
with long-term depression (LTD), or a decrease in synaptic strength following an 
initial stimulus. Cell culture experiments with a PP2B peptide inhibitor demonstrated 
that PPP3 inhibition facilitates LTP [133], whereas overexpression of a constitutively 
active PPP3 inhibits LTP [134].    
Alcohol and Synaptic Plasticity 
 In addition to the body of work identifying NMDA and AMPA receptors as 
targets of alcohol’s action in the brain as previously discussed, direct evidence also 
implicates lasting changes in LTP and subcellular targets known to be involved in 
synaptic plasticity in the etiology of alcoholism.  CaMKII appears to be alcohol-
sensitive, mediate some behavioral responses to alcohol and be involved in the 
motivation to consume alcohol. Low-dose alcohol drinking has been shown to 
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increase α-CaMKII in the amygdala of male mice, and both CaMKII inhibitors and 
AMPAR antagonists microinjected into the amygdala reduced operant self-
administration of alcohol in mice [110]. In a genetic model of CaMKII 
autophosphorylation-deficient mice, alcohol drinking and locomotor stimulation in 
response to alcohol were both reduced, and DA and 5-HT release in response to 
alcohol were altered in the nucleus accumbens and prefrontal cortex, respectively 
[135]. The same model was found to reduce conditioned place preference for 
alcohol in subsequent experiments [136]. Finally, SNPs in the human CAMK2A gene 
have been associated with alcoholism in humans [135].   
 Although PPP3 has an important role in synaptic plasticity and interacts with 
GluA1 in a way that opposes the activity of CaMKII, very few experiments have 
investigated the effects of alcohol on PPP3 and vice versa. Observations from 
alcoholics who undergo liver transplantation for alcohol-induced liver disease have 
noted that rates of relapse to alcoholism following transplantation are low, and some 
have attributed these reductions in drinking to the anti-rejection medication 
cyclosporine A, a PPP3 inhibitor [137]. Two studies have assessed the effects of 
PPP3 inhibitors on alcohol drinking in mice, finding that PPP3 inhibition decreases 
alcohol drinking [138, 139]. The extent to which PPP3 is alcohol-sensitive, the brain 
regions responsible for the effects of systemic PPP3 inhibition on alcohol intake, and 
the specific neural mechanisms that mediate these effects remain to be investigated.   
A complexity in the relationship between alcohol and synaptic plasticity is the 
need to specify which synaptic inputs and neural circuits are being strengthened. In 
the prefrontal cortex, alcohol exposure appears to affect excitatory efferents with 
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input to downstream limbic regions involved in drug reward. Chronic alcohol 
exposure and repeated withdrawal has been shown to enhance the excitability of 
glutamate projection neurons in the PFC as well as increase the AMPA/NMDA ratio 
[106]. Recent work by Ma and colleagues [140] suggests that alcohol consumption 
potentiates synaptic strengthening of glutamatergic inputs from the PFC to the 
dorsal striatum via an AMPA-associated process, highlighting the importance of 
cortical regulation of limbic brain regions in the etiology of excessive alcohol 
consumption. In the amygdala, where some drug-associated efferents from the PFC 
terminate, chronic alcohol potentiates synaptic plasticity as indexed by an increase 
in the expression and activity of AMPA receptors [141].    
Vulnerability to Alcoholism 
 
The identification of factors that impart vulnerability to the development of an 
AUD is an important goal of alcoholism research.  Risk factors for alcoholism have 
the potential to aid in the determination of AUD liability in individual patients, point 
towards avenues for pharmacotherapeutic intervention, and suggest strategies for 
the prevention of AUDs in the general population.  To date, strong evidence 
supports a role for genetic, environmental, and developmental components of the 
composite risk for developing alcoholism over the lifespan.  
Results from twin studies suggest the heritability of AUD is approximately 
50% [142], and research on the descendants of alcoholics suggest that a genetic 
risk for alcoholism persists in the offspring of alcoholics even if they are not raised in 
an alcoholic household [143]. Several specific genetic polymorphisms have been 
linked to incidence of AUD, including the aldehyde dehydrogenase 2 gene [144] and 
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the α-2 subunit of the gamma-Aminobutyric acid (GABA) receptor  [45]. However, 
the contribution of such polymorphisms to overall alcoholism liability appears to be 
small (2% or less of the variance), indicating that genetic and environmental factors 
both contribute to the development of the disease.   
Environmental factors also contribute to the development of AUDs. Stress is 
well-characterized as a component of alcohol seeking and drinking behavior [145], 
and has been shown to increase alcohol intake in both alcoholics [146] and non-
alcoholics [147] as well as precipitate relapse in abstinent alcoholics [148]. 
Socioeconomic status [149] and culture [150] have also been shown to influence the 
development of AUDs.  
Finally, key developmental stages have been linked to the incidence of 
alcoholism over the lifespan. Prenatal exposure to alcohol can result in Fetal 
Alcoholism Spectrum Disorder (FASD), a condition characterized by a mosaic of 
physical and behavioral abnormalities including increased risk for alcohol addiction 
in adulthood [151]. Significantly, the vast majority of alcoholics initiate alcohol 
drinking during adolescence [152], and exposure to alcohol during this 
developmental stage is associated with much higher rates of lifetime AUD than 
exposure to alcohol during early adulthood [153].  These data make adolescence of 
particular interest in service of the overall aim of understanding and preventing the 
development of alcoholism.   
 
Adolescence 
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Adolescence is a developmental period that occurs as an organism matures 
from a juvenile into an adult. In humans, adolescence can be broadly defined as 
occupying the years between pubertal development and complete physiological 
maturity (including adult brain development), usually between the early teens and 
early twenties [154]. Adolescence is conserved across mammalian species such that 
adolescent-typical physiological development and behavioral characteristics can be 
observed in rodents, primates and humans [155]. Evolutionarily, adolescent 
behaviors serve a drive to leave the familial environment and explore new territory, 
seek social peers and sexual partners, and establish independence as an adult 
[156]. As such, key behavioral hallmarks of adolescence across species include 
novelty-seeking, impulsivity, risk tolerance, and heightened sensitivity to reward 
[157]. These traits position adolescence as a developmental stage ripe with both 
opportunity and danger. Adolescence is the typical age of onset for several 
psychiatric illnesses, including anxiety, depression and psychotic disorders [158, 
159]. Adolescents engage in risky behaviors such as dangerous driving, unprotected 
sex and drug use at higher rates than adults [160]. Rates of accidental death are 
highest for this age group, particularly for males [161]. These characteristics set 
adolescence apart as a distinct developmental period, as different from childhood 
and adulthood as those developmental periods are from one another.  
Taken together, these features provide insight into some of the specific 
challenges of the adolescent epoch in humans. With increased novelty-seeking, 
impulsivity, reward sensitivity and risk tolerance, the adolescent is poised to 
experience many new challenges and temptations. Although these characteristics 
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serve an evolutionary purpose to facilitate the transition away from the family unit 
and into an independent new environment, they also put adolescents at a 
disadvantage in their motivated behavioral decision making as compared with adults 
[162].  
Animal Models of Adolescence 
 
The conservation of adolescence across species facilitates the use of animal 
models to replicate key behavioral features of human adolescence for use in 
developmental neurobiology [163]. Behavioral procedures using rodent models have 
revealed strong similarity with the adolescent phenotype observed in humans. The 
increased propensity for novelty-seeking has been assessed in rodents with the 
novel objection recognition (NOR) task, in which the subject is presented with a 
novel object in the test environment and the amount of time spent 
investigating/interacting with the novel object is measured. Adolescent rats have 
consistently been shown to spend more time with a novel object than adults [164, 
165] and prefer interactions with the novel object to a greater extent than adult rats 
[166]. Adolescent mice have also been shown to spend more time exploring a novel 
environment than adults and to prefer the novel setting to a familiar one [167], which 
mirrors the novelty-seeking observed in human adolescents.  
Impulsivity can be assessed in rodents using an intolerance-to-delay (ID) task 
[168]. In this task, making a quick response results in a smaller reward (i.e. 1 food 
pellet), but delaying the response leads to a larger reward (i.e. 3-5 food pellets). 
Subjects that can withhold responding in favor of the larger reward in the future are 
interpreted to be less impulsive, and adolescent mice and rats have been found to 
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favor the immediate smaller reward over a future large reward (i.e. enhanced 
impulsivity) [169-171]. This behavior is reminiscent of human studies which have 
also showed diminished behavioral inhibition in human adolescents [172], as well as 
strong motivational salience of immediate rewards versus long-term payouts [173].  
Risk-taking behavior is a complex phenomenon and can be assessed through 
the interpretation of several different behavioral tasks. The degree to which a rodent 
explores the open arms of an elevated plus maze has been interpreted as an index 
of risk-tolerance [174],  and adolescent mice have been shown to more readily 
explore the open arm than adult mice [175]. This procedure may represent an 
animal correlate to the dangerous behaviors exhibited by adolescent humans that 
result in accidental injury or death [160]. Studies of risky decision-making in rats, 
wherein subjects have the choice between a certain but small reward and a larger 
but uncertain reward, have also demonstrated an increased tolerance to risk in 
adolescent versus adult rats  [176].  These findings are reminiscent of human data 
indicating that adolescents tend to favor larger rewards over smaller [177].  
Finally, increased sensitivity to reward is a feature of adolescence that can be 
directly assessed in rodents through self-administration of highly palatable foods and 
solutions. Adolescent mice display increased intake of sweetened solutions and 
foods, and show greater preference for these substances than their adult 
counterparts. Additionally, for adolescent rodents the presence of a peer is 
rewarding: adolescents spend more time with peers than adults [178, 179] and show 
stronger preference for social interaction than their adult counterparts [see 180 for 
review].  These same behaviors are a hallmark of adolescence in human 
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populations [181]. A related behavioral phenomenon of relevance to adolescent 
reward salience is aversion learning. Unlike the clear enhancement of reward 
sensitivity seen in adolescent rodents and humans, aversive stimuli appear to be 
less potent in adolescents than in adults. The conditioned taste aversion (CTA) task 
is a common method to assess aversion learning in rodents; a novel sweetened 
solution (conditioned stimulus) can be pared with an aversive injection of lithium 
chloride (unconditioned stimulus), and subsequent intake of the solution can be 
measured (conditioned response). Decreased intake following injection is interpreted 
as a measure of the aversion induced by the injection. Adolescent mice and rats 
have been shown to be less sensitive to CTA than their adult counterparts [182]. 
Taken together, the increased sensitivity to reward and decreased sensitivity to 
aversion exhibited by adolescents appears to drive increased behaviors directed 
towards obtaining rewards.    
Across a variety of behavioral domains, the characteristic features of 
adolescence in humans can be readily observed and quantified in rodent models. 
Both mice and rats have been found to display a discrete adolescent period between 
the juvenile and adult stage accompanied by increases in impulsivity, novelty-
seeking, risk taking and reward sensitivity. Although there are differences in the 
precise timing of the pubertal period and full maturation of the brain between mice 
and rats [163], both species clearly display the characteristic features of adolescent 
behavior. These features make rodent models ideal to address questions about the 
underlying neurobiology of adolescent brain development that cannot be ethically 
assessed in humans.   
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Neurobiology of Adolescent Brain Development 
The behavioral characteristics that define adolescence are reflective of 
changes in brain anatomy and function that occur during this developmental stage.  
Structural Maturation of the Adolescent Brain 
 Although the brain undergoes a legion of specific structural changes as it 
matures from childhood into adulthood, one of the defining features of the 
developing adolescent cortex is the phenomenon of neural pruning. From birth to 
childhood, the number of total neurons in the human cortex (as indexed by gray 
matter) increases in a linear fashion, reaching peak density between two and three 
years of age [183]. Beginning between ages six-ten and progressing well into the 
late twenties, notable decreases in cortical gray matter are observed in parallel with 
increases in white matter (reflective of myelinated processes) [184]. Similar 
decreases have been observed in rodent and primate models [185]. These changes 
have been shown to represent a process of synaptic refining, wherein some synaptic 
connections are pruned back whereas others are strengthened [186]. This process 
is dependent upon experience, prioritizing myelination of synapses with heavier 
traffic and pruning of neurons with inefficient pre- and post-synaptic connectivity 
[187]. Indeed, functional connectivity assessments in humans have revealed that 
increasing coordination between multiple brain regions is a defining feature of 
adolescent development [188, 189].  
 The process of structural maturation proceeds in an posterior-to-anterior 
fashion, with regions in the hindbrain and midbrain reaching structural maturity first 
whereas regions in the cortex lag behind [190]. The PFC is one of the last regions to 
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achieve structural maturity, continuing to develop into the second decade of life in 
some human MRI studies [191]. Importantly, limbic regions such as the amygdala 
and nucleus accumbens complete neural pruning well before the PFC has fully 
developed [192]. As the PFC exerts regulatory control over these downstream brain 
regions, a current theory of adolescent neurobehavioral development suggests that 
the immaturity of the PFC inhibits normal regulatory function over limbic brain areas, 
leading to adolescent-typical behaviors such as increased reward salience and risk-
taking [157]. In support of this hypothesis, recent neuroimaging data suggest that 
amygdala-prefrontal cortex connectivity undergoes a developmental “switch” during 
adolescence, shifting in valence from positive functional connectivity to negative 
functional connectivity during late childhood [193]. As this change was accompanied 
by a reduction in amygdala reactivity, it likely reflects frontal regulation of limbic 
regions becoming available as the cortex matures.   
Alterations in Neurotransmitter Signaling During Adolescent Brain Development  
 Virtually all major neurotransmitters have been shown to exhibit fluctuations in 
extracellular concentration and/or receptor density during adolescent brain 
development. Although the specific effects of these developmental alterations in 
neurotransmitter systems have not been concretely established, these processes 
suggest potential mechanisms that may underlie adolescent-typical behavior. 
Additionally, the same neurotransmitter systems can exhibit different developmental 
trajectories in different brain regions, complicating interpretation of these data. 
 Extensive research in animal models has indicated that GABA 
neurotransmission undergoes significant changes during adolescent brain 
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development. Between birth and adolescence, whole-brain GABA concentrations 
double in rodent models [194]. GABAA receptor density increases linearly during 
adolescence to reach adult levels in rats [195], whereas in non-human primates 
GABAA expression peaks during adolescence and then declines to achieve adult 
levels [196]. Importantly, age-related differences in the expression of GABAA 
subunits have also been reported and may be responsible for differences in 
GABAergic neurotransmission between adolescents and adults [197]. By contrast, 
work examining the effects of adolescence on GABA in the human brain has been 
limited. One MRS study has indicated that GABA levels in the anterior cingulate 
cortex of the frontal lobe were lower in adolescents versus adults [198]. Positron 
emission tomography (PET) has indicated that GABAA receptors reach adult density 
in subcortical regions during early adolescence, but do not achieve adult levels in 
the frontal cortex until the late teens [199]. These findings are generally consistent 
with overall trends reported in the rodent and primate literature to date. Lower levels 
of GABA during adolescence versus adulthood, particularly in the frontal cortex, 
have been hypothesized to represent a reduction in inhibitory control of limbic brain 
regions, and may therefore underlie some of the impulsive and risky behaviors 
associated with adolescence [198]. 
 Of the monoamines, most research in adolescents has focused on dopamine 
fluctuations during brain development, particularly in brain regions known to be 
involved in reward, learning and executive function. The expression of dopamine 
receptors D1 and D2 peaks during early adolescence in the striatum and nucleus 
accumbens, whereas D1 and D2 expression in the mPFC peaks during late 
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adolescence, with both areas experiencing a subsequent decline to adult expression 
[200]. Dopamine levels in the midbrain have repeatedly been found to peak during 
adolescence [201], a finding which may underlie the increased reward sensitivity 
exhibited by adolescent mammals. Importantly, during the transition to adulthood 
tonic dopamine increases in the PFC [202] whereas dopamine levels in the striatum 
decrease [203]. These alterations represent a shift from juvenile mesolimbic 
dopaminergic regulation of behavior (promoting emotional/reward-related behaviors) 
towards mature mesocortical dopaminergic prominence (top-down regulation of 
limbic regions) [204]. Dopaminergic regulation of neuronal excitation via modulation 
of GABAergic interneurons appears to be particularly sensitive to developmental 
state, with D2 receptor antagonists mildly inhibiting excitability of cortical slices 
during the prepubertal period but becoming strongly excitatory on slices from young 
adult rats [205]. Dopamine signaling may also play an important role in plastic 
alterations in adolescent synaptogenesis, as activation of D2 receptors alters spine 
density in adolescent but not adult mice [206]. Due to the strong association 
between dopamine and reward learning, many of these alterations in dopamine 
signaling have been hypothesized to play a role in the demonstrated increase in 
reward salience exhibited by adolescents. Indeed, the adolescent nucleus 
accumbens has been shown to exhibit markedly different dopamine responses to 
reward across multiple brain regions (see [207] for review.) 
 The endocannabinoid systems undergo dramatic reorganization during the 
adolescent developmental period, particularly in the prefrontal cortex. In the human 
PFC, mRNA for the cannabinoid receptor 1 (CB1) peaks during childhood and 
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remains elevated throughout early adolescence before decreasing to adult levels 
[208]. Similar decreases have been observed in rat mRNA and CB1 protein [209, 
210]. Concurrently, alterations in the endogenous ligands for the CB1 receptor 
(anadamide and 2- arachidonoylglycerol) are exhibited by adolescent rodents [211, 
212]. Activation of the CB1 receptor suppresses neuronal firing via retrograde 
neurotransmission; thus, increased cortical CB1 expression and activity has been 
hypothesized to contribute to the hypofunction of the adolescent PFC [210]. Recent 
work has established a functional role for CB1 activity in several adolescent-typical 
behaviors. In rats, enhancement of CB1 activity in adults through a gain-of-function 
mutation increased risk taking, peer interaction, and reward sensitivity for natural 
and drug reinforcers [213]. Additionally, polymorphisms in the human CNR1 gene 
(which encodes the CB1 receptor) have been associated with impulsivity in 
adolescents [214].       
 Current understanding of synaptic plasticity strongly suggests a role for this 
process in the maturation of the adolescent brain [215], implicating changes in the 
glutamate signaling systems as important contributors to adolescent brain 
development and behavior. In rodents, glutamate activity steadily increases from 
birth, with a peak during adolescence and a subsequent decline into adult levels 
[216]. Expression of the NMDA receptor increases during the pubertal period and 
begins to decrease to adult levels at the start of the adolescence [217]. There are 
also dramatic ontogenetic shifts in the relative expression of the constitutive NMDAR 
subunits; GluN2B expression predominates at birth but gradually decreases across 
adolescence to reach adult levels, whereas NR2A levels are low at birth and reach 
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adult levels during early adolescence [218]. Cortical AMPA receptors are similarly 
regulated by age, with peak expression achieved in early adolescence followed by a 
decline to adult levels [219]. The AMPA receptor may also play a functional role in 
adolescent development of executive function. Overexpression of calcyon, an AMPA 
accessory protein that facilitates internalization of the AMPA receptor, produced 
learning and memory deficits only during the adolescent critical period [220]. 
Developmental increases in critical glutamate signaling molecules such as CaMKIIα 
have also been observed, with expression increasing during the immediate postnatal 
period and levels stabilizing only in adulthood [221]. Metabotropic glutamate 
receptors have received limited investigation  in the context of adolescent brain 
development, but one previous report indicates that Type I mGluRs may have 
different impacts on LTD in the hippocampus during the early postnatal, adolescent 
and adult development epochs [222]. In primates, the density of excitatory dendritic 
spines in the PFC increases during postnatal development and stabilizes until 
adolescence, after which spine density decreases to adult levels [185]. In the human 
cortex, neural pruning appears to selectively target excitatory projection neurons, the 
loss of which accounts for 40% of the reduction in synapses observed during the 
adolescent development period [187, 223]. These varied alterations in glutamate 
receptor expression and function indicate that adolescence is accompanied by 
substantial shifts in excitatory neurotransmission, a process likely guided by synaptic 
plasticity in key brain regions such as a prefrontal cortex.    
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Alcohol Use During Adolescence  
 
 The initiation of drug use, including alcohol, during adolescence is a defining 
feature of neurobehavioral development in humans. This peak of interest in drugs of 
abuse has been replicated in animal models; human, non-human primate and rodent 
[224] adolescents have been shown to self-administer more alcohol (and most other 
drugs of abuse) than adults when intake is adjusted for differences in body weight. 
Adolescent exposure to alcohol also appears to be uniquely dangerous, with 
initiation of alcohol use during the early adolescent period associated with an 
approximately 35% increase in lifetime risk for the development of an AUD [225]. 
Unfortunately, alcohol use is ubiquitous amongst adolescents in the United States, 
with more than half of 12th-grade students reporting the consumption of intoxicating 
doses of alcohol within the past two weeks [226].  Although the specific 
neurobiological mechanisms that may be responsible for both increased alcohol 
intake during adolescence and long-term consequences of adolescent alcohol 
exposure remain unclear, insight from animal studies has indicated several potential 
explanations for these phenotypes. 
Behavioral Mechanisms 
 A wealth of literature indicates that adolescents display altered sensitivity to 
many of the acute/intoxicating effects of alcohol. In rodent models, adolescents 
exhibit blunted sensitivity to the sedating/hypnotic effects of alcohol [227], locomotor 
deficits following an intoxicating dose of alcohol [228], conditioned taste aversion to 
alcohol [229, 230], social impairment from high-dose alcohol [231], and anxiety 
exhibited during withdrawal from high-dose alcohol [232]. However, adolescent 
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rodents display enhanced sensitivity to the social facilitation induced by low-
moderate dose alcohol [233] and the reinforcing properties of alcohol [234]. Taken 
together, these findings suggest a pattern of enhanced sensitivity to the rewarding 
effects of alcohol and reduced sensitivity to the aversive effects of alcohol [235].  
Adolescent rats are also less sensitive to the interoceptive properties of alcohol, 
requiring higher doses than adults for alcohol to serve as a discriminative stimulus 
[236]. Many of these same age differences in the behavioral response to alcohol 
have been observed in human adolescents, most notably diminished sensitivity to 
the locomotor impairing effects of alcohol [237] and heightened sensitivity to the 
stimulating [238] and social facilitating effects of alcohol [239]. This mosaic of 
increased and decreased sensitivity results in adolescents who experience the 
rewarding properties of alcohol more strongly, the aversive consequences less 
harshly, and have difficulty assessing their level of intoxication relative to adults. The 
biological underpinnings of this behavioral phenotype have not yet been definitively 
identified. 
 Age-Related Changes in Dopamine 
 Due to the central role dopamine signaling plays in reward learning, and more 
specifically alcohol reward, and the significant changes the dopamine systems 
undergo during adolescence, the potential for dopamine to mediate age-related 
changes in alcohol behavior has received considerable investigation. During 
adolescence, experimenter-administered alcohol induces greater dopamine release 
in the nucleus accumbens of adolescent rats as compared to adult rats [240]. 
Adolescent alcohol exposure has also been shown to lead to long-lasting increases 
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in basal dopamine [241] and alcohol-evoked dopamine release in the adult nucleus 
accumbens [242], . Similarly, adolescent alcohol has been shown to reduce D1 
receptor modulation of neuronal activity in the adult mPFC [243]. Evidence also 
suggests a role for dopamine signaling in regulating the adolescent response to 
drugs of abuse, including alcohol. Overexpression of the dopamine D1 receptor in 
projection neurons of the PFC created adolescent-typical behaviors in adult rats, 
including heightened place preferences for low dose alcohol [244]. D1 receptor 
inhibition in the PFC also reduces the motivational salience of cocaine cues [245]. In 
human participants, the gene for the dopamine D2 receptor (DRD2) has been 
associated with elevated risk for alcoholism in adolescent populations [246]. 
Together, these findings indicate a role for dopaminergic signaling in some of the 
age-related differences in behavioral and brain response to drugs of abuse, 
including alcohol.       
Role of Other Neurotransmitter Systems in Adolescent Alcohol Use 
 A complete review of the interactions between neurotransmission in the 
developing brain and the impact of alcohol on the adolescent is beyond the scope of 
the present work. However, the potential for age X dose interactions during 
adolescence is high, due to the nature of alcohol (a small molecule capable of 
interacting with a wealth of signaling targets) and the nature of the adolescent brain 
(an organ in a state of dramatic flux, impacting virtually all neurotransmitter systems 
to varying degrees.) Thus, good evidence also implicates GABA [197], serotonin 
[247] and endocannabinoid [248] signaling in the adolescent response to alcohol. 
Importantly, one of the most prominent unanswered questions with respect to 
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adolescence and alcohol remains the mechanism by which adolescent exposure to 
alcohol can impart such high risk for problem drinking later in life. The current state 
of the field would seem to indicate that most brain signaling systems contribute to 
this elevated risk in some way. However, a unifying theme for some of the acute 
responses to alcohol described above may be the degree to which they impact long-
term changes in brain structure and function.   
 
Synaptic Plasticity: A Link between Adolescence and Alcoholism 
 
 Synaptic plasticity is a critical component of adolescent brain development, 
playing a role in synaptic strengthening and synaptic pruning. Mechanisms of LTP 
have also been shown to be sensitive to disruption by alcohol, and to mediate some 
of the consequences of alcohol exposure. However, the degree to which molecular 
changes in the receptors and subcellular proteins that mediate synaptic plasticity are 
involved in the adolescent response to alcohol, and more importantly the enduring 
changes in the adolescent brain imposed by alcohol, has received relatively limited 
investigation to date.  
 Several experiments using rodent models have indicated that alcohol 
selectively alters glutamatergic signaling in adolescents. Repeated administration of 
alcohol downregulates the expression of the GluN2B subunit of the NMDA receptor 
in the adolescent but not adult PFC [240]. Santerre and colleagues [219] 
demonstrated that low-dose alcohol (1 g/kg) increased GluA2 phosphorylation in the 
adult hippocampus but reduced pGluA2 in the adolescent hippocampus, suggesting 
that alcohol may exert opposing effects on AMPA receptors in adolescent and adult 
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rats. The same group has also produced evidence for age differences in the 
expression and alcohol sensitivity of PKC, a regulator of AMPA receptor 
phosphorylation and mediator of synaptic plasticity [249]. In contrast, in the nucleus 
accumbens adolescent rats appear to be relatively insensitive to alcohol-induced 
changes in the expression of mGluR1, mGluR5, GluN2B, PKC and CaMKII [250] 
exhibited by adults. Another subcellular mediator of synaptic plasticity is extracellular 
signal-regulated kinase 1/2 (ERK1/2), which is a critical component of a signaling 
cascade known to be involved in plasticity and alcohol reward [251]. Adolescents 
have been shown to display greater expression of ERK1/2, and ERK1/2 is more 
sensitive to alcohol-induced phosphorylation changes in the adolescent 
hippocampus and amygdala versus adult [252]. Evidence also suggests that 
adolescent rats may be more sensitive than adults to alcohol-induced suppression of 
LTP in the hippocampus [253].   
Evidence from human studies also indicates a role for alterations in 
glutamatergic signaling during adolescence in increased risk for problem drinking 
and AUDs across the lifespan. Elevated hippocampal glutamate levels have been 
associated with risky alcohol drinking in non-dependent adolescents [254], and 
adolescent-typical changes in glutamate/glutamine ratios have been shown to be 
altered in individuals with a family history of alcoholism [255]. Conversely, 
adolescent drinking to the point of blackout has also been associated with reductions 
in glutamate levels in the frontal cortex [256].Genome-wide association studies 
(GWAS) have also linked alcoholism to Glun2a polymorphisms [257], which have 
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independently been associated with risky drinking during adolescence and a family 
history of alcoholism [258].  
Findings from both preclinical animal models and assessments of adolescent 
drinkers point to mechanisms of glutamatergic plasticity being responsive to alcohol 
and involved in adolescent alcohol-related behavior. These observations lead to the 
hypothesis that age-related changes in synaptic plasticity during adolescent brain 
development would be sensitive to alcohol and functionally involved in the increased 
risk for escalated alcohol consumption following adolescent alcohol exposure.  
Rationale 
 
 The experiments in this dissertation were aimed at three complementary 
goals: 
 1) To characterize the developmental trajectory of the adolescent brain both at 
baseline and under the influence of alcohol drinking 
2) To determine the relative contributions of two key synaptic plasticity enzymes, 
CaMKII and PPP3R1, to alcohol drinking in adolescent and adult mice. These 
experiments focused on two key brain regions: the prefrontal cortex, for its role in the 
regulation of adolescent behavior, and the amygdala, for its role in alcohol reward 
and reinforcement. Initially, an unbiased proteomics screen of the adolescent and 
adult PFC revealed substantial developmental differences in this brain region, with 
major changes in the expression of proteins known to regulate synaptic plasticity. A 
subsequent proteomics experiment comparing the effects of alcohol or water 
drinking independently in adolescent and adult mice demonstrated that several of 
the developmentally-regulated proteins were alcohol-sensitive, illustrating the 
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qualitatively different responses of the adolescent and adult PFC to alcohol. The 
protein phosphatase calcineurin (PPP3R1) was chosen for functional evaluation in 
adolescent and adult alcohol drinking behavior because it was both subject to 
developmental regulation and alcohol-sensitive. Systemic calcineurin inhibition 
reduced alcohol drinking more potently in adolescent versus adult mice. Next, a 
model of adolescent alcohol exposure and subsequent operant self-administration in 
adulthood was developed in order to assess the role of PPP3R1 signaling in long-
term vulnerability to alcoholism following adolescent drinking. The role of the PFC in 
mediating these effects was assessed using site-directed inhibition of PPP3R1 in 
adult mice that had been exposed to either alcohol or water during adolescence. To 
examine the downstream brain regions that are regulated by the PFC and involved 
in alcohol reinforcement, the amygdala, dorsal striatum and nucleus accumbens 
were assessed for alterations in plasticity-associated proteins. Age differences 
emerged in the amygdala, with CaMKII phosphorylation reduced in the adolescent 
but not adult amygdala accompanied by increased pGluA1 in the adult but not 
adolescent amygdala. Finally, systemic potentiation of CaMKII-pGluA1 activity was 
used to assess the effects of global alterations of synaptic plasticity on adolescent 
and adult drinking behavior.   
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CHAPTER TWO: COMPARISON OF THE ADOLESCENT AND ADULT 
PREFRONTAL CORTEX PROTEOME1 
Introduction 
 Adolescence is a critical developmental period during which organisms make 
the transition from childhood to adulthood. This time period is characterized by 
significant changes in brain architecture [1], pubertal development and sexual 
maturity, and several unique behavioral characteristics, including increases in risk-
taking, sociability, novelty-seeking, reward sensitivity and impulsivity [2]. Both the 
physical and behavioral manifestations of adolescence are conserved across 
mammalian species, facilitating the use of rodent models in the study of adolescent 
development [3]. Adolescence is also a potentially vulnerable time, associated with 
increased rates of alcohol and drug use, risky sexual practices, and reckless driving 
[4]. Additionally, adolescence in humans and rodents is an epoch of heightened 
stress, characterized by increases in anxiety- like behavior as well as enhanced 
sensitivity of the hypothalamic-pituitary-adrenal axis (HPA axis) response to 
stressors [5]. Importantly, adolescence is the typical time of onset of many 
neurological and psychiatric conditions, including epilepsy, neurodegenerative 
disorders and neuromuscular dysfunction [6] as well as anxiety, impulse-control, 
substance use, schizophrenia and mood disorders [7]. In spite of widespread
                                                          
1 This chapter previously appeared as an article in PLoS ONE. The original citation is as follows: 
Agoglia AE, Holstein SE, Small AT, Spanos M, Burrus BM, Hodge CW (2017). Comparison of the 
adolescent and adult prefrontal cortex proteome. PLoS ONE, 12(6): e0178391.   
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recognition of the adaptive and maladaptive changes associated with adolescence, 
the specific neuronal mechanisms that usher the brain into adult maturity (and 
potentially mediate both behavior and dysfunction) remain unclear.  
During adolescence, the brain undergoes substantial structural and functional 
alteration. Of considerable significance is the decline of cortical gray matter, which 
usually begins in late childhood/early adolescence [8] and may be driven by both 
synaptic pruning [9] and enhanced myelination of existing axons [10]. Notably, loss 
of gray matter density follows an anterior-to-posterior trajectory, with maturation 
occurring first in sensorimotor areas and last in higher-order regions such as the 
prefrontal cortex (PFC) [11]. The PFC is functionally involved in the executive control 
of behavior and decision-making processes [12], and the relative immaturity of the 
adolescent PFC is associated with lack of inhibitory control over behavior exhibited 
by adolescents [13, 14]. At the same time, limbic brain areas associated with 
emotional arousal and reward, such as the amygdala and nucleus accumbens, 
reach maturity earlier than cortical regions and receive fewer neural projections from 
the immature PFC [15], resulting in an imbalance in top-down control of limbic 
regions and greater reward seeking and impulsive behavior in adolescents [16]. The 
PFC is therefore both a site of significant neuronal development during adolescence 
and a potential contributor to adolescent behavioral phenotypes.  
Previous reports have begun to characterize the development of the PFC 
proteome from birth to adulthood [17-20], but several important questions have not 
been addressed by the existing literature. The specific alterations of protein 
expression and network function during adolescence remain unclear, due to the 
 
 
70 
 
combination of pre-adolescent and adolescent data for comparison with adults in 
prior studies. Further, the majority of findings in the developing PFC to date have 
focused on the synaptic fraction of proteins. Although this strategy brings important 
insight into the development of synaptic connections and signaling during brain 
development, proteins that are expressed outside of the membrane fraction may 
play an important role in the maturation of the adolescent cortex.  Additionally, some 
studies have failed to distinguish between the subregions of the PFC collected for 
analysis. The prelimbic and infralimbic PFC have different projections and different 
functional roles in behavior and therefore may be subject to different developmental 
processes during the adolescent period [21]. Finally, previous reports have focused 
exclusively on the expression of proteins in the PFC, creating uncertainty as to 
whether the observed protein expression differences in the PFC are unique to that 
region or part of a general developmental trend across multiple brain regions.  
To investigate the subcellular machinery involved in adolescent brain 
development and behavior, we used a high-throughput unbiased proteomics 
analysis to characterize age differences in protein expression between adolescent 
and adult male C57BL/6J mice. Mice have a defined period of adolescence 
(approximately 2 weeks) in which they display “adolescent typical” behavior, such as 
impulsivity and novelty seeking [22], and were therefore a useful model for these 
studies. We chose to focus on the transition from early- to mid-adolescence in order 
to capture a snapshot of the adolescent brain midway through maturation to 
adulthood, and therefore collected tissue on post-natal day (PND) 36 [23]. We 
focused on the prelimbic medial prefrontal cortex (mPFC) as this region is critically 
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involved in executive control of behavior and sends projections to the amygdala and 
nucleus accumbens [24]. We also used a bioinformatics approach to identify protein 
networks that may play a role in adolescent brain development, particularly 
neurochemical signaling and structural alterations. By identifying proteins that are 
differentially expressed in the adult and adolescent mouse mPFC, as well as 
additional brain regions of interest, these experiments give insight into cellular 
correlates of adolescent-typical behaviors and dysfunctions.  
Materials and Methods 
Subjects 
All procedures were performed in accordance with the NIH Guide to the Care 
and Use of Laboratory Animals [25] and approved by the Internal Review Board as 
compliant with all institutional guidelines at the University of North Carolina, Chapel 
Hill (approved protocol number: 13-217).  
Proteomic analysis 
Adolescent (postnatal day 21 [PND21]) and adult (PND65 ± 3) male 
C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME) were pair-housed upon 
arrival in standard laboratory cages with corn-cob bedding and a small PVC tube for 
environmental enrichment. Food and water were available ad libitum for the duration 
of the experiment. Subjects were minimally handled throughout the experiment to 
minimize stress. 
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Immunoblotting 
 An additional group of adolescent (PND 21) and adult (PND 65 ± 3) male 
C57BL/6J mice (Jackson) were housed and handled under identical conditions to 
the proteomics cohort in order to confirm expression changes observed in the 
proteomics experiments using Western blots. 
Proteomic analysis 
Adolescent and adult mouse mPFC proteomes were analyzed utilizing 2-
Dimentional in-gel electrophoresis  (2D-DIGE) for protein expression profiling, 
DeCyder software for selection of significantly altered spots, and matrix-assisted 
laser desorption/ionization-Time of Flight (MALDI-TOF) mass spectrometry (MS) for 
protein identification (Fig 1 D) [26]. 
Tissue collection  
Fifteen days after arrival (Fig 1A), 12 adolescent (P36) and 12 adult (P80  3) 
mice were weighed and deeply anesthetized with sodium pentobarbital (150 mg/kg, 
IP). Once anesthetized, mice were transcardially perfused with ice-cold phosphate-
buffered saline (PBS, 0.1M, pH 7.4) for 2 min at rate of 3 ml/min in order to remove 
blood from the brain tissue. The brain was then quickly isolated and flash-frozen in 
isopentane (2-methylbutane; Sigma-Aldrich, St. Louis, MO) at -20 – -30°C for 1 min, 
weighed, and stored at -80°C. To isolate the mPFC, tissue was sliced coronally on a 
cryostat (Leica CM3050S, Leica Biosystems, Buffalo Grove, IL), with a 0.5 mm 
tissue slice being taken between +1.5-2.0 mm (± 0.2) anterior to Bregma. The mPFC 
was dissected out bilaterally using a 1.0 mm tissue punch (Fig 1C). The isolated 
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tissue included the prelimbic and dorsal infralimbic cortices, as well as the posterior 
anterior cingulate cortex. Tissue was pooled from n=3 mice per age group resulting 
in a final group size of N=4 adolescent and N =4 adult mPFC samples for analysis 
on 4 replicate 2D gels. Protein samples were kept at -80°C and shipped to Applied 
Biomics (Hayward, CA) for 2-D DIGE analysis. 
Tissue preparation  
Tissue samples were sonicated on ice in 2D lysis buffer (2 M thiourea, 7 M 
urea, 4% CHAPS, 30 mM Tris-HCl, pH 8.8) and shaken for 30 min at room 
temperature. Samples were then spun at 14000 rpm at 4°C for 30 min, and the 
resulting supernatant was collected. Protein concentrations were determined using 
the Bio-Rad protein assay method (Hercules, CA), and samples were diluted to 5 
mg/ml in 2-D lysis buffer. 
CyDye labeling 
Adult and adolescent tissue samples (30 μg) were combined within age group 
with 1.0 μl of the appropriate diluted CyDye (Cy2, Cy3, or Cy5; 1:5 concentration, 
diluted with dimethylformamide (DMF) from a 1 nmol/μl stock), vortexed, and kept on 
ice for 30 min in the dark. Afterwards, 1.0 μl of 10 mM Lysine was added to each 
sample, vortexed, and incubated on ice for 15 min in the dark. The CyDye-labeled 
samples (Cy2, Cy3, Cy5) for each age group were then combined and mixed with a 
2X 2-D sample buffer (8 M urea, 4% CHAPS, 20 mg/ml dithiothreitol, 2% 
pharmalytes, trace amount of bromophenol blue) and 100 μl of Destreak Solution 
and Rehydration Buffer (7 M urea, 2 M thiourea, 4% CHAPS, 20 mg/ml DTT, 1% 
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pharmalytes, trace amount of bormophenol blue) to a final volume of 350 μl for the 
18 cm IPG strip. Labeled samples were mixed well and spun before loading into the 
strip holder. 
2D-DIGE  
Following loading of samples into the 18 cm IPG strip holder, the strip was 
placed facing down and 1.5 ml mineral oil was added to the top of the strip. Samples 
were then run using isoelectric focusing (IEF) under dark conditions at 20°C using 
an established protocol (GE Healthcare, Pittsburgh, PA). Following IEF, the IPG 
strips were incubated in fresh equilibration buffer 1 (50 mM Tris-HCl, pH 8.8, 
containing 6 M urea, 30% glycerol, 2% SDS, trace amount of bromophenol blue, 10 
mM DTT) for 15 min with gentle shaking. Strips were then washed in fresh 
equilibration buffer 2 (50 mM Tris-HCl, pH 8.8, containing 6 M urea, 30% glycerol, 
2% SDS, trace amount of bromophenol blue, and 45 mg/ml lodacetamide) for 10 min 
with gentle shaking. IPG strips were then washed and transferred to a 12% SDS gel 
(prepared using low fluorescent glass plates) and sealed with 0.5% w/v agarose 
solution in SDS-gel running buffer. Gels were run at 15°C. 
Image scan and data analysis  
Immediately following the SDS-PAGE portion of the 2D-DIGE experiment, 
image scans were conducted using a Typhoon TRIO imager (GEHealthcare). 
Scanned images were analyzed by ImageQuantTL (IQTL) software (GE Healthcare) 
and subjected to both in-gel and cross-gel analyses using the DeCyder software 
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package (v. 6.5, GE Healthcare), which provided a ratio change of protein 
expression from the in-gel analyses.  
Spot picking and trypsin digestion 
Protein spots that met our a priori spot-picking criteria (differential expression 
in the same direction in all four gels, an overall significant difference in expression 
[p<0.05], and a 1.2-fold change or greater increase or decrease in expression) were 
isolated by the Ettan Spot Picker (GE Healthcare) (Fig 1D). Gel spots were washed 
and digested in-gel with a modified porcine trypsin protease (Trypsin Gold, 
Promega, Madison, WI). Digested peptides were desalted (Zip-tip C18 column, 
Millipore, Billerica, MA) and eluted with 0.5 μl of matrix solution (α-cyano-4-
hydroxycinnamic acid, 5 mg/ml in 50% acetonitrile, 0.1% trifluoroacetic acid, 25 mM 
ammonium bicarbonate) and spotted on the matrix-assisted laser 
desorption/ionization (MALDI) plate. 
Mass spectrometry 
Both MALDI-TOF (time-of-flight) mass spectrometry (MS) and TOF/TOF 
(tandem MS/MS) analyses were performed on a 5800 mass spectrometer (AB 
Sciex, Redwood City, CA). Mass spectra from the MALDI-TOF analysis were 
acquired in reflectron positive ion mode (average of 2000 laser shots/spectrum), 
whereas the TOF/TOF tandem MS fragmentation spectra were acquired for each 
sample (average of 2000 laser shots/fragementation spectrum) on each of the 10 
most abundant ions present in the sample (with the exclusion of trypsin autolytic 
peptides and other background ions) 
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Database search  
Resulting peptide masses and fragmentation spectra were submitted to GPS 
Explorer (v. 3.5) with the MASCOT search engine (Matrix Science, Boston, MA) in 
order to explore the database of the National Center for Biotechnology Information 
non-redundant (NCBInr). Searches were not constrained by protein molecular 
weight or isoelectric point; additionally, the search allowed for variable 
carbamidomethylation of cysteine and oxidation of methionine residues, and one 
missed cleavage was allowed in the search parameters. Both ion score (statistical 
likelihood that a peptide sequence experimentally observed and identified in the 
MASCOT database are matched based on random chance [-Log10P]) and protein 
score (sum of the highest ion scores for each sequence) were calculated; increased 
protein score indicates increased confidence in the identification of the protein. 
Candidate proteins with a protein score confidence interval greater than 95% were 
considered significant. For samples with multiple candidate proteins exceeding the 
identification criteria, an identity was assigned based on the highest protein score.  
Full identification data, including all candidate proteins for each spot, are available 
on the open access proteomics data repository ProteomeXchange 
(www.proteomexchange.org). 
Bioinformatics 
Protein identifiers, fold-change, and p-values from the proteomic analysis 
were uploaded to QIAGEN’s Ingenuity Pathway Analysis (IPA; QIAGEN Redwood 
City, CA) system for dataset enrichment. A Core Analysis was performed on the 
dataset, using the following parameters: reference set- Ingenuity Knowledge Base 
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(genes only), relationships- direct and indirect, networks- interaction, data sources- 
all, confidence- experimentally observed, species- mouse, tissues and cells lines- 
nervous system/CNS cell lines. Proteins were assessed via Global Functional 
Analysis (GFA) and Global Canonical Pathways (GCP) to identify functional protein 
networks and canonical signaling systems that were impacted by developmental 
state. Statistical significance of the predicted functions and pathways was 
determined using the right-tailed Fisher’s Exact Test, where significance indicates 
that an identified set of proteins is overrepresented in a set of proteins with known 
function and is interpreted to indicate altered function in the experimental set.  
Protein interaction networks were derived via Ingenuity’s interconnectivity 
algorithm. p values, representing the probability of finding proteins identified in the 
proteomics analysis (Focus Molecules) in a set of n genes randomly selected from 
the Global Molecular Network, were calculated using Fisher’s Exact Test and 
displayed as p-scores [p-score = -log10 (p-value); i.e. p-score indicates the exponent 
of the significance of the protein network identification].  Ingenuity Pathway Designer 
(QIAGEN) was used to visualize the statistically significant protein interaction 
networks revealed by GFA.  
Immunoblotting: mPFC confirmations and additional brain regions 
Tissue collection 
Brain tissue was collected from adolescent (P36) and adult (P80  3) 
[n=12/age] as described above. In addition to the mPFC as described, the dorsal 
striatum (dSTR), nucleus accumbens (NAc), primary motor cortex (MC), amygdala 
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(AMY) and ventral tegmental area (VTA) were isolated and dissected to analyze 
protein changes in additional brain areas with relevance to adolescent behavior. The 
coordinates for each region (relative to Bregma) were: +1.0-1.5 mm (± 0.2) for 
dSTR, NAc and M1, -0.9-1.4 mm (± 0.2) for AMY and -3.3-3.8 mm (± 0.2) for VTA. 
Following dissection of regions of interest, tissue punches were homogenized 
by pulse sonication (4 s) in 10 mM Tris (pH 7.4 at 23°C) with 1% w/v SDS and 1:100 
Halt EDTA-free Protease and Phosphatase Inhibitor Cocktail (Pierce, ThermoFisher 
Scientific, Rockford, IL).  Brain tissue was stored at -80°C. The Pierce BCA kit 
(ThermoFisher Scientific) was used to determine protein concentrations (µg/ µL) of 
each tissue sample.  
Immunoblots 
Protein samples from each brain region, at 5 µg per sample, were run on a 
TGX 4-15% 18-well gel (BioRad) with 1x tris-glycine-SDS running buffer (Tris 25 
mM, Glycine 192 mM, 0.1%SDS) with Protein Plus Dual Color (Bio-Rad) and See 
Blue ladders (ThermoFisher Scientific) and dry-transferred onto a PDVF membrane 
using the Invitrogen iBlot protocol (ThermoFisher Scientific). Membranes were 
blocked for 2 hours at room temperature in 3% bovine serum albumin (BSA, for 
STXBP1 and DPYSL2; Sigma-Aldrich), 1% BSA (actin) or 5% w/v non-fat dry milk 
(for DNM1 and CFL1; ThermoFisher Scientific). Membranes were incubated with the 
following primary antibodies overnight at 4°C with gentle rocking: rabbit polyclonal 
anti-STXBP1-1 [1:1000 in 3% BSA; Cell Signaling Technology, Inc., Danvers, MA], 
rabbit polyclonal anti-CFL1 [1:5000 in 5% non-fat dry milk, Cell Signaling 
Technology, Inc. [27]], mouse monoclonal anti-DNM1 [1:1000 in 5% non-fat dry milk, 
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Cell Signaling Technology, Inc.]. Blots were incubated with rabbit polyclonal anti-
DPYSL2 [1:10,000 in 3% BSA; AbCam, Cambridge, MA [28]] and mouse 
monoclonal anti-actin [1:5000; Millipore] for 1 hour at room temperature. Membranes 
were then extensively washed and incubated with an HRP-labeled goat-anti rabbit or 
goat-anti mouse secondary antibody (1:20,000 in the same blocking buffer as the 
primary antibody; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). 
Protein expression was assessed via an enhanced chemiluminescence protocol 
(Pierce ECL, ThermoFisher Scientific), with exposure to autoradiography film (Bio 
Express, Kaysville, UT). Protein bands were quantified by optical density analysis 
(NIH/Scion Image) and normalized to actin which was used as a loading control. 
 Antibody selectivity for the target protein was established by the vendor 
(example blots are available on the manufacturers’ websites.) Prior to immunoblot 
analysis of experimental tissue, blots with additional adolescent and adult mouse 
brain homogenate were probed with each antibody to validate the vendor’s findings. 
All antibodies chosen for the confirmation experiments showed a single band at the 
correct molecular weight marker for the indicated protein. Actin was chosen as a 
loading control for these experiments because it was not found to show differential 
expression between adolescent and adult mice in the mPFC in the proteomics 
screen. To confirm that this housekeeping protein was appropriate, adolescent and 
adult actin optical density was compared in all brain regions tested during analysis. 
No age differences in actin optical density emerged in any brain region.  
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Data Analysis 
 Western blot data were analyzed using GraphPad Prism software (GraphPad 
Software, Inc, La Jolla, CA, v5). To determine the difference between adolescent 
and adult mice in the expression of proteins of interest, data were transformed to 
percent change in optical density from the adult control for each gel. As the 
immunoblotting represented a confirmation of the protemics data, significant 
differences were analyzed by a one-tailed unpaired t-test, with significance set a 
priori at p ≤ 0.05. Subjects with a percent change less than or greater than 2 
standard deviations away from the group mean were considered outliers and were 
removed from the analysis (one adult mouse was removed from the STXBP1 and 
DNM1 blots, respectively).  
Results 
 
Proteomic analysis  
To identify proteins with developmentally altered expression in the mPFC, 
brains from adolescent (PND 36) and adult (PND 80) mice were collected (Fig 
1A). At the time of brain tissue collection, adolescent body weight was 
significantly lower than adult mice [t(22) = 8.10, p <0.0001] but brain weight 
was equivalent among the two age groups (p > 0.05; Fig 1B). The mPFC was 
dissected from each brain (Fig 1C), homogenized and labeled with red (adult) 
and green (adolescent) Cy dyes, run on 2D-DIGE, analyzed for expression 
differences between ages, and finally identified using tandem MALDI TOF/TOF 
mass spectrometry (Fig 1D).   
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The automated proteomic analysis spot picker detected 87 spots with 
differential expression in the adolescent and adult mPFC (Fig 1E). Manual curation 
to fulfil the criteria set (≥20% difference in all 4 gels) resulted in 58 differentially 
expressed spots, while an additional 4 spots were significantly altered at 15% 
across all 4 gels. All 62 spots were identified using MALDI-TOF and tandem 
TOF/TOF mass spectrometry (Table 1). mPFC data were analyzed as adolescent / 
adult expression, with positive fold change representing decreased protein 
expression in adolescents compared to adults and negative fold change 
representing increased protein expression in adolescents relative to adults. The 
majority of the identified proteins fell within the functional categories of cell-to-cell 
signaling, cell growth and motility, and cell metabolism. 
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Figure 1. Proteomic analysis of the adolescent and adult medial prefrontal 
cortex (mPFC).  
(A) Timeline of experimental procedure.  (B) Adult body weight was significantly 
greater than adolescent body weight at tissue collection (left), but brain weight 
did not differ between the two ages (right). (C) Photomicrograph (left) and 
schematic (right) of mouse brain section showing location of mPFC tissue 
punch for two-dimensional differential in-gel electrophoresis (2D-DIGE) and 
immunoblot studies. (D) Schematic describing proteomics workflow. Adult 
tissue is combined with Cy3 (red) and adolescent with Cy2 (green) dye and run 
in 2D-DIGE, with protein separating in the y plane via molecular weight and the 
x plane via isoelectrical focusing (IEF). DeCyder software identifies protein 
spots with significantly different florescent signals. Selected spots are subjected 
to tryptan digestion and identified via tandem MALDI TOF/TOF mass 
spectrometry. (E) Representative 2D-DIGE gel run in the proteomics analysis of 
mPFC. Adult samples were combined with red Cydye (left top); adolescent 
samples were combined with green CyDye (left bottom). Overlay of adult and 
adolescent samples (right). IEF is indicated on the x axis with pH values and 
molecular weight is indicated on the y axis in kDa. Circles indicate location of 
differentially expressed spots on the gel, with numeric markers prior to 
identification. Focus proteins are indicated in bold, with red representing 
increased expression in adults and green representing increased expression in 
adolescents. (**** indicates p≤0.0001) 
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Table 1. 62 Differentially Expressed Proteins in adult versus adolescent mPFC 
Identified in Proteomics Analysis. 
Protein Name Gene ID Spot # 
Peptide Protein Relative p 
Count Score Change Value 
Fatty acid-binding 
protein  
FABP7 62 7 368 -2.14 < 0.0001 
Neurocalcin-δ NCALD 75 9 328 -1.76 < 0.0001 
Dihydropyrimidin
ase-like 3 
DPYSL3* 18 16 209 -1.72 < 0.0001 
ATP synthase 
subunit delta  
ATP5D 58 3 178 -1.70 < 0.0001 
β-synuclein  SNCB 56 6 503 -1.68 0.0014 
Dihydropyrimidin
ase-like 5 
DPYSL5 23 22 675 -1.61 < 0.0001 
Clathrin light 
chain A 
CLTA 36 8 220 -1.60 < 0.0001 
Cofilin-1  CFL1 54 9 158 -1.58 0.00028 
Phosphoglycerat
e mutase 1 
PGAM1 44 17 817 -1.54 0.0066 
Membrane 
protein, 
palmitoylated 2 
(MAGUK p55 
subfamily 
member 2) 
MPP2 17 19 421 -1.52 < 0.0001 
Protein kinase C 
γ 
PRKCG* 8 19 195 -1.51 0.013 
Glyceraldehyde-
3-phosphate 
dehydrogenase  
GAPDH* 38 10 318 -1.51 0.0054 
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Protein 
phosphatase 3, 
regulatory 
subunit B, alpha 
PPP3R1* 60 10 171 -1.48 0.0014 
Growth 
associated 
protein 43 
GAP43 31 9 201 -1.46 0.00048 
Dihydropyrimidin
ase-like 4 
DPYSL4 22 24 1030 -1.43 0.00022 
Calreticulin  CALR 15 19 740 -1.42 0.00081 
Dihydropyrimidin
ase-like 3 
DPYSL3* 19 14 291 -1.42 < 0.0001 
Protein 
phosphatase 3, 
regulatory 
subunit B, alpha 
PPP3R1* 59 12 600 -1.40 0.011 
Protein kinase C 
γ 
PRKCG* 9 21 392 -1.40 0.021 
Fascin actin-
bundling protein 
1 
FSCN1 24 17 674 -1.37 < 0.0001 
Drebrin  DBN1 72 23 858 -1.34 0.0018 
Collapsin 
Response 
Mediator Protein 
1  
CRMP1 21 20 515 -1.33 < 0.0001 
CB1 cannabinoid 
receptor-
interacting 
protein 1  
CNRP1 53 9 594 -1.32 0.033 
3-oxoacid CoA 
transferase 1 
OXCT1* 25 7 359 -1.32 < 0.0001 
3-oxoacid CoA 
transferase 1 
OXCT1* 26 14 891 -1.29 < 0.0001 
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Fatty acid-binding 
protein 
FABP5 63 11 438 -1.28 < 0.0001 
Voltage-
dependent anion-
selective channel 
protein 3  
VDAC3 50 11 613 -1.27 0.0014 
Dynamin-1 DNM1* 6 34 625 -1.25 0.0022 
Synapsin II SYN2 27 13 328 -1.24 0.0016 
Guanine 
nucleotide 
binding protein 
(G protein), beta 
polypeptide 4 
GNB4 37 15 231 -1.23 0.0028 
HYDIN, 
axonemal central 
pair apparatus 
protein 
HYDIN 82 21 41 -1.23 0.0078 
Clathrin, light 
chain B 
CLTB 74 13 424 -1.23 0.0096 
Calbindin 2 CALB2 41 14 388 -1.22 0.014 
3-
hydroxybutyrate 
dehydrogenase, 
type 1 
BDH1 49 12 489 -1.22 0.013 
Fatty acid binding 
protein 3 
FABP3 71 8 421 -1.20 0.0017 
Guanine 
nucleotide 
binding protein 
(G protein), beta 
polypeptide 2-like 
1 
GNB2L1 68 18 972 -1.17 0.00024 
Dihydropyrimidin
ase-like 2 
DPYSL2* 14 28 878 1.14 0.00088 
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Enolase 2 
(gamma, 
neuronal) 
ENO2 30 19 861 1.18 0.0019 
Creatine kinase, 
brain 
CKB 32 21 881 1.18 < 0.0001 
Ubiquinol-
cytochrome c 
reductase core 
protein II 
UQCRC2 69 16 465 1.19 0.017 
NADH 
dehydrogenase 
[ubiquinone] 
flavoprotein 1, 
mitochondrial 
NDUFV1 77 18 380 1.20 < 0.0001 
EF-hand domain-
containing protein 
D2  
EFHD2 40 10 302 1.21 0.004 
Bridging 
integrator 1 
BIN1 10 22 801 1.22 0.015 
V-type proton 
ATPase subunit 
B, brain isoform  
VATB2 81 12 87 1.23 0.0022 
Pyruvate kinase 
isozymes M1/M2  
KPYM 80 24 624 1.24 < 0.0001 
Voltage-
dependent anion-
selective channel 
protein 1  
VDAC1* 47 7 540 1.25 0.0015 
Syntaxin-binding 
protein 1  
STXB1* 79 26 716 1.26 0.0002 
Guanine 
nucleotide-
binding protein 
G(o) subunit α 
GNAO1 35 13 647 1.27 < 0.0001 
Glutathione S-
transferase mu 5 
GSTM5 73 18 639 1.28 < 0.0001 
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N-
ethylmaleimide-
sensitive factor 
NSF 78 21 280 1.29 0.0078 
Voltage-
dependent anion-
selective channel 
protein 1  
VDAC1* 67 13 611 1.29 0.00029 
Dynamin-1 DNM1* 4 22 338 1.31 0.00078 
Septin-3 SEPT3 34 6 103 1.32 < 0.0001 
Mitochondrial 
inner membrane 
protein  
IMMT 7 28 625 1.32 0.00026 
Carbonic 
anhydrase 2  
CAH2 46 13 615 1.34 < 0.0001 
Dihydropyrimidin
ase-like 2 
DPYSL2* 13 25 719 1.35 0.00012 
Cysteine and 
glycine-rich 
protein 1  
CSRP1 51 8 334 1.36 0.017 
Dihydropyrimidin
ase-like 2 
DPYSL2* 12 26 800 1.38 < 0.0001 
Syntaxin-binding 
protein 1  
STXB1* 20 28 788 1.39 < 0.0001 
Complexin-2  CPLX2 57 6 163 1.41 0.018 
Septin-2  SEPT2 33 10 352 1.48 0.00058 
Glyceraldehyde-
3-phosphate 
dehydrogenase  
GAPDH* 48 12 280 4.33 < 0.0001 
 
Table 1. 58 spots showed ≤20% difference in expression in all 4 2D-DIGE gels 
(p<0.05; standard font), with an additional 4 spots with ≤15% difference in 
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expression in all 4 2d-DIGE gels (p<0.05; italics). Each spot was identified via 
MALDI TOF/TOF mass spectrometry with a confidence of 1.0. Spot change 
was expressed as fold change ratio of adolescent from adult, with negative 
numbers reflecting reduced expression in adults relative to adolescents and 
positive numbers indicating greater expression in adults. Asterisks denote 
spots that appear more than once in the proteomics report. 
Ingenuity pathway analyses 
All proteins identified in the proteomics analysis were uploaded to Ingenuity 
Pathway Analysis for Global Functional Analysis (GFA) and Global Canonical 
Pathway (GCP) determination (Table 2). GFA revealed participation of identified 
proteins in cellular functions including cell-to-cell signaling and interaction, cellular 
morphology and cellular development. Additionally, identified proteins were shown to 
be involved in neurological disease, including schizophrenia and movement 
disorders. GCP analysis indicated the involvement of identified proteins in several 
known signaling cascades, including semaphoring signaling and axonal guidance 
signaling, androgen signaling, and glycolysis I and gluconeogenesis I signaling. 
Table 2. Role of identified proteins in biofunctions and disorders, and 
canonical signaling networks. 
Biofunctions and disorders 
Function/Disorder p-Value Higher in adults 
Higher in 
adolescents 
Cell-to-cell Signaling 
and Interaction 
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Synaptic transmission 
of synapse 
0.000033 STXBP1,VDAC1 SNCB,VDAC3 
Synaptic transmission 
of nervous tissue 
0.0000549 
NSF,STXBP1, 
VDAC1 
SNCB,VDAC3 
Synaptic transmission 0.00000124 
NSF,STXBP1, 
VDAC1 
PPP3R1,SNCB,SYN2, 
VDAC3 
Long-term potentiation 
of synapse 
0.00000198 CPLX2,VDAC1 
CALB2,CRMP1, 
PPP3R1, 
PRKCG, VDAC3 
Long-term potentiation 0.00000453 CPLX2,VDAC1 
CALB2,CRMP1, 
DPYSL4,PPP3R1, 
PRKCG,VDAC3 
Synaptic depression 0.0122  
PPP3R1,PRKCG, 
SYN2 
Cellular Morphology p-Value Higher in adults 
Higher in 
adolescents 
Size of neurons 0.00333  
DPYSL3,GAP43, 
SNCB 
Morphology of neurites 0.0187 CKB DPYSL4,GAP43 
Morphology of neurons 0.00716 CKB,DNM1 
CRMP1,DPYSL4, 
DPYSL5,GAP43 
Length of neurites 0.00173 DPYSL2 DPYSL3,DPYSL4 
Length of neurons 0.000214 DPYSL2 
DBN1,DPYSL3, 
DPYSL4 
Formation of filopodia 0.0000124 CSRP1 DPYSL3,DPYSL5 
Extension of plasma 
membrane projections 
0.0213 DPYSL2 DBN1,DPYSL5 
Outgrowth of neurites 0.011 DPYSL2,GNAO1 
DPYSL3,DPYSL5, 
GAP43 
Branching of neurons 0.000225 CSRP1,DPYSL2 
CRMP1,DBN1, 
DPYSL3,DPYSL4, 
GAP43 
Morphogenesis of 
neurites 
0.00276 
CSRP1,DPYSL2,
SEPT2 
CRMP1,DBN1, 
DPYSL4,GAP43 
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Dendritic growth/ 
branching 
0.00244 CSRP1 
CRMP1,DBN1, 
DPYSL4,GAP43 
Branching of neurites 0.00125 CSRP1,DPYSL2 
CRMP1,DBN1, 
DPYSL4,GAP43 
Morphology of cells 0.00137 CKB,DNM1 
CRMP1,DPYSL3, 
DPYSL4, 
DPYSL5,GAP43, 
SNCB 
Size of brain 0.0248 CKB FSCN1,GAP43 
Cellular Development p-Value Higher in adults 
Higher in 
adolescents 
Abnormal morphology 
of cerebral cortex 
0.00591 CKB,CPLX2 CRMP1,GAP43 
Abnormal morphology 
of brain 
0.0138 CKB,CPLX2 
CRMP1,GAP43, 
SNCB,SYN2 
Abnormal morphology 
of nervous system 
0.0332 
CKB,CPLX2, 
DNM1 
CRMP1,GAP43, 
SNCB,SYN2 
Morphology of nervous 
system 
0.00607 
CKB,CPLX2, 
DNM1 
CRMP1,DPYSL4, 
DPYSL5,GAP43, 
SNCB,SYN2 
Proliferation of cells 0.00297 
CSRP1,DPYSL2, 
GNAO1,PKM 
CFL1,DPYSL3, 
DPYSL5, 
FABP7,GAP43 
Proliferation of neuronal 
cells 
0.00476 
CSRP1,DPYSL2, 
GNAO1 
CFL1,DPYSL3, 
DPYSL5,GAP43 
Differentiation of cells 0.0014 CSRP1,DPYSL2 
CRMP1,DBN1, 
DPYSL3,DPYSL4, 
FABP7, GAP43 
Transport of synaptic 
vesicles 
0.00000475 
BIN1,CPLX2, 
DNM1,DPYSL2 
SNCB 
Endocytosis of synaptic 
vesicles 
0.000186 BIN1,DNM1 SNCB 
Growth of neurites 0.0056 
CSRP1,DPYSL2, 
GNAO1 
DPYSL3,DPYSL5,GA
P43 
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Neurological Disease p-Value Higher in adults 
Higher in 
adolescents 
Neuromuscular disease 0.000121 CA2,CKB,ENO2 
DPYSL3,FABP7, 
GAP43,PPP3R1, 
PRKCG 
Schizophrenia 0.00000118 
ATP6V1B2, 
CSRP1,VDAC1 
CLTB,GAP43,OXCT1, 
PGAM1,SNCB 
Disorder of basal 
ganglia 
0.000117 CA2,CKB,ENO2 
DPYSL3,FABP7, 
GAP43,PPP3R1, 
PRKCG 
Movement Disorders 0.00014 CA2,CKB,ENO2 
DPYSL3,FABP7, 
GAP43, 
PPP3R1,PRKCG 
Huntington's Disease 0.000119 CA2,CKB,ENO2 
DPYSL3,FABP7, 
PPP3R1,PRKCG 
    
 
 
Canonical pathways and upstream regulators 
Pathways  p Value  Higher in adults 
Higher in 
adolescents 
Semaphorin Signaling 
in Neurons 
2.31E-08 DPYSL2 
CRMP1,CFL1,DPYSL3
DPYSL4,DPYSL5 
Glycolysis I 7.01E-07 PKM,ENO2,GAPDH PGAM1 
Huntington's Disease 
Signaling 
8.93E-07 DNM1,NSF,CPLX2 
CLTA,CLTB,GNB2L1,
GNB4,PRKCG 
Androgen Signaling 4.05E-05 GNAO1 
CALR,GNB4,GNB2L1,
PRKCG 
Gluconeogenesis I 4.84E-05 ENO2,GAPDH PGAM1 
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Axonal Guidance 
Signaling 
7.26E-05 DPYSL2,GNAO1 
GNB4,CFL1,PPP3R1,
GNB2L1,DPYSL5, 
PRKCG 
Regulators     
MAPT 1.15E-16 
CKB,CPLX2,DPYSL2,
ENO2,GAPDH, 
GNAO1,PKM, 
STXBP1,VDAC1, 
ATP5D,CFL1,CLTA, 
CLTB,PGAM1,SNCB 
APP 3.88E-15 
CKB,CPLX2,DNM1, 
DPYSL2,ENO2, 
GAPDH,GNAO1,PKM
STXBP1,VDAC1 
ATP5D,CFL1,CLTA, 
CLTB,DBN1,FABP3, 
GAP43,PGAM1,SNCB, 
SYN2 
PSEN1 7.74E-14 
CKB,CPLX2,DPYSL2,
ENO2,GAPDH, 
GNAO1,PKM, 
STXBP1,VDAC1 
ATP5D,CFL1,CLTA, 
CLTB,PGAM1,SNCB 
MKNK1 2.84E-08 
CPLX2,GNAO1, 
STXBP1 
CRMP1,DPYSL3, 
GAP43,SYN2 
BDNF 6.22E-08 
CPLX2,GNAO1, 
STXBP1 
CALB2,CRMP1,DPYS
L3,FSCN1,GAP43, 
SYN2 
Table 2. Proteomics results were analyzed via Ingenuity Pathway Analysis for 
known interactions with other proteins, signaling systems and networks in the 
Ingenuity Knowledge Base. Proteins that displayed higher expression during 
adulthood are shown on the left, and proteins that displayed higher 
expression during adolescence are shown on the right, as seen in Table 1. p 
values were derived from Ingenuity Pathway Analysis by right-tailed Fisher 
exact test and indicate relative overrepresentation of proteins in a given 
function compared with what is expected by chance. 
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Network analysis and Western blot confirmation  
Ingenuity Pathway Analysis was performed to identify functional protein 
networks likely to be impacted by the developmentally regulated proteins identified in 
the proteomics analysis. Three significant networks were identified: Network 1, 
cellular assembly and organization, cellular function and maintenance, and cellular 
movement (p-score 29); Network 2, behavior, cell signaling and interaction, nervous 
system development and function (p-score 31); Network 3, neurological disease, 
skeletal and muscular disorders, and psychological disorders (p-score 22).  
Complete Western blot gel images for all proteins tested are shown in supporting 
information figures (S1 – S24 Figs). 
Network 1 
Network 1 (Cellular Assembly & Organization) includes 18 focus molecules identified 
in the proteomics analysis of adolescent and adult mPFC as well as 17 significant 
interaction proteins (Fig 2). Noteworthy predicted regulators of this network include 
interferon gamma (INFG) and reticulon 4 (RTN4).  
Of the focus molecules, dihydropyrimidinase-like 2 (DPYSL2) was a locus of 
significant interconnectedness in Network 1 and was thus selected for further 
analysis. DPYSL2 appeared at Spot 12 in the proteomics analysis (Fig 1E), where 
its standardized log abundance was 0.041 in adults and -0.098 in adolescents, 
representing a 38% reduction in adolescents versus adults (Fig 3, A-C). Spot 12 was 
identified as DPYSL2 with a protein score of 800 (Table 1), and no other candidate 
proteins met the pre-hoc criteria for identification at Spot 12. Western blot analysis 
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confirmed the decrease observed in the proteomics analysis, with adolescent 
expression of DPYSL2 27% in mPFC lower than adult [t(26) = 2.27, p <0.05; Fig 3, 
D & E].  
  
Figure 2.  Adolescent development impacts a functional protein network 
involved in cellular assembly and organization, cellular function and 
maintenance, and cellular movement.  
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Visualization of a protein interaction network identified by Ingenuity Pathway 
Analysis as being altered by adolescent brain development (p-score= 29). 
Proteins shown in red were up-regulated in the adult mPFC, proteins in green 
were up-regulated in the adolescent mPFC, and proteins in yellow indicate 
statistically significant interaction proteins identified by IPA network analysis. 
Solid lines indicate a direct interaction, and dashed lines indicate an indirect 
interaction mediated by additional, non-significant proteins. Asterisks denote 
proteins that were identified multiple times in the proteomic analysis that have 
been consolidated into a single point in the functional network. Molecules for 
confirmation are indicated in bold, e.g. syntaxin binding protein 1 (STXBP1), 
dynamin-1 (DNM1) and dihydropyrimidinase-like-2 (DPYSL2).  
 
In addition to the results of the proteomic analysis and Western blots in the 
mPFC, other brain regions were of interest based on their association with 
adolescent-typical behaviors. The dorsal striatum (dSTR), nucleus accumbens 
(NAc), primary motor cortex (MC), amygdala (AMY) and ventral tegmental area 
(VTA) were also analyzed for expression of the selected confirmation proteins. 
DPYSL2 expression was significantly reduced in adolescent mice as compared with 
adult mice in all brain regions examined excepting the VTA (p >0.05; Fig 3F). Age 
differences were most pronounced in the MC [22% decrease; t(23) = 9.00, p 
<0.0001] and AMY [26% decrease; t(19) = 4.45, p <0.0001], with less pronounced 
differences in the dSTR [18% decrease; t(22) = 3.59, p <0.001] and NAc [9% 
decrease; t(23) = 2.42, p <0.05].   
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Figure 3. Adult and adolescent expression of dihydropyrimidinase-like-2 
(DPYSL2). (A) Representative 3D plot of DPYSL2 expression in adult (left) 
and adolescent (right) mice for Spot #20. (B) Standardized abundance (log) 
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of DPYSL2 demonstrating higher expression in adults versus adolescents. 
(C) Representative gel image of a Western blot for DPYSL2 expression to 
confirm 2D-DIGE changes. Both resulting bands were quantified. (D) 
Quantification of Western blot results, confirming reduced expression of 
DPYSL2 (normalized to actin) in adolescents as compared to adults. (E) Top, 
representative gel images for each brain region; bottom, quantification of 
Western blots for each brain region. Adults show increased expression of 
DPYSL2 in dStr, NAc, MC and Amy. No significant age differences were 
observed in the VTA (p>0.05). Data were expressed as percent change from 
mean adult within the same blot and graphed as mean  SEM. (* indicates 
p≤0.05, *** indicates p≤0.001).  
Dynamin-1 (DNM1) was also significantly interconnected in Network 1 and was 
subsequently analyzed. In the proteomics analysis DNM1 was identified twice, at 
Spot #4 and Spot #6 (Fig 1E). At Spot 4, DNM1 standardized log abundance was -
0.003 for adults and -0.056 for adolescents, representing a 31% decrease in 
adolescent mice compared to adults (Fig 4, A-C). Spot 4 was identified as DNM1 
with a peptide score of 338 (Table 1), and no other candidate proteins met the pre-
hoc criteria for identification at Spot 12. At Spot 6, DNM1 standardized log 
abundance was -0.058 for adults and 0.400 for adolescents, representing a 26% 
increase in adolescent mice compared to adults (Fig 4, D-F). At Spot 6, the 
candidate proteins DNM1 and DNM2 both exceeded the pre-hoc criteria of 95% C.I., 
and DNM1 was selected as the identity for Spot 6 based on the higher peptide score 
for DNM1 (625) versus DNM2 (83). Western blot analysis indicated that DNM1 
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expression was decreased by 22% in adolescent mPFC as compared to adults [t(25) 
= 5.84, p <0.0001; Fig 4, G & H]. DNM1 expression was also significantly lower in 
adolescents compared with adults in dSTR [12% decrease; t(22) = 4.48; p <0.0001], 
MC [13% decrease; t(23) =5.48, p <0.0001], AMY (14% decrease; t(18) =2.73, p 
<0.01] and VTA (9% decrease; ; t(21) =2.68, p <0.01, Fig 4 I]. The NAc displayed no 
age differences in DNM1 expression (p >0.05). 
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Figure 4. Adult and adolescent expression of dynamin-1 (DNM1).  
(A) Representative 3D plot of DNM1 expression in adult (left) and adolescent 
(right) mice for Spot #4. (B) Standardized abundance (log) of DNM1 (Spot 4) 
demonstrating higher expression in adults versus adolescents (C) 
Representative 3D plot of DNM1 expression in adult (left) and adolescent (right) 
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mice for Spot #6. (D) Standardized abundance (log) of DNM1 (Spot 6) 
demonstrating higher expression in adults versus adolescents. (E) 
Representative gel image of a Western blot for DNM1 expression to confirm 
2D-DIGE changes. (F) Quantification of Western blot results, confirming 
reduced expression of DNM1 (normalized to actin) in adolescents as compared 
to adults. (G) Top, representative gel images for each brain region; bottom, 
quantification of Western blots for each brain region. DNM1 expression was 
higher in adults in dStr, M1, Amy, and VTA. There was no significant change in 
DNM1 expression in NAc (p>0.05). Data were expressed as percent change 
from mean adult within the same blot and graphed as mean  SEM. (* indicates 
p≤0.05, ** indicates p≤0.01, *** indicates p≤0.001, **** indicates p≤0.0001). 
 
Network 2 
Network 2 (Behavior/Signaling) includes 19 focus molecules identified in the 
proteomics analysis as well as 16 proteins statistically predicted to interact with the 
focus proteins in a functional network (Fig 5). Of the focus molecules, 9 exhibited 
higher expression in adult mPFC whereas 10 exhibited greater expression in 
adolescents Notable predicted regulators of this network include brain-derived 
neurotrophic factor (BDNF) and huntingtin (HTT).  
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Figure 5.  Adolescent development impacts a functional protein network 
involved in behavior, cell-to-cell signaling and interaction, and nervous 
system development and function.  
Visualization of a protein interaction network identified by Ingenuity Pathway 
Analysis as being altered by adolescent brain development (p score= 31). 
Proteins shown in red were up-regulated in the adult mPFC, proteins in green 
were up-regulated in the adolescent mPFC, and proteins in yellow indicate 
statistically significant interaction proteins identified by IPA network analysis. 
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Solid lines indicate a direct interaction, and dashed lines indicate an indirect 
interaction mediated by additional, non-significant proteins. Asterisks denote 
proteins that were identified multiple times in the proteomic analysis that have 
been consolidated into a single point in the functional network. Focus molecule 
syntaxin binding protein 1 (STXBP1) is indicated in bold.  
 
Of the focus molecules identified in the proteomics analysis in Network 2, 
syntaxin-binding protein 1 (STXBP1) was a significant hub of interconnectedness 
within the network and was therefore selected for further analysis. In the proteomics 
analysis of the mPFC STXBP1 was identified twice, at spot #20 and spot #79 (Fig 
1E). At Spot 20, STXBP1 standardized log abundance was 0.039 for adults and -
0.100 for adolescents, representing a 39% decrease in adolescent mice compared 
to adults (Fig 6, A-C). Spot 20 was identified as STXBP1 with a peptide score of 
788, and no additional candidate proteins met the pre-hoc criteria for identification at 
that spot. 
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Figure 6. Adult and adolescent expression of syntaxin binding protein 1 
(STXBP1).     
(A) Representative 3D plot of STXBP expression in adult (left) and adolescent (right) 
mice for Spot #20. (B) Standardized abundance (log) of STXBP1 (Spot 20) 
demonstrating higher expression in adults versus adolescents. (C) Representative 
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3D plot of STXBP1 expression in adult (left) and adolescent (right) mice for Spot#79. 
(D) Standardized abundance (log) of STXBP1 (Spot 79) demonstrating higher 
expression in adults versus adolescents. (E) Representative gel image of a Western 
blot for STXBP1 expression to confirm 2D-DIGE changes. (F) Quantification of 
Western blot results, confirming reduced expression of STXBP1 (normalized to 
actin) in adolescents as compared to adults. (G) STXBP1 expression was greater in 
adults in dStr, NAc, M1, Amy, and VTA. Top, representative gel images for each 
brain region; bottom, quantification of Western blots for each brain region. (*** 
indicates p≤0.001, **** indicates p≤0.0001.) 
At Spot 79, the candidate proteins STXBP1 and TPX2 both exceeded the pre-
hoc criteria of 95% C.I., and STXBP1 was selected as the identity of Spot 79 based 
on the higher peptide score of STXBP1 (716) versus TPX2 (65). STXBP1 
standardized log abundance was 0.036 for adults and -0.058 for adolescents, 
representing a 26% decrease in adolescent mice compared to adults (Fig 6, D-F). 
Western blot analysis confirmed the decreases observed in the proteomics analysis 
with adolescent expression of STXBP1 18% lower than adult expression in mPFC 
[t(25) =3.89, p <0.001; Fig 6, G & H].  STXBP1 expression was consistently reduced 
in adolescent mice as compared to adult mice in all brain regions examined (Fig 6I). 
The age difference was most pronounced in MC, where adolescent STXBP1 
expression was decreased by 39% compared to adults [t(23) =7.85, p <0.0001]. Age 
differences in the dSTR [11% decrease; t(23) =3.98, p <0.001], NAc [17% decrease; 
t(23) =3.35, p <0.01], AMY [11% decrease; t(18) =2.48, p <0.05] and VTA [15% 
decrease; t(21) =3.91, p <0.001] were more modest.  
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Network 3 
 Network 3 (Disease) includes 15 focus molecules identified in the proteomics 
analysis that were differentially expressed in adolescent as compared to adult mPFC 
as well as 20 significant interaction proteins (Fig 7). Of the focus molecules, 8 
exhibited greater expression in adults whereas 7 had greater expression in 
adolescents. Significant predicted regulators of this network included amyloid-β 
precursor protein (APP), microtubule-associated protein tau (MAPT) and presenilin-1 
(PSEN1).  
The focus molecule cofilin-1 (CFL1) was a significant component of the network 
connectivity and was selected for further analysis. CFL1 appeared at Spot 54 in the 
proteomics analysis of the mPFC (Fig 1E), where its standardized log abundance 
was -0.378 in adults and -0.180 in adolescents, representing a 58% increase in 
adolescents versus adults (Fig 8, A-C). Both the candidate proteins CFL1 and CFL2 
exceeded the pre-hoc criteria for identification, and CFL1 was chosen as the identity 
for Spot 54 based on the higher peptide score of CFL1 (158) versus CFL2 (149). 
Western blot analysis confirmed the increase observed in the proteomics analysis, 
with adolescent expression of CFL1 21% higher than adult [t(26) =1.84, p <0.05; Fig 
8, D & E] in the mPFC. CFL1 expression was also significantly higher in adolescents 
versus adults in the VTA [23% increase; t(21) =1.85, p <0.05; Fig 8F). No significant 
age differences in CFL1 emerged in the dSTR, NAc, MC or AMY (p >0.05).  
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Figure 7. Adolescent development impacts a functional protein network involved 
with neurological disease, skeletal and muscular disorders, and psychological 
disorders.  
Visualization of a protein interaction network identified by Ingenuity Pathway 
Analysis as being altered by adolescent brain development (p-score= 22). Proteins 
shown in red were up-regulated in the adult mPFC, proteins in green were up-
regulated in the adolescent mPFC, and proteins in yellow indicate statistically 
significant interaction proteins identified by IPA network analysis. Solid lines indicate 
a direct interaction, and dashed lines indicate an indirect interaction mediated by 
additional, non-significant proteins. Asterisks denote proteins that were identified 
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multiple times in the proteomic analysis that have been consolidated into a single 
point in the functional network. Focus molecule cofilin-1 (CFL1) is indicated in bold. 
 
Discussion 
 
Although significant structural changes in the prefrontal cortex during 
adolescence have been well established, the molecular changes that mediate these 
developmental alterations remain to be more fully characterized. The present study 
utilized a high-throughput unbiased proteomics approach to identify specific proteins 
and protein networks that show differential expression in adolescent compared to 
adult mPFC. 2D-DIGE followed by MALDI TOF/TOF identified 62 individual proteins 
with significant age-dependent differences in expression. Ingenuity Pathway 
Analysis identified 3 networks in which these target proteins were overexpressed.  
Further results confirmed key changes from previous investigations [20] while 
focusing the analysis on adolescent-specific protein changes, and extended these 
findings in additional brain regions (dSTR, MC, NAc, AMY and VTA). Together, the 
results indicate that, compared to adults, the adolescent mPFC has developmentally 
linked alterations in protein networks that regulate cellular organization/structure, 
neuronal signaling, anxiety-related behavior and neurological disease. These 
findings strengthen existing hypotheses about the progression of postnatal cortical 
development and point to several novel potential functional regulators of adolescent-
typical behavior and vulnerability.  
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Figure 8. Adult and adolescent expression of cofilin-1 (CFL1). (A)  
(A) Representative 3D plot of CFL1 expression in adult (left) and adolescent 
(right) mice for Spot #54. (B) Standardized abundance (log) of CFL1 
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demonstrating higher expression in adults versus adolescents. (C) 
Representative gel image of a Western blot for CFL1 expression to confirm 2D-
DIGE changes. (D) Quantification of Western blot results, confirming reduced 
expression of CFL1 (normalized to actin) in adolescents as compared to adults. 
(E) Top, representative gel images for each brain region; bottom, quantification 
of Western blots for each brain region. Adolescents show higher expression of 
CFL1 in VTA. There were no significant changes in CFL1 expression in dSTR, 
NAc, MC or Amy (p>0.05). (* indicates p≤0.05, *** indicates p≤0.001). 
Structural development 
The present results provide several lines of evidence that suggest that the 
adolescent mPFC is characterized by widespread alterations in protein expression 
related to the regulation of cellular assembly & structure, cellular organization and 
structural plasticity. Many of the proteins identified in the proteomic analysis have 
roles in cellular morphology and synaptic plasticity.  Ingenuity Global Canonical 
Pathway analysis also suggested that canonical signaling pathways known to 
regulate cellular growth and development in the adult mPFC were likely to differ from 
the adolescent condition, based on the interactions between proteins identified in the 
proteomics screen (Table 2). Both semaphorin signaling and axonal guidance 
signaling were identified as canonical signaling pathways that were impacted by the 
developmental state of the mPFC (Table 2). The majority of identified proteins in 
these canonical pathways were up-regulated in the adolescent cortex. Semaphorins 
are a family of receptors and secretory proteins that have a well-established role in 
guiding axonal outgrowth during embryonic development [29] and are also involved 
 
 
111 
 
in neuronal maturation, synaptic plasticity and cell death in the adult cortex [30, 31]. 
Although the role of sempahorin signaling in adolescent brain maturation and 
synaptic pruning has not been investigated to date, this signaling system is a 
plausible mediator of morphological changes in adolescent cortex and merits 
examination in future studies.  
Ingenuity Pathway Analysis identified a functional protein network involved in 
cellular assembly and organization that was significantly impacted by age (Fig 2). 
Several proteins identified in this network have been shown to play a role in synaptic 
development, including PP3R1 [32], CALR [33] and NSF [34], as well as the focus 
protein DPYSL2. DPYSL2 (or CRMP2) is a member of the CRMP family, which 
binds tubulin heterodimers to facilitate microtubule assembly [35]. These proteins 
function in growth cone formation, contributing to neuronal outgrowth [36] and may 
also play a role in cell death [37] and thus neural pruning. The expression of CRMP1 
and DPYSL3, 4, and 5 was higher in the adolescent mPFC, consistent with 
increased neuronal outgrowth and synaptic formation during this developmental 
period (Table1). However, DPYSL2 expression was found to be consistently higher 
in adults in the mPFC, dSTR, NAc, M1, and AMY (Fig 4). The reason why this 
CRMP subtype, but not the others, is up-regulated in adulthood is unknown, but 
could be due to a developmental shift from dominant expression of CRMP 1, 
DPYSL3, 4, or 5 in the adolescent brain to DPYSL2 in the adult brain. DPYSL2 was 
identified three times in the proteomic screen, at spots #12, 13 and 14. Spots 13 and 
14 appeared at the same molecular weight range but exhibited different isoelectrical 
focusing, which may suggest a posttranslational modification affecting one of the two 
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spots. Spot #12 exhibited shifts in both isoelectrical focusing and molecular weight, 
which could indicate a possibility of protein contamination, significant 
posttranslational modification, or both. Immunoblots confirmed the increase in total 
DPYSL2 in the adolescent mPFC, but additional assessment with antibodies 
targeting posttranslational modifications of DPYSL2 would provide clarity as to the 
variable spots detected in the proteomics screen. 
Signaling and behavior 
In addition to their roles as mediators of cellular assembly and development, 
many of the proteins identified in the proteomics analysis are known to be involved 
in cell-to-cell signaling and neurotransmission. Indeed, Ingenuity Pathway Analysis 
identified a significant protein interaction network associated with cell signaling and 
behavior that was impacted by adolescent brain maturation (Fig 4). The immaturity 
of the prefrontal cortex has been suggested to underlie many adolescent-typical 
behaviors, such as impulsivity, reward sensitivity and risk taking. Subcortical areas 
involved in emotional processing (such as the nucleus accumbens, ventral 
tegmental area and amygdala) reach adulthood before regulatory control of these 
regions from the PFC is fully mature [16], leading to enhanced response to reward 
and impairments in inhibitory control under emotionally salient conditions [38].          
At the cellular level, previous studies have demonstrated that the adolescent 
mPFC has altered responses to neurotransmitters and cell signaling molecules, 
including dopamine [39, 40], glutamate [41] and GABA [42]. Moreover, several 
studies have provided evidence for the regulation of adolescent-typical behaviors by 
diverse signaling systems including the cannabinoid systems [43], glutamate [44], 
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dopamine [45]  and GABA [46]. Within the network identified by IPA, several proteins 
with established roles in adolescent-related behaviors were observed, including 
BDNF [47, 48], GAP43 [49] and mTOR [50].  Regulation of both PFC function and 
behavior by these varied signaling systems may reflect large-scale structural 
changes occurring in the adolescent forebrain during development, consistent with 
the alterations in structural proteins we observed.  
The focus proteins STXBP1 and DNM1 have both been shown to be involved 
in neurotransmitter signaling, and both displayed different expression patterns in the 
adolescent and adult mPFC. STXBP1 contributes to the regulation of exocytosis in 
cells, assisting in vesicle fusion and neurotransmitter release [51]. The proteomics 
screen revealed two individual spots that were each identified as STXBP1 (spot #20 
and #79), both of which displayed decreased expression in adolescents versus 
adults (Fig 6). While it is possible that these multiple spots could represent 
contamination with other proteins, each spot was identified as STXBP1 with high 
confidence; spot #20 was identified as STXBP1 with 28 peptides and a peptide 
score of 788, and spot #79 was identified as STXBP1 with 26 peptides and a peptide 
score of 716. Based on these identifiations, another explanation for the multiple 
identifications of STXBP1 in the proteomics screen is post-translational 
modifications. The presence of phosphate groups, methylation and other post-
translational modifications can shift the isoelectrical focusing of a spot without 
altering the observed molecular weight or peptide identification. Immunoblotting 
confirmed that total STXBP1 expression is reduced in the adolescent mPFC relative 
to adults. This alteration in STXBP1 expression in the adolescent mPFC was also 
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observed in each additional brain region examined (dStr, NAc, M1, Amy and VTA), 
which may indicate that this developmental change in STXBP1 levels is part of a 
brain-wide process, perhaps in response to the widespread changes in 
neurotransmitter signaling reported throughout the brain during adolescence [2].  
The increased STXBP1 observed in the mature brain may contribute to greater 
regulation of synaptic transmission in adults, and ultimately greater refinement in the 
executive functioning of the PFC.  
DNM1 participates in vesicle budding in both clathrin-mediated endocytosis 
and activity-dependent bulk endocytosis [52, 53], and mutations in dynamin cause 
developmental abnormalities in drosophila [54]. Proteomic analysis of DNM1 
revealed two individual spots that were each identified as DNM1 (spot #4 and #6) As 
was the case for STXBP1, each spot was identified as DNM1 with high confidence; 
spot #4 was identified as DNM1 with 22 peptides and a peptide score of 338, and 
spot #6 was identified as DNM1 with 34 peptides and a peptide score of 625. Unlike 
STXBP1, however, in this instance one DNM1 spot displayed increased expression 
in the adult mPFC (spot #4) while the other showed increased expression in the 
adolescent mPFC (spot #6). To resolve this apparent contradiction, immunoblotting 
for total DNM1 protein showed that DNM1 expression was lower in the adolescent 
versus the adult mPFC, consistent with spot #4. The increased expression in DNM1 
at spot #6 may indicate that a posttranslational modification of DNM1 has higher 
expression in the adolescent mPFC, perhaps in compensation for reduced protein 
levels. Future studies should examine the phosphorylation state and activity of 
DNM1 in the adolescent and adult cortex to test this hypothesis. Similar to STXBP1, 
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Western blot analysis of total DNM1 expression in other brain regions showed higher 
DNM1 expression in adults across most brain regions, with the exception of the NAc 
where levels did not significantly differ between the two ages. Much like STXBP1, 
the generally elevated expression of DNM1 in the adult brain may represent more 
mature control of receptor expression at the cell surface and therefore refinement of 
synaptic signaling.  
Whereas DPYSL2, STXBP1 and DNM1 showed a general decrease in the 
adolescent brain relative to the adult brain, the expression of the focus protein 
cofilin-1 (CFL1) was found to have higher expression in the adolescent prefrontal 
cortex in the proteomics analysis. Furthermore, the age-dependent alteration in 
CFL1 expression was relatively selective for the mPFC; of the additional brain 
regions tested, only the VTA showed a similar age difference (Fig 8). Spot 54 was 
identified as CFL1, but the 3D image rendered by DeCyder revealed a shoulder onto 
another spot, and the candidate protein CFL2 was also a significant identity for Spot 
54. Ultimately CFL1 was chosen as the protein identity for Spot 54 based on the 
higher protein score of CFL1 versus CFL2, and immunoblotting experiments 
confirmed that the expression of CFL1 is increased in the adolescent mPFC versus 
the adult. However, the potential for CFL2 in addition to CFL1 being altered during 
adolescent brain development remains a strong possibility.  
Both cofilin-1 and -2 are actin depolymerizing proteins [55] that contribute to 
spine growth and shrinkage [56, 57], cell migration [58] and AMPAR and NMDAR 
trafficking during both long-term potentiation (LTP) and long-term depression (LTD) 
[59, 60]. These observations make cofilin a particularly interesting protein in the 
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context of adolescent development of the cortex and the developmental disorders 
associated with adolescent cortical disruption, such as schizophrenia.  
 Schizophrenia is a psychotic disorder characterized by significant 
impairments in cognition, hallucinations and delusions, and social withdrawal and 
mood disturbances [61] that is usually diagnosed during adolescence [62]. A 
significant neurobiological component of schizophrenia appears to be alterations in 
cortical gray matter; schizophrenia patients present with both faster reductions in 
cortical gray matter during adolescence [63] and greater total volume reductions in 
the prefrontal cortex [64], which may predate symptom onset [65]. Decreased 
dendritic spines [66] and synaptic markers [67] have also been reported in the 
schizophrenic cortex. Taken together, these findings suggest a “hyper-adolescent” 
state in the schizophrenic cortex, such that adolescent-typical neural pruning occurs 
in excess [68], eliminating necessary synaptic connections in the PFC and reducing 
ability to regulate brain function and behavior.  
Several recent reports have linked actin dynamics and cofilin to schizophrenia [69, 
70]. Additionally, Ingenuity Global Functional Analysis revealed significant 
enrichment of the identified protein dataset for proteins previously shown to be 
linked to schizophrenia, including GAP43 [71], VDAC1 [72] and SNCB [73], all of 
which have been shown to play a role in synaptic communication. These results 
underscore the association between normal adolescent brain development and 
pathology. However, neither the protein identifications nor the bioinformatics utilized 
in the present studies were able to assess a functional role for the observed protein 
alterations either in normal development or in disease. A major goal for future work 
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will be the evaluation of protein targets like cofilin that may regulate adolescent brain 
development and be mechanistically involved in the etiology of developmental 
disorders such as schizophrenia. 
Limitations and future directions   
The most significant limitation of the present work was the inability to assess 
the functional relevance of protein changes observed in these experiments. Although 
the identified proteins and subsequent bioinformatics analyses provide insight into 
the biochemical processes that may underlie the development occurring in the 
adolescent mPFC, these results are correlational and do not directly address the 
causative relationship, if any, between protein expression changes and 
structural/functional maturation.  However, the high-throughput nature of the 
proteomics analysis enabled the identification of several novel targets and signaling 
pathways, providing significant heuristic value for subsequent investigations. The 
Ingenuity Pathway Analysis provided useful insight into additional protein targets 
whose activity, but not expression, may be altered during adolescent brain 
development, but the suggested impact of development on predicted interaction 
proteins was not directly assessed in these experiments. Future work should confirm 
changes in the activity or phosphorylation state of protein predicted by IPA to be 
altered in the adolescent mPFC.  
The proteomic screen was conducted using 2D-DIGE and MALDI TOF/TOF 
MS, a high-throughput and cost-effective means of obtaining a “snapshot” of the 
mPFC proteome in adolescent and adult samples. However, gel-based proteomics 
applications have important limitations, the most significant of which are the inability 
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to detect low-abundance proteins and the difficulty of resolving membrane-bound 
proteins [74]. Several previous studies have examined the synaptic fraction of the 
mPFC proteome in developing rodents [17-20], thus the present findings add to a 
preexisting literature by shedding light on the whole-cell protein alterations occurring 
during adolescent brain maturation. Still, the methods used in these experiments 
leave open the strong possibility that additional proteins not detected here may be 
altered during cortical development.  
Additionally, the immunoblots were developed with radiography, which 
presents limited resolution compared with digital imaging systems. Subsequent 
experiments to expand the present findings could strengthen the conclusions 
reported herein by combining MS-based proteomics with digital imaging of 
immunoblots to confirm the protein expression changes observed. In the immunoblot 
experiments, actin was selected as a housekeeping protein due to its previous use 
as a loading control in development proteomics screens [18] and the lack of 
evidence for age differences in actin expression in the present proteomics 
assessment. Across all brain regions and proteins tested, the optical density of actin 
was not different between adolescents and adults. Nevertheless, the actin values 
were not compared to total protein in the immunoblot experiments, leaving open the 
possibility that loading errors could have occluded a genuine age difference, rending 
actin inappropriate as a housekeeping protein. However, four previous proteomics 
screen have failed to identify actin as developmentally altered during adolescent 
brain development [17-20]. Combined with the consistent lack of age differences in 
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actin optical density observed in each brain region tested, the possibility of occult 
age differences in actin expression remains but seems unlikely.  
During tissue collection, mice were perfused using 1.0M PBS to remove blood 
that could potentially contaminate brain tissue and alter the protein differences 
reported in the proteomics screen. However, this treatment entailed the use of an 
injected anesthetic, and injection stress could have altered the expression of 
identified proteins, as could the perfusion process itself. To avoid identifying age 
differences in proteins based on stress/perfusion alone, both adolescent and adult 
samples were treated identically during anesthesia and perfusion. Still, protein 
abundance in both ages could have been altered by these procedures.  
Conclusion 
The present findings supplement an existing body of work that suggests that 
adolescence is characterized by enhancement of neural pruning, synaptic plasticity, 
and morphological changes as the brain matures into adulthood. Importantly, many 
of the proteins identified in the current experiments have previously been observed 
to be altered at the protein level in mouse cortex [20] and at the gene expression 
level in the postmortem human adolescent cortex [75]. The results of the proteomics 
analysis provide novel insight into a wider array of molecular alterations that may 
underlie the large-scale alterations in cortical gray matter and connectivity observed 
during adolescence. Further, functional protein networks involved in cellular 
assembly and signaling point toward pathways for future research into the 
mechanistic regulation of postnatal brain development. Future experiments to 
evaluate the role of the identified proteins and signaling systems in adolescent brain 
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maturation, particularly in the context of psychiatric diseases such as schizophrenia, 
will shed further light on this crucial developmental period.  
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CHAPTER THREE- THE DRUNKEN ADOLESCENT PREFRONTAL CORTEX 
PROTEOME: CALCINEURIN AS A MOLECULAR MECHANISM OF ENHANCED 
ALCOHOL INTAKE AFTER ADOLESCENT ALCOHOL EXPOSURE 
Introduction 
 
 Alcoholism is a debilitating neuropsychiatric condition characterized by 
excessive alcohol consumption, physical dependence upon alcohol, and continued 
use of alcohol in the face of negative consequences of drinking. Incidence of 
alcoholism in the United States is approximately 6-10%, and alcohol-related disease 
and injury is the fifth leading cause of death in the US [1]. Current treatment 
modalities for alcoholism include cognitive-behavioral therapy, support groups such 
as Alcoholics Anonymous, and the medications Antabuse, acamprosate and 
naltrexone [2]. Unfortunately, despite these interventions relapse rates amongst 
alcoholics remain high (as much as 90% over four years) [3]. There is a pressing 
need for new treatments to help reduce alcohol drinking as well as interventions to 
prevent risky drinking from transitioning to an Alcohol Use Disorder (AUD). The 
study of at-risk populations advances both goals as it can inform prevention efforts 
as well as identify new molecular mechanisms of alcohol activity to target for 
medication development. One such at-risk population is adolescents, or 
children/young adults between ages 13-22. 
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Alcohol use during adolescence is associated with significantly increased risk for 
AUD during adulthood [4], suggesting that unique features of the adolescent brain 
may play a role in the lasting effects of alcohol exposure. 
 Adolescence is a distinct developmental period occurring during the transition 
from childhood to adulthood. This epoch is defined by unique behavioral and 
physiological characteristics that are conserved across mammalian species. 
Behaviorally, adolescents have been shown to exhibit increased impulsivity, risk-
taking and reward-related behaviors while also displaying cognitive deficits 
(particularly when under emotional duress) [5]. The behavioral phenotype of 
adolescence arises as a result of the differing developmental trajectories of sub-
regions of the brain. In both rodents and humans, adolescent brain development is 
driven by increases in white matter (indicative of myelination of maturing synapses) 
and decreases in gray matter (indicative of pruning of extraneous synaptic 
connections to increase synaptic efficacy) [6]. This development proceeds in an 
anterior-to-posterior fashion, with limbic brain regions such as the nucleus 
accumbens and amygdala maturing faster than forebrain regions such as the medial 
prefrontal cortex (mPFC) which participate in executive control of emotional behavior 
[7]. This mosaic of mature brain regions associated with reward, aversion and 
emotion and relatively immature forebrain regions that regulate these downstream 
regions may be responsible for the adolescent-typical behaviors exhibited by 
humans and rodents.  
 Adolescent experimentation with drugs of abuse, including alcohol, is 
extremely common; recent estimates in the United States indicate that 42% of high 
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school students routinely consume alcohol [8]. This widespread level of adolescent 
alcohol consumption is alarming, given that alcohol intake prior to age 21 is 
associated with an increase in lifetime risk for AUD ranging from 10-30% (with 
younger age of drinking onset associated with greater lifetime risk) [9]. Adolescents 
also consume more alcohol than adults in both humans and rodent models when 
intake is adjusted for body weight [10]. In accordance with the general behavioral 
manifestations of adolescent brain development, adolescents have been shown to 
have altered sensitivity to many of the acute effects of alcohol. Adolescents appear 
to be more sensitive to the rewarding and social facilitation effects of alcohol 
consumption but relatively insensitive to the aversive properties of alcohol [11]. 
Evidence also suggests that the cognitive impairment imparted by alcohol drinking 
may be more severe in adolescent drinkers [12]. However, the neurobiological 
mechanisms that mediate both altered sensitivity to alcohol during adolescence and 
long-term increased risk for AUDs following adolescent alcohol drinking remain 
unclear.    
 To investigate the role of adolescent brain development on sensitivity to 
alcohol, an unbiased high-throughput proteomics screen of the effects of alcohol on 
the adolescent and adult mPFC, respectively, was conducted following two weeks of 
intermittent 24-hour two-bottle choice drinking. The mPFC was chosen due to its 
clear role in regulating both alcohol drinking behavior [13] and adolescent-typical 
behavior [14], and previous work suggesting substantial differences in the 
adolescent and adult mPFC at the level of protein expression [15].  Next, to assess 
the functional relevance of the identified proteins in adolescent alcohol drinking, the 
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candidate protein calcineurin (PPP3) was selected for further manipulation. Systemic 
inhibition of calcineurin was achieved with the inhibitor FK506 and the effects of this 
drug on adolescent and adult alcohol and sucrose consumption were examined. 
Finally, to determine the role of calcineurin in the long-term risk for increased alcohol 
consumption following adolescent alcohol exposure, a model was developed using 
adolescent intermittent 24-hour TBC drinking followed by operant self-administration 
of alcohol in adulthood. Adolescent but not adult alcohol exposure produced long-
lasting increases in operant responding for alcohol, which was manipulated via 
systemic calcineurin inhibition with FK506. To determine whether calcineurin activity 
in the mPFC was responsible for the effects of FK506 on operant responding for 
alcohol, cannulae aimed at the mPFC were implanted and drug was infused directly 
into the mPFC. The findings suggest that differences between the adolescent and 
adult response of the mPFC to alcohol, and particularly calcineurin signaling in the 
mPFC, may be responsible for age differences in the effects of alcohol intake and 
mediate some of the risk for enhanced alcohol consumption following adolescent 
alcohol exposure. 
 
Materials and Methods 
 
Subjects 
Adolescent (postnatal day 21 [PND21]) and adult (PND65 ± 3) male 
C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME) were single-housed upon 
arrival in standard laboratory cages with corn-cob bedding and a small nestlet for 
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environmental enrichment. The colony was maintained on a 12-hour reverse 
light/dark cycle (lights on at 1900). All testing occurred during the dark cycle. Food 
and water were available ad libitum except where noted. All procedures were 
performed in accordance with the NIH Guide to the Care and Use of Laboratory 
Animals [16] and approved by the Internal Review Board as compliant with all 
institutional guidelines at the University of North Carolina, Chapel Hill. 
Proteomic analysis 
Intermittent Alcohol Drinking 
 All mice (n=12/age/dose) were given seven days to acclimate to vivarium 
conditions prior to testing. Beginning at 10:00AM on PND 28 (adolescent)/PND 72 
(adult), the home-cage water bottle was removed and replaced with two drinking 
tubes; mice in the alcohol groups received one tube with 20% alcohol (v/v) and one 
tap water tube, whereas mice in the water groups received two water tubes. The 
following day, all tubes were removed and replaced with two water tubes for all 
subjects. This intermittent home-cage access procedure was repeated at 24-hour 
intervals for two weeks, from PND 28-42 (adolescent) and PND 72-86 (adult). Intake 
was recorded at 2, 4 and 24-hour intervals throughout the drinking period. 
Tissue collection  
Beginning at 8:00AM on the last drinking day (PND 42/86), a time when blood 
alcohol levels were naturally low, all mice were weighed and deeply anesthetized 
with sodium pentobarbital (150 mg/kg, IP). Once anesthetized, mice were 
transcardially perfused with ice-cold phosphate-buffered saline (PBS, 0.1M, pH 7.4) 
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for 2 min at rate of 3 ml/min. Brains were flash-frozen in isopentane (2-
methylbutane; Sigma-Aldrich, St. Louis, MO) at -20 – -30°C for 1 min and stored at -
80°C. Tissue was sectioned coronally on a cryostat (Leica CM3050S, Leica 
Biosystems, Buffalo Grove, IL) and the mPFC was isolated with a 0.5 mm tissue 
slice taken +1.5-2.0 mm (± 0.2) anterior to Bregma. The mPFC was bilaterally 
dissected using a 1.0 mm sterile tissue punch. Tissue was pooled from n=3 mice per 
age, per dose resulting in a final group size of N=4 in each group for analysis on 4 
replicate 2D gels. Protein samples were kept at -80°C and shipped to Applied 
Biomics (Hayward, CA) for 2-D DIGE analysis. 
Proteomics 
Tissue samples were prepared for proteomics analysis as described in 
Chapter Two. Briefly, tissue was homogenized in lysis buffer, spun for supernatant, 
and protein concentration was determined using the Bio-Rad protein assay 
(Hercules, CA). All samples were diluted to 5 mg/ml in 2-D lysis buffer. Samples in 
each dose group were combined with the appropriate CyDye (water, Cy3 [green]; 
alcohol, Cy5 [red]) and prepared for electrophoresis.  
All 2D gels were run separately between the two ages, with alcohol and water 
compared within each age group only. Samples were run using isoelectric focusing 
(IEF) under dark conditions at 20°C using an established protocol (GE Healthcare, 
Pittsburgh, PA). Following IEF, the IPG strips were incubated in fresh equilibration 
buffer, washed and transferred to a 12% SDS gel for separation based on molecular 
weight (polyacramide gel electrophersis [SDS-PAGE[). Each of the four replicate 
gels within each age groups was scanned using a Typhoon TRIO imager 
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(GEHealthcare). Scanned images were analyzed by ImageQuantTL (IQTL) software 
(GE Healthcare) and subjected to both in-gel and cross-gel analyses using the 
DeCyder software package (v. 6.5, GE Healthcare), which provided a ratio change 
of protein expression from the in-gel analyses.  
Protein spots that met our a priori spot-picking criteria (differential expression 
in the same direction in all four gels, an overall significant difference in expression 
[p<0.05], and a 1.15-fold change or greater increase or decrease in expression) 
were isolated by the Ettan Spot Picker (GE Healthcare). Gel spots were washed and 
digested in-gel with a modified porcine trypsin protease (Trypsin Gold, Promega, 
Madison, WI) and spotted on the matrix-assisted laser desorption/ionization (MALDI) 
plate. Both MALDI-TOF (time-of-flight) mass spectrometry (MS) and TOF/TOF 
(tandem MS/MS) analyses were performed on a 5800 mass spectrometer (AB 
Sciex, Redwood City, CA).  
Peptide masses and fragmentation spectra were submitted to the MASCOT 
search engine (Matrix Science, Boston, MA) via GPS Explorer (v. 3.5) in order to 
search the database of the National Center for Biotechnology Information non-
redundant (NCBInr) for protein identifications. Ion score (chance that an 
experimentally observed peptide sequence and MASCOT database identity are 
matched based on random chance [-Log10P]) and protein score (sum of the highest 
ion scores for each sequence) were calculated; putative identifications with a protein 
score confidence interval greater than 95% were considered significant. Samples 
with multiple candidate proteins exceeding the identification criteria were assigned 
the putative identity with the highest protein score. 
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Phosphorylated Protein Expression Profiling 
 Following the total protein expression profiling, 2D-DIGE gels were fixed 
overnight and stained with ProQ Diamond (Fisher) to identify phosphoproteins in the 
gel. Gels were rinsed and imaged with the Typhoon TRIO Imager (GE Healthcare), 
then each image was compared with the total protein gel obtained during the protein 
expression experiment. Comparisons in the phospho-protein experiment were made 
within a single representative gel, with the Ettan Spot Picker identifying spots with 
significantly different phosphorylation staining between the alcohol and water 
samples, respectively within each age. Selected spots were then identified using 
tandem MS/MS as described above. Differences in phosphorylation between alcohol 
and water drinking samples were quantified using an internal control spot, astrocytic 
phosphoprotein PEA-15 (spot 14), that did not differ between the two drinking 
conditions in either adolescent or adult gels. p-values were not calculated for the 
phosphoprotein experiments since each experiment was conducted within a single 
gel, rather than across four replicates as with the total protein experiment.   
   
Bioinformatics 
Protein identifiers, fold-change, and p-values from the proteomic analyses 
were uploaded to QIAGEN’s Ingenuity Pathway Analysis (IPA; QIAGEN Redwood 
City, CA) system for dataset enrichment as described in Chapter Two. Proteins were 
assessed via Global Functional Analysis (GFA) and Global Canonical Pathways 
(GCP) to identify functional protein networks and canonical signaling systems that 
were impacted by alcohol exposure. Statistical significance was determined using 
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the right-tailed Fisher’s Exact Test to assess potential overrepresentation of target 
proteins biofunctions, disorders and canonical signaling pathways. Protein 
interaction networks were derived via Ingenuity’s interconnectivity algorithm. p 
values, representing the probability of finding proteins identified in the proteomics 
analysis (Focus Molecules) in a set of n genes randomly selected from the Global 
Molecular Network, were calculated using Fisher’s Exact Test and displayed as p-
scores [p-score = -log10 (p-value); i.e. p-score indicates the exponent of the 
significance of the protein network identification].  Ingenuity Pathway Designer 
(QIAGEN) was used to visualize the statistically significant protein interaction 
networks revealed by GFA. 
Pharmacology 
Acute Alcohol Drinking in Adolescence and Adulthood 
 Adolescent (n=12) and adult (n= 12) mice arrived at PND 21/65 and were 
housed as previously described. Beginning on PND 28/72, the home cage water 
bottle was removed at 10:00AM and replaced with one tube containing 20% alcohol 
(v/v) and one tube containing tap water for all subjects. The following day, all tubes 
were removed and replaced with two tubes containing tap water for all subjects. This 
intermittent access procedure was repeated for the duration of the experiment. 
During the first week of drinking, mice received habituation intraperitoneal (i.p.) 
injections of 20% β-cyclodextrin (BCD; Sigma) and intake was recorded at 2, 4 and 
24-hour intervals. Beginning on PND 36 (adolescent) and PND79 (adult), all subjects 
received the calcineurin inhibitor FK506 (0, 0.56, 1, or 3 mg/kg) 30 minutes prior to 
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the alcohol drinking session in a Latin square design. Drug testing continued on 
PND 38/81, 40/83 and 42/85. 
 To determine if effects of FK506 were associated with nonspecific changes in 
motor function, on PND 44/83 mice were given the lowest effective dose (1 g/kg 
FK506 i.p.) 30 minutes prior to a 2-hour open-field locomotor activity test. 
 To determine whether the effects of FK506 were selective for alcohol or 
generalized to other reinforcing solutions, a separate cohort of adolescent (n=6) and 
adult (n=6) was treated identically as above except drinking solutions consisted of 
1% sucrose and tap water. Beginning on PND 36/79, mice received either the lowest 
effective dose of FK506 (1 mg/kg i.p.) or vehicle in a randomized order. Injections 
were repeated on PND 38/81 in a within-subjects design. 
Model of Adult Operant Self-Administration Following Adolescent or Adult Alcohol 
Drinking 
 Adolescent (n=16) and adult (n=16) mice arrived at PND21/655 and were 
housed as previously described. Beginning on PND 28/72, the home cage water 
bottle was removed at 10:00AM and replaced with one tube containing 20% alcohol 
(v/v) and one tube containing tap water (alcohol exposure group; n=8/age) or two 
tubes containing tap water (water exposure group; n=8/age). The following day, all 
tubes were removed and replaced with two tubes containing tap water for all 
subjects. Intake was recorded at 2,4 and 24-hour intervals. This intermittent access 
procedure was repeated for two weeks, with the final drinking day occurring on PND 
42/85. Beginning on PND 43/86, the home-cage water bottle was returned to each 
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cage and mice were left undisturbed for a period of six weeks, apart from weekly 
handling and weighing.  
 Beginning on PND 89 (adolescent exposure groups)/PND 134 (adult 
exposure groups), mice were presented with one tube containing the reinforcing 
solution of 9% alcohol (v/v)/2% sucrose (w/v) and one tube containing tap water for 
24 hours in the home cage to familiarize the subjects with the solution. The following 
day, all bottles were removed and mice were water deprived for 23 hours to facilitate 
operant responding for the reinforcing solution. At the end of the deprivation period, 
beginning at 5:00PM mice began a 16-hour overnight operant self-administration 
session on afixed-ratio 1 (FR-1) schedule with 0% alcohol/2% sucrose as the 
reinforcing solution. For the next three days, overnight operant sessions were 
conducted on an escalating fixed ratio schedule; beginning with FR-1, after each 
mouse achieved 25 reinforcements the schedule was increased to FR-2 (i.e. two 
lever presses yield one reinforcement), and after each subject achieved 25 
reinforcements on an FR-2 schedule the schedule was increased to FR-4 (i.e. four 
lever presses yield one reinforcement). Once the FR-4 schedule was achieved, mice 
remained on this schedule for the duration of the overnight training sessions. 
 After the fourth overnight session, all subjects had achieved stable 
responding on the FR-4 schedule. Beginning on Monday of the following week, 
operant sessions were shortened to one hour occurring between 2:00PM-4:00PM 
daily Monday-Friday and all subjects responded on an FR-4 schedule. For the first 
week of operant testing, the concentration of alcohol in the reinforcing solution was 
increased daily from 0% to 3%-6%-9%-15% (while the sucrose concentration was 
 
 
142 
 
maintained at 2% throughout) to test the effect of age of alcohol exposure on 
operant responding across a range of doses. On the second week of operant 
testing, the alcohol concentration was reduced to 9% alcohol/2% sucrose and 
maintained at this concentration for the remainder of all operant experiments. To 
establish baseline differences in the effect of alcohol or water exposure on 
subsequent operant responding for sweetened alcohol in adulthood, mice continued 
operant sessions for 12 weeks, from PND 103-187 (adolescent exposure 
groups)/147-231 (adult exposure groups). 
Effect of Systemic Calcineurin Inhibition on Operant Responding for Alcohol 
 After baseline operant responding had been established, beginning on PND 
190 (adolescent exposure)/PND 233 (adult exposure) mice were given habituation 
injections of 20% BCD 30 minutes prior to operant sessions. A total of 8 habituation 
injections (2 injections/week) were administered until operant responding no longer 
decreased following injection. Beginning on PND 218 (adolescent exposure)/261 
(adult exposure), subjects were injected with 0, 0.56 or 1 mg/kg FK506 i.p. in a Latin 
square design 30 minutes prior to operant testing. Mice were injected over the 
course of two weeks, with at least two days between each injection.  
Effect of Intra-mPFC Microinjection of FK506 on Operant Responding for Alcohol 
 Following systemic pharmacology, mice in the adult exposure group were 
approaching PND 300 and were therefore transitioning into a geriatric state of 
development. Therefore, the remainder of the experiments were conducted in the 
adolescent alcohol or water exposure groups only. 
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Two weeks after the cessation of systemic pharmacology experiments, 
beginning on PND 246 mice were anesthetized with 3% isoflurane (Vet One, Boise, 
ID) placed within a stereotaxic frame (Kopf Instruments, Tujunga, CA) and implanted 
with unilateral 26-guage guide cannulae (Plastics One, Roanoke, VA) aimed at the 
right or left mPFC (approximate coordinates: AP +1.7mm; ML ±0.4mm; DV −1.2mm, 
from skull surface.) Cannulae were secured to the skull with dental cement (Durelon, 
Butler Schein, Dublin, OH) and 33-gauge obturators (Plastics One) were inserted. All 
subjects were given one week for recovery, during which each mouse was weighed 
daily, monitored for health problems, and administered ibuprofen (15 mg/kg i.g.) for 
analgesia.  
The following week, all subjects resumed operant responding for 9% 
alcohol/2% sucrose on an FR-4 schedule until operant responding returned to 
baseline for each subject. Once operant responding had stabilized, mice were given 
two sham injections and one habituation injection of 20% BCD to familiarize them 
with the injection procedure. After responding re-stabilized, mice were injected with 
either 20% BCD or FK506 (1 µg) immediately prior to the operant session.  
Materials 
Home-Cage Drinking 
 All drinking solutions (alcohol, sucrose and tap water) were presented to mice 
within tubes constructed from 10mL serological pipettes fitted with double ball-
bearing sippers. Customized ventilation mouse cage lids fitted with screws were 
used to fasten the tube securely to the lid. Each drinking experiment included two 
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empty cages with tubes of each fluid type to control for leakage. The amount leaked 
each day was averaged across all drinking days at the end of the testing period and 
subtracted from all mouse intake values (within solution).  
Operant Self-Administration 
 Self-administration sessions were conducted in 16 operant conditioning 
chambers (Med Associates, St. Albans, VT). Each operant chamber was housed 
within a sound-attenuating cubicle with a fan for ventilation and ambient noise 
suppression. Both lateral walls of each chamber contained a stainless steel lever 
with a cue light directly above and a drinking trough immediately adjacent. 
Responding on only one of the levers (the “active” lever) resulted in the delivery of a 
0.14 mL 9% alcohol (v/v)/2% sucrose (w/v) reinforcement via a connected syringe 
and pump, as well as the illumination of the cue light, whereas responding on the 
second lever (the “inactive” lever) had no contingency. Responses during 
reinforcement delivery (800ms) were measured but did not contribute towards the 
response requirement (time-out period). Each chamber was connected to an 
interface and computer that recorded lever presses (active and inactive), number of 
reinforcements delivered and head entries into the drinking trough for each subject 
(MED-PC for Windows v.4.1). 
Locomotor Activity 
 Open field activity was measured in Plexiglas activity monitor chambers (27.9 
cm2; ENV-510, Med Associates, Georgia, VT). Two sets of 16 pulse-modulated 
infrared photobeams were located on opposite walls and recorded X–Y ambulatory 
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movements. Distance traveled (in meters) throughout the session was quantified by 
assessing the mouse’s position in the open field every 100 miliseconds. Data from 
each chamber were collected by a computer. 
Drugs 
 Home cage alcohol drinking solutions were prepared by diluting 95% ethanol 
(Pharmco Products Inc., Brookfield, CT) with tap water (v/v). Home cage sucrose 
drinking solutions were prepared by dissolving sucrose in tap water (w/v). Operant 
reinforcing solutions were prepared by diluting 95% ethanol with tap water (v/v) and 
dissolving sucrose in the resulting solution (w/v). Sodium pentobarbital was freshly 
dissolved in 0.9% saline immediately prior to tissue collection. The calcineurin 
inhibitor FK506 was added to 20% β-cyclodextrin (BCD), sonicated and spun at 
room temperature to create a fine suspension. Doses were determined based on 
Beresford et al. 2012 [17]. Isoflurane was administered via inhalation through a 
nosecone attached to the stereotax and delivered at a flow rate of 0.05-0.08 L/min 
throughout the surgical procedures, beginning with 3% isoflurane/97% oxygen for 
anesthesia induction, 2% for drilling and cannula placement, and 1.5% for cementing 
and suturing. 
Data Analysis 
 All statistical analyses and graphical representation of behavioral data were 
performed using GraphPad Prism (version 6.0; GraphPad, La Jolla, CA).  
 In the home-cage drinking experiments, adolescent and adult alcohol and 
water drinking, respectively, and alcohol preference ratio were compared via two-
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way ANOVA (age X time). Blood alcohol levels were compared via two-tailed t-test 
(adolescent vs. adult). The effects of the calcineurin inhibitor FK506 on home-cage 
alcohol drinking were assessed via two-way repeated measures ANOVA (Dose X 
Time) separately between adolescents and adults, with Dunnett’s multiple 
comparisons test as the post-hoc analysis. The effects of FK506 on home-cage 
sucrose self-administration were assessed via two-tailed t-tests separately between 
adolescents and adults. The effects of FK506 on open-field locomotor activity were 
analyzed via two-way repeated measures ANOVA (dose X time) separately between 
adolescents and adults. The effects of FK506 on total distance traveled were 
analyzed via two-tailed t-test separately between adolescents and adults. One 
adolescent mouse was excluded from the alcohol drinking analysis due to failure to 
consume alcohol (average 24hr alcohol consumption < 3 g/kg).      
 In the operant experiments, operant responding for alcohol was averaged for 
each subject per week and analyzed via two-way repeated measures ANOVA (water 
vs. alcohol exposure, separately between adolescent and adult exposure). 
Adolescent and adult alcohol exposure mice were also directly compared across an 
increasing alcohol concentration curve via two-way repeated measures ANOVA 
(exposure age X dose). The effects of FK506 on operant responding for alcohol 
were assessed via two-way repeated measures ANOVA (exposure condition 
[alcohol vs. water] X FK506 dose) separately between adolescent exposure and 
adult exposure groups, with Sidak’s multiple comparisons test as the post-hoc 
analysis. The effects of mPFC microinjection of FK506 on operant responding for 
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alcohol were analyzed via two-tailed t-test separately between alcohol and water 
exposure groups.  
 
Results 
 
Proteomics 
Two-Bottle Choice Alcohol Drinking during Adolescence and Adulthood  
 Figure 9A depicts a timeline of the alcohol exposure procedure. Adolescent 
and adult mice consumed roughly equivalent amounts of alcohol (Figure 9B) and 
water (data not shown) over the two weeks of intermittent two-bottle choice drinking. 
A main effect of Day emerged (F [6, 132] = 19.03, p < 0.0001), with both 
adolescents and adults increasing their intake of alcohol over time. A trend for an 
Age X Day interaction emerged (p = 0.10), likely driven by the increase in alcohol 
intake exhibited by adolescent mice on the last two days of alcohol drinking. 
Average intake on the last drinking day was 31 g/kg/24hr for adolescents and 25 
g/kg/24hr for adults. Analysis of alcohol preference revealed an Age X Day 
interaction, F(6, 132) = 2.549, p <0.05.  
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Figure 9. Two-bottle choice home cage drinking in adolescent and adult male 
C57BL/6J mice. (A) Timeline of experimental procedure. (B) Adolescent and 
adult mice consumed similar amounts of 20% unsweetened alcohol in the 24-
hour, every-other-day two bottle choice procedure. (C) Adults displayed 
greater preference for alcohol on the first two days of drinking, after which 
both age groups exhibited similarly high preference for alcohol. (D) Blood 
alcohol levels obtained during tissue collection were equally low in both 
adolescent and adult mice. (E) Blood alcohol levels obtained from a separate 
cohort of mice treated identically to the proteomics animals were similarly 
high in both adolescent and adult subjects. (* indicates p <0.05) 
Sidak’s multiple comparisons test indicated that on the first two days of alcohol 
drinking, adult mice displayed increased preference for alcohol relative to adults 
(Day 1, p <0.05; Day 3, p < 0.0001; Figure 9C). Adolescent preference subsequently 
rose to match adult preferences on Day 5 and remained high for the duration of 
testing; adolescent preference on the last drinking day was 77% and adult 
preference was 83%. Blood alcohol samples obtained during tissue collection 
following the last drinking session revealed that both adolescent and adult BACs 
were minimal at the time of brain extraction (adolescent average BAC = 7.2 mg/dL, 
adult average BAC = 10.7 mg/dL; Figure 9D), and no age differences in BAC 
emerged (p >0.05). Blood samples from a separate cohort of mice run identically to 
the proteomics subjects were collected two hours into the drinking session on the 
last day of drinking. These samples confirmed that the two-bottle choice drinking 
procedure resulted in intoxicating levels of alcohol consumption, but no age 
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differences in BAC emerged from this cohort (adolescent average BAC = 149 
mg/DL, adult average BAC = 152 mg/dL, p > 0.05; Figure 9E). Proteomics Analysis 
 To identify proteins within the adolescent and adult mPFC, respectively, that 
were sensitive to alcohol drinking in terms of their expression, following two weeks of 
home-cage two-bottle choice alcohol or water drinking brains were collected and 
mPFC tissue was dissected for 2D-DIGE and subsequent mass spectrometry. The 
automated Ettan Spot Picker identified 43 spots with differential expression between 
the adolescent water and adolescent alcohol gels, of which 24 met the a priori 
inclusion criteria (Figure 10A). All 24 spots were identified using tandem MS/MS 
(Table 3).  
 
The automated Spot Picker identified 44 spots with differential expression 
between the adult water and adult alcohol gels, of which 16 met the a priori inclusion 
criteria (Figure 11A), and all 16 spots were identified using tandem MS/MS (Table 
4). 
Data in both age groups were analyzed as alcohol / water expression, with 
positive fold change representing increased protein expression following alcohol 
drinking and negative fold change representing decreased protein expression 
following alcohol drinking.  
 
 
 
 
151 
 
 
 
 
152 
 
Figure 10. Total protein and phosphoprotein 2D-DIGE gels of the adolescent 
mouse mPFC. 
(A) Adolescent total protein 2D-DIGE gel. Green CyDye labels water 
samples, red CyDye labels alcohol samples, and the predominantly yellow 
image shows the merge of the alcohol and water digital images. Significantly 
different spots are indicated in white on the merged image. Proteins are 
separated by IEF on the X axis and molecular weight on the Y axis. (B) 
Adolescent phosphoprotein staining for water (left panel) and alcohol (right 
panel) drinking. In each composite image, red staining indicates 
phosphoproteins and green indicates total protein imaged from the total 
protein experiment (i.e. Figure 10A).  
 
Table 3. 24 proteins with differential expression following two weeks of 
intermittent alcohol drinking in the adolescent mPFC. 
Protein Name 
Protein 
ID 
Spot 
# 
Peptid
e 
Count 
Protei
n 
Score 
Relativ
e 
Chang
e 
p- 
value 
CB1 cannabinoid 
receptor-interacting 
protein 1  
CRIP1A 14 9 199 -2.16 
< 
0.0001 
Calreticulin  CALR 1 22 665 -1.97 0.0021 
Actin ACTB 3 15 459 -1.81 0.0019 
Peroxisomal biogenesis 
factor 19  
PEX19 6 4 75 -1.76 0.0018 
Beta-synuclein  SNCB 17 3 199 -1.74 0.083 
NSFL1 cofactor p47  
NSFL1
C 
4 12 401 -1.73 0.0027 
Bis(5'-nucleosyl)-
tetraphosphatase  
NUDT2 19 10 199 -1.72 0.00021 
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Prostaglandin E 
synthase 3  
PTGES
3 
10 10 199 -1.55 0.077 
Calcineurin subunit B 
type 1  
PPP3R
1 
21 13 199 -1.51 0.0047 
Beta-synuclein  SNCB 16 7 199 -1.45 0.012 
Cofilin-2  CFL2 15 9 199 -1.44 0.017 
Putative hydrolase 
RBBP9  
RBBP9 12 7 199 -1.41 0.00062 
Actin ACTB 5 13 330 -1.37 0.002 
Clathrin light chain A  CLTA 7 8 153 -1.33 0.047 
Toll-interacting protein  TOLLIP 8 8 240 -1.26 0.019 
Calcineurin subunit B 
type 1  
PPP3R
1 
22 14 199 -1.24 0.0019 
Cytochrome b5  CYB5A 20 5 137 1.19 0.0087 
Protein BRICK1  BRICK1 23 5 199 1.32 0.0024 
Dynactin subunit 3  DCTN3 11 5 199 1.35 0.0025 
Cofilin-1 CFL1 13 5 199 1.38 0.072 
Gamma-enolase  ENO2 2 13 173 1.4 0.087 
Cytochrome c oxidase 
subunit 6B1 
COX6B
1 
24 7 199 1.46 
< 
0.0001 
Complexin-2  CPLX2 18 8 199 1.47 0.026 
Glyceraldehyde-3-
phosphate 
dehydrogenase 
GAPDH 9 11 199 2.37 0.045 
 
Table 3. 24 spots showed ≥15% difference in expression in all 4 adolescent 2D-
DIGE gels (p<0.05). Each spot was identified via MALDI TOF/TOF mass 
spectrometry with a confidence of 1.0. Spot change was expressed as fold 
change of alcohol from water, with negative numbers reflecting reduced 
expression in alcohol relative to water and positive numbers indicating greater 
expression in alcohol relative to water. Table is presented in order of lowest 
expression in the alcohol group to highest expression in the alcohol group.  
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Figure 11. Total protein and phosphoprotein 2D-DIGE gels of the adult mouse 
mPFC. 
(A) Adult total protein 2D-DIGE gel. Green CyDye labels water samples, red 
CyDye labels alcohol samples, and the predominantly yellow image shows 
the merge of the alcohol and water digital images. Significantly different spots 
are indicated in white on the merged image. Proteins are separated by IEF on 
the X axis and molecular weight on the Y axis. (B) Adult phosphoprotein 
staining for water (left panel) and alcohol (right panel) drinking. In each 
composite image, red staining indicates phosphoproteins and green indicates 
total protein imaged from the total protein experiment (i.e. Figure 11A).  
Table 4. 16 proteins with differential expression following two weeks of 
alcohol drinking in the adult mPFC. 
Protein Name 
Protein 
ID 
Spo
t # 
Peptide 
Count 
Protei
n 
Score 
Relative 
Change 
p 
Value 
Bis(5'-nucleosyl)-
tetraphosphatase 
NUDT2 10 3 85 -1.7 0.0038 
Clathrin light chain A  CLTA 3 9 283 -1.52 
< 
0.0001 
Myosin light 
polypeptide 6  
MYL6 11 9 234 -1.52 
0.0007
7 
Myosin light 
polypeptide 6  
MYL6 13 6 158 -1.46 
0.0006
2 
Calmodulin  CALM1 5 3 145 -1.39 0.0033 
Clathrin light chain A CLTA 2 10 331 -1.35 0.07 
Myosin light 
polypeptide 6  
MYL6 12 8 175 -1.35 0.011 
Cofilin-2  CFL2 8 8 337 -1.32 0.0046 
Calreticulin  CALR 1 20 738 -1.28 0.02 
Cytochrome c oxidase 
subunit 6B1  
COX6B
1 
16 6 330 1.2 0.0036 
 
 
156 
 
Neurogranin  NRGN 14 1 72 1.21 0.0025 
Complexin-2  CPLX2 7 7 177 1.26 0.074 
Histone H4 
HIST4H
4 
15 3 155 1.3 0.048 
Calmodulin  CALM1 6 3 81 1.34 0.027 
Dynactin subunit 3  DCTN3 4 8 328 1.45 0.002 
Low molecular weight 
phosphotyrosine 
protein phosphatase  
ACP1 9 6 141 1.66 
0.0009
5 
  
Table 4. 16 spots showed ≥15% difference in expression in all 4 adult 2D-DIGE gels 
(p<0.05). Each spot was identified via MALDI TOF/TOF mass spectrometry 
with a confidence of 1.0. Spot change was expressed as fold change of 
alcohol from water, with negative numbers reflecting reduced expression in 
alcohol relative to water and positive numbers indicating greater expression in 
alcohol relative to water. Table is presented in order of lowest expression in 
the alcohol group to highest expression in the alcohol group.   
 
Protein Phosphorylation 
 To determine the effects of alcohol drinking on protein phosphorylation in the 
adolescent and adult mPFC, the same gels used in the total protein expression 
assays were stained for phosphorylation and imaged. The automated Ettan Spot 
Picker identified 13 spots in the adolescent gels (Figure 10B) and 34 spots in the 
adult gels (Figure 11B) that exhibited differential phosphorylation between the 
alcohol and water conditions. All 47 spots were identified using tandem MS/MS 
(Table 5 [Adolescent] and Table 6 [Adult]).  
 
 
157 
 
Table 5. 14 spots with differential phosphorylation following two weeks of 
alcohol drinking in the adolescent mPFC. 
Protein Name 
Protein 
ID 
Spot # 
Peptide 
Count 
Protein 
Score 
Relative 
Change 
Myc box-dependent-
interacting protein 1  
BIN1 B 5 80 -2.24 
Calcineurin subunit alpha  PPP3A C 20 409 -0.55 
Tubulin alpha-1B chain  TBA1B 4 22 623 0.76 
Phosphatidylethanolamin
e-binding protein 1  
PEBP1 10 8 67 1.18 
Stathmin  STMN1 11 7 86 1.22 
Neurabin-2  NEB2 1 17 136 1.28 
Heterogeneous nuclear 
ribonucleoprotein K  
HNRPK 2 20 457 1.42 
Guanine nucleotide-
binding protein G(o) 
subunit alpha  
GNAO 5 17 772 1.54 
Alpha-soluble NSF 
attachment protein  
SNAA 8 25 590 1.63 
NADH dehydrogenase 1 
alpha subcomplex 
subunit 8  
NDUA8 13 12 409 2.27 
Spermatogenesis-
associated protein 22  
SPT22 12 5 42 2.43 
Drebrin DREB 50 14 323 2.67 
Aspartate 
aminotransferase, 
mitochondrial  
AATM 7 23 588 4.49 
Actin, cytoplasmic 2  ACTG 9 13 71 5.17 
      
Astrocytic 
phosphoprotein PEA-15 
PEA15 14 9 458 1.00 
 
Table 5. 14 spots showed ≥15% difference in expression in one adolescent 2D-
DIGE gel (p<0.05). Each spot was identified via MALDI TOF/TOF mass 
spectrometry with a confidence of 1.0. Spot change was expressed as fold 
change of alcohol from water, with negative numbers reflecting reduced 
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expression in alcohol relative to water and positive numbers indicating greater 
expression in alcohol relative to water. Table is presented in order of lowest 
expression in the alcohol group to highest expression in the alcohol group. 
Italics indicate the protein PEA15, which was used as an internal standard for 
relative change determination based on lack of change between alcohol and 
water conditions (fold change 1.00).  
Table 6. 34 spots with differential phosphorylation following two weeks of 
alcohol drinking in the adult mPFC. 
Protein Name 
Protein 
ID 
Spot 
# 
Peptide 
Count 
Protein 
Score 
Relative 
Change 
14-3-3 protein zeta/delta  1433Z J 19 792 -2.41 
Calcium/calmodulin-dependent 
protein kinase type II subunit alpha  
KCC2A G 14 116 -1.91 
Calcium/calmodulin-dependent 
protein kinase type II subunit alpha  
KCC2A H 8 82 -1.27 
Calcium/calmodulin-dependent 
protein kinase type II subunit alpha 
KCC2A I 21 687 -0.57 
Actin, cytoplasmic 2  ACTG 33 16 336 -0.41 
14-3-3 protein gamma  1433G K 6 62 -0.39 
Enolase-phosphatase E1  ENOPH 41 9 263 -0.36 
Dihydropyrimidinase-related protein 
2 
DPYL2 27 32 829 -0.06 
Myc box-dependent-interacting 
protein 1  
BIN1 25 28 467 0.04 
Calcineurin subunit alpha  PP2BA 28 22 236 0.15 
Tubulin alpha-1A chain  TBA1A 29 16 330 0.23 
UMP-CMP kinase  KCY 46 13 382 0.25 
Sushi repeat-containing protein 
SRPX2  
SRPX2 42 15 36 0.26 
Creatine kinase B-type  KCRB 32 14 158 0.26 
Serine racemase  SRR 36 11 281 0.30 
Dynactin subunit 3  DCTN3 47 7 223 0.34 
Transcriptional activator protein Pur-
alpha  
PURA 35 8 336 0.37 
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Amphiphysin AMPH 22 18 585 0.39 
Actin, cytoplasmic 2  ACTG 34 17 529 0.39 
Pleckstrin homology-like domain 
family A member 1  
PHLA1 45 6 39 0.41 
Serine/threonine-protein 
phosphatase PP1-alpha catalytic 
subunit  
PP1A 37 21 513 0.43 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-2  
GBB2 38 20 551 0.69 
Malate dehydrogenase, cytoplasmic  MDHC 39 11 242 0.73 
Actin-related protein 3  ARP3 31 24 650 0.73 
Neurofilament medium polypeptide  NFM 21 30 772 0.79 
S-phase kinase-associated protein 1  SKP1 48 14 379 0.82 
Actin, cytoplasmic 1  ACTB 43 12 179 0.83 
Gamma-enolase  ENOG 30 17 349 0.86 
Microtubule-associated protein 
RP/EB family member 1  
MARE1 40 12 347 0.90 
78 kDa glucose-regulated protein  GRP78 26 29 951 1.06 
Heat shock protein HSP 90-beta HS90B 23 32 732 1.64 
Sepiapterin reductase  SPRE 44 14 181 2.11 
Heat shock protein HSP 90-beta  HS90B 24 28 726 2.53 
ATP synthase subunit delta ATPD 49 2 167 3.60 
      
Astrocytic phosphoprotein PEA-15 PEA15 14 9 458 1.00 
 
Table 6. 34 spots showed ≥15% difference in expression in one adult 2D-DIGE gel 
(p<0.05). Each spot was identified via MALDI TOF/TOF mass spectrometry 
with a confidence of 1.0. Spot change was expressed as fold change of 
alcohol from water, with negative numbers reflecting reduced expression in 
alcohol relative to water and positive numbers indicating greater expression in 
alcohol relative to water. Table is presented in order of lowest expression in 
the alcohol group to highest expression in the alcohol group. Italics indicate 
the protein PEA15, which was used as an internal standard for relative 
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change determination based on lack of change between alcohol and water 
conditions (fold change 1.00).   
  Data in both groups were expressed as a fold change of alcohol / water 
phosphorylation, with fold changes > 1.0 indicating increased phosphorylation 
following alcohol drinking and ratios < 1.0 indicating decreased phosphorylation 
following alcohol drinking (Tables 2 and 3).    
Bioinformatics 
Ingenuity Global Functional Analysis and Global Canonical Pathway Analysis. 
 All proteins identified in the total protein expression analysis in both age 
groups were separately uploaded to Ingenuity Pathway Analysis for Global 
Functional Analysis (GFA) and Global Canonical Pathway (GCP) assessment. 
Among adolescent mice, GFA indicated that two weeks of intermittent alcohol 
drinking was associated with changes in several major cellular processes, including 
cellular signaling, cellular assembly, cellular function, nervous system development, 
neurological disease and behavior (Table 7). Five canonical pathways, including 
actin cytoskeletal signaling, were predicted to be impacted by the drinking procedure 
in adolescents, with key upstream regulators IGF2BP1, MECP2, FMR1, ADORA2A 
and PPARG. 
 In adult mice, two weeks of intermittent alcohol drinking was 
associated with changes in cellular signaling, function and assembly only (Table 8). 
Four canonical pathways, including Ephrin B signaling, were predicted to be 
 
 
161 
 
impacted by the drinking procedure in adolescents, with the key upstream regulator 
PPARG.  
 
 
Table 7. Role of proteins identified in the adolescent mPFC in biofunctions, 
disorders and canonical signaling pathways.  
Biofunctions and Disorders 
 
Function/Disorder p-value 
Higher 
in water 
Higher in 
alcohol 
Cell-to-Cell Signaling and Interaction    
Neurotransmission 0.00112 
PPP3R1
, SNCB 
CPLX2 
Synaptic transmission 0.0123 
PPP3R1
, SNCB 
 
Excitatory postsynaptic potential of neurons 0.00748  CPLX2 
Excitatory postsynaptic potential of cerebral 
cortex 
0.003  CPLX2 
Miniature excitatory postsynaptic currents 0.003  CPLX2 
Long-term potentiation of mossy fibers 0.00897  CPLX2 
Long-term depression 0.0119 PPP3R1 CFL1 
Long-term depression of hippocampus CA1    
Delay in initiation of calcium clearance 0.0045  CFL1 
Cellular Assembly/Organization & 
Development 
  
Transport of synaptic vesicles 0.000972 SNCB CPLX2 
Exocytosis of synaptic vesicles 0.0149  CPLX2 
Size of excitatory synapses 0.0045 SNCB  
Priming of vesicles 0.00208  CPLX2 
Quantity of nerve endings 0.00282 SNCB  
Behavior    
Learning 0.00501 PPP3R1 CFL1 
Aversion learning 0.0015  CFL1 
Reward learning 0.0015  CFL1 
Object localization task learning 0.0015  CFL1 
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Working memory 0.00599 PPP3R1  
Cellular Function & Molecular Transport    
Calcium-triggered exocytosis 0.003  CPLX2 
Exocytosis by neurons 0.003  CPLX2 
Nervous System Development    
Development of Schwann cells 0.0267 PPP3R1  
Neurogenesis of dentate gyrus 0.0296 SNCB  
Abnormal morphology of striatum 0.0383 SNCB  
Neurological Disease    
Huntington's Disease 0.0172 PPP3R1 ENO2 
Progressive high-frequency hearing 
impairment 
0.0015 ACTB  
Canonical Pathways and Upstream Regulators 
Pathways p-value 
Higher 
in water 
Higher in 
alcohol 
Actin Cytoskeleton Signaling 0.0002 
ACTB, 
CFL2 
BRICK1, 
CFL1 
Glycolysis I 0.000401  
ENO2, 
GAPDH 
Gluconeogenesis I 0.000401  
ENO2, 
GAPDH 
RhoA Signaling 0.000567 
ACTB, 
CFL2 
CFL1 
Rac Signaling 0.000629 CFL2 
BRICK1, 
CFL1 
Regulators    
IGF2BP1 0.00148 ACTB  
MECP2 0.00158 ACTB CYB5A 
FMR1 0.00191  
CFL1, 
GAPDH 
ADORA2A 0.0068 PPP3R1 GAPDH 
PPARG 0.00191  CPLX2 
  
Table 7. Adolescent proteomics results were analyzed via Ingenuity Pathway 
Analysis for known interactions with other proteins, signaling systems and 
networks in the Ingenuity Knowledge Base. Proteins with decreased 
expression after alcohol drinking are shown on the right, and proteins with 
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increased expression after alcohol drinking are shown on the left. p-values 
were derived from Ingenuity Pathway Analysis by right-tailed Fisher exact test 
and indicate relative overrepresentation of proteins in a given function 
compared with what is expected by chance.      
Table 8. Role of proteins identified in the adult mPFC in biofunctions, 
disorders and canonical signaling pathways.  
Biofunctions and Disorders 
Function/Disorder p-value 
Higher in 
water 
Higher in 
alcohol 
Cell-to-cell signaling & nervous system 
development 
   
Excitatory postsynaptic potential of cerebral 
cortex cells 
0.00321  CPLX1 
Excitatory postsynaptic potential of neurons 0.00321  CPLX1 
Miniature excitatory postsynaptic currents 0.00321  CPLX1 
Long-term potentiation of mossy fibers 0.00385  CPLX1 
Cellular Function & Molecular Transport    
Calcium triggered exocytosis 0.00129  CPLX1 
Exocytosis of neurons 0.00129  CPLX1 
Cellular Assembly & Organization    
Exocytosis of synaptic vesicles 0.00642  CPLX1 
Priming of vesicles 0.00897  CPLX1 
Canonical Pathways and Upstream Regulators 
Pathways    
Ephrin B signaling 
0.00086
8 
CFL2 ACP1 
PAK Signaling 0.00153 
CFL2, 
MYL6 
 
Cdc42 Signaling 0.0018 
CFL2, 
MYL6 
 
RhoA Signaling 0.00213 
CFL2, 
MYL6 
 
Regulators    
PPARG 0.00824  CPLX2 
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Table 8. Adult proteomics results were analyzed via Ingenuity Pathway Analysis for 
known interactions with other proteins, signaling systems and networks in the 
Ingenuity Knowledge Base. Proteins with decreased expression after alcohol 
drinking are shown on the right, and proteins with increased expression after 
alcohol drinking are shown on the left. p-values were derived from Ingenuity 
Pathway Analysis by right-tailed Fisher exact test and indicate relative 
overrepresentation of proteins in a given function compared with what is 
expected by chance.  
Ingenuity Pathway Analysis 
 Ingenuity Pathway Analysis was performed to identify protein networks 
statistically predicted to be impacted by the effects of alcohol in the adolescent and 
adult mPFC, respectively. In the adolescent mPFC, four statistically significant 
protein interaction networks were predicted to have altered function following alcohol 
drinking. The most significant interaction network was associated with behavior, cell-
to-cell signaling and interaction, and nervous system development/function and 
contained the identified proteins PPP3R1, ACTB, GAPDH, CYB5A and CFL1 
(Figure 12).  
In the adult mPFC, two statistically significant protein interaction networks 
were found to be impacted by alcohol drinking. The most significant network was 
associated with neurological disease, organismal injury/abnormality and cellular 
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compromise and contained the identified proteins CFL2, CLTA and CPLX2 (Figure 
13). 
 
Figure 12. Adolescent alcohol drinking impacts a functional protein 
network involved in behavior, cell-to-cell signaling/interaction and 
nervous system development/function. Visualization of a protein 
interaction network in the adolescent mPFC identified by Ingenuity Pathway 
Analysis as being altered by alcohol drinking (p-score= 9). Proteins shown in 
green exhibited decreased expression in the alcohol drinking tissue, proteins 
in green exhibited increased expression in the alcohol drinking tissue, and 
proteins in yellow indicate statistically significant interaction proteins identified 
by IPA network analysis. Solid lines indicate a direct interaction, and dashed 
 
 
166 
 
lines indicate an indirect interaction mediated by additional, non-significant 
proteins. 
 
 
Figure 13. Adult alcohol drinking impacts a functional protein network 
involved in neurological disease, organismal injury/abnormality and 
cellular compromise. Visualization of a protein interaction network in the 
adult mPFC identified as being altered by alcohol drinking (p-score = 8). 
Proteins shown in green exhibited decreased expression in the alcohol 
drinking tissue, proteins in green exhibited increased expression in the 
alcohol drinking tissue, and proteins in yellow indicate statistically significant 
interaction proteins identified by IPA network analysis. Solid lines indicate a 
direct interaction, and dashed lines indicate an indirect interaction mediated 
by additional, non-significant proteins. 
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Identification of Calcineurin in the Adolescent and Adult mPFC 
 The protein calcineurin (PPP3R1) was identified as having alcohol-sensitive 
total protein expression in the adolescent mPFC. Calcineurin appeared in two spots 
on the adolescent gels, Spot #21 (Figure 14A) and Spot #22 (Figure 14B). At Spot 
#21, the expression of total calcineurin protein was decreased by 51% following 
alcohol drinking (Figure 14A). At Spot #22, the expression of total calcineurin protein 
was decreased by 24% following alcohol drinking (Figure 14B). Changes in 
calcineurin expression were not detected in the adult alcohol/water gels. In the 
phosphorylated protein assay, calcineurin was detected in both the adolescent and 
adult alcohol / water comparisons, respectively. In the adult gel, calcineurin 
phosphorylation was increased by 15% following alcohol drinking (Figure 14C, left 
gray bar). In the adolescent gel, calcineurin phosphorylation was decreased by 55% 
following alcohol drinking (Figure 14C, right blue bar). Based on the age differences 
in alcohol sensitivity to both protein expression and protein phosphorylation, 
calcineurin was selected as a focus protein for further pharmacological assessment 
in adolescent and adult mice. 
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Figure 14. Alcohol drinking reduces calcineurin expression and 
phosphorylation in the adolescent but not adult mPFC. (A) At Spot #21 in 
the adolescent mPFC gel, calcineurin expression was reduced by 51% in 
alcohol drinking mice compared with water. (B) At Spot #22 in the adolescent 
mPFC gel, calcineurin expression was reduced by 24% in alcohol drinking 
mice compared with water. (C) In the adult mPFC, calcineurin 
phosphorylation was increased by 15% in alcohol drinking mice compared 
with water (left gray bar). In the adolescent mPFC, calcineurin 
phosphorylation was decreased by 55% in alcohol drinking mice relative to 
water drinking mice (right blue bar). (** indicates p < 0.01) 
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Role of Calcineurin Signaling in Alcohol Drinking 
Effects of FK506 on Adolescent and Adult Two-Bottle Choice Drinking 
 To determine the contributions of calcineurin signaling to adolescent and 
adult alcohol drinking, the selective calcineurin inhibitor FK506 was administered 30 
minutes prior to a 24-hour intermittent alcohol drinking procedure in adolescent and 
adult mice. Figure 7A depicts a timeline of the experimental procedure. Overall, the 
24-hour intake data displayed a trend for increased adolescent alcohol consumption 
relative to adults (adolescent average intake = 19 g/kg, adult average intake = 15 
g/kg, p = 0.09; data not shown.) Analysis of adolescent alcohol intake data revealed 
main effects of Dose (F[3, 40] = 6.912, p <0.001) and Time (F[1, 40] = 43.60, p < 
0.0001), as well as a Dose X Time interaction (F[3, 40] = 4.322, p < 0.01). Dunnett’s 
multiple comparisons test indicated that at the four-hour time point, both the 1 and 3 
mg/kg doses of FK506 reduced alcohol drinking in adolescent mice (Figure 7B). 
Adult alcohol intake data also indicated main effects of Dose (F[3, 44)]= 4.838, p < 
0.01) and Time (F[1, 44] = 64.59, p < 0.0001), as well as a Dose X Time interaction 
(F[3, 44] = 6.112, p < 0.01). Dunnett’s multiple comparison test indicated that at the 
four-hour time point, only the 3 mg/kg dose of FK506 was effective at reducing 
alcohol intake in adult mice (Figure 7C). In both adolescent and adult mice, no 
effects of FK506 remained by the 24-hour time point (p > 0.05; data not shown.)  
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Figure 15. Adolescent mice exhibit increased sensitivity to the reduction 
in alcohol drinking induced by pretreatment with a calcineurin inhibitor. 
(A) Timeline of experimental procedures. (B) Both 1 and 3 mg/kg FK506 
reduced alcohol drinking in adolescent mice at the four-hour time point. (C) 
Only the 3 mg/kg dose of FK506 reduced alcohol drinking in adult mice. (D) 
FK506 had no effect on sucrose drinking in adolescents. (E) FK506 had no 
effect on sucrose drinking in adults. (F) FK506 did not alter open-field 
locomotor activity in adolescents in terms of distance over time (main image) 
or total distance traveled (insert). (G) FK506 did not alter open-field locomotor 
activity in adults in terms of distance over time (main image) or total distance 
traveled (insert).  
To determine whether the effects of FK506 were selective for alcohol or 
generalized to other reinforcing solutions, a separate group of adolescent and adult 
(n =6) male mice consumed 1% sucrose and tap water in a two-bottle choice 
procedure in the home cage and were tested with the lowest effective dose of FK506 
(1 mg/kg). Neither adolescent (Figure 15D) nor adult (Figure 15E) mice displayed 
any changes in sucrose intake following FK506 pretreatment (p > 0.05).    
 In the open-field test, a main effect of time emerged in adolescent mice, F(23, 
230) = 37.93, p < 0.0001, with mice in both treatment groups tending to decrease 
locomotor activity over the course of the two-hour test. No effect of FK506 emerged 
in adolescent mice, either in the distance over time (Figure 15F, main panel) or total 
distance traveled (Figure 15F, insert) data (p > 0.05). Adult mice displayed a similar 
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lack of effect of FK506 (p > 0.05) on locomotor activity in distance over time (Figure 
15G, main panel) and total distance traveled (Figure 15G, insert). 
Effects of Adolescent and Adult Alcohol Drinking on Subsequent Operant 
Responding for Alcohol 
To establish a model for the lasting effects of adolescent alcohol exposure on 
adult behavior, adolescent and adult mice were exposed to seven days of 24-hour 
two-bottle choice home cage alcohol or water drinking. Following a six and a half-
week abstinence period, during which adolescent mice matured to adulthood, all 
subjects were trained to self-administer 9% alcohol/2% sucrose in operant 
chambers. Figure 16A depicts a timeline for the entirety of the operant behavior 
experiments. During the initial two-bottle choice drinking, no age differences 
emerged in 24-hour alcohol intake (adolescent average intake = 17 g/kg, adult 
average intake = 14 g/kg on the last drinking day, p > 0.05; Figure 16B) or alcohol 
preference (adolescent average preference = 46%, adult average preference = 56%, 
p > 0.05; Figure 16C). Blood alcohol concentration also did not differ between the 
two ages when assayed two hours into the drinking session on the last day of 
drinking (adolescent average BAC = 63 mg/dL, adult average BAC = 77 mg/dL, p > 
0.05; Figure 16D).   
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Following the six and a half weeks of aging, mice were first tested on an 
increasing alcohol concentration curve during one-hour test sessions in the operant 
chambers. A main effect of concentration emerged, F(3, 39) = 99.83, p < 0.0001, 
indicating that mice achieved a higher dose of alcohol with increasing alcohol 
concentration. A main effect of exposure age was also evident, F(1, 13) = 5.9610.05, 
indicating that across all concentrations tested, mice exposed to alcohol during 
adolescence achieved a higher dose of alcohol than mice exposed to alcohol during 
adulthood (Figure 16E).   
Figure 16. Adolescent but not adult alcohol drinking increases operant 
responding for sweetened alcohol in adulthood. (A) Timeline of the 
entirety of experiments in the operant self-administration context. (B) 
Adolescent and adult mice consumed similar amounts of alcohol in a two-
bottle choice home-cage drinking procedure. (C) Preference for alcohol in the 
home-cage drinking did not differ between adolescent and adult mice. (D) 
Blood alcohol levels collected two hours into the last day of home cage 
alcohol drinking did not differ between adolescent and adult mice. After 
adolescent mice had reached adulthood (P90), both adolescent and adult 
mice were tested for subsequent operant responding for alcohol. (E) Upon 
initial testing across an alcohol concentration curve, mice exposed to alcohol 
during adolescence exhibited increased operant self-administration of alcohol 
compared with mice exposed to alcohol during adulthood. (F) Over a 12-week 
baseline testing period, mice with exposure to alcohol during adolescence 
exhibited increased operant responding for alcohol as compared with mice 
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exposed to water during adolescence. (G) No differences emerged between 
adults with a history of either alcohol or water drinking. (** indicates p < 0.01) 
Over the next 12 weeks of testing, operant responding for 9% alcohol/2% 
sucrose was compared within each treatment age to determine the specific effects of 
the timing of alcohol exposure on subsequent operant responding for alcohol. In 
mice exposed during adolescence, a main effect of Time emerged, F(11, 154) = 
8.811, p < 0.0001, with mice exposed to both alcohol and water increasing their 
operant responding for alcohol over time. A significant Exposure Condition X Time 
interaction also emerged, F(11, 154) = 2.637, p < 0.01. Although no individual day 
reached significance via Sidak’s multiple comparisons test, the trend evidenced by 
the data indicate that after the first six weeks of responding, the adolescent alcohol 
exposure group exhibited increased responding for alcohol compared to the 
adolescent water exposure group (Figure 16F). The same Exposure Condition X 
Time interaction emerged in the number of reinforcements earned (F[11, 154] = 
2.532, p < 0.01) and dose of alcohol achieved (F[11, 154] = 2.781, p < 0.01; data not 
shown.)  
In mice exposed during adulthood, only a main effect of Time emerged, with 
mice exposed to both alcohol and water during adulthood increasing their operant 
responding for alcohol over time (F[11, 154] = 5.818, p < 0.0001; Figure 16G). No 
significant main effects or interactions by Exposure Condition emerged for active 
lever responses, reinforcements earned, or dose of alcohol achieved, p > 0.05. 
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Effects of Systemic Calcineurin Inhibition on Operant Responding for Alcohol 
After baseline responding had been established, the calcineurin inhibitor 
FK506 was administered systemically via i.p injection 30 minutes prior to a 1-hour 
operant self-administration session. This experiment assessed the effects of FK506 
on the reinforcing properties of alcohol in mice with or without a history of adolescent 
alcohol drinking. In mice exposed to alcohol or water during adolescence, a Dose X 
Exposure Condition interaction emerged, F(2, 24) = 5.902, p < 0.01; Figure 17A. 
Sidak’s multiple comparisons test revealed that mice exposed to alcohol 
drinking during adolescence exhibited reductions in operant responding for alcohol 
after pretreatment with both the 0.56 (p < 0.05) and 1 mg/kg (p < 0.01) doses of 
FK506 (Figure 17A). Mice exposed to water drinking were insensitive to both doses, 
p > 0.05. The same interaction was observed in the dose of alcohol achieved, F(2, 
24) = 6.236, p < 0.01, with Sidak’s test indicating that both the 0.56 (p < 0.05) and 1 
mg/kg ( p <0.01) doses of FK506 reducing g/kg alcohol intake in the operant setting 
(Figure 17B). No differences in percent responding on the active lever were 
observed in either the water or alcohol exposure groups (p > 0.05, Figure 17C.)  
In mice exposed to either alcohol or water during adulthood, no significant 
effects of FK506 on operant responding for alcohol emerged in either exposure 
condition. Active lever responses (Figure 17D), dose of alcohol achieved (Figure 
17E), and percent responding on the active lever (Figure 17F) were all unaffected by 
FK506 pretreatment (p > 0.05).  
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Figure 17. The calcineurin inhibitor FK506 selectively reduces operant self-
administration of sweetened alcohol only in mice with a prior history of 
adolescent alcohol exposure. (A) FK506 reduced operant responding for 
alcohol in mice with a history of adolescent alcohol (dark blue) but not water 
(light blue) drinking. (B) FK506 reduced the dose of alcohol obtained by mice 
with a history of adolescent alcohol (dark blue) but not water (light blue) 
drinking. (C) FK506 did not alter the proportion of responding on the active 
versus inactive lever in mice with a history of adolescent alcohol (dark blue) 
or water (light blue) drinking. (D) FK506 did not alter operant responding for 
alcohol in mice with exposure to either alcohol (dark grey) or water (light grey) 
in adulthood. (E) FK506 did not alter alcohol dose achieved of mice with 
either a history of adult alcohol (dark grey) or water (light grey) drinking. (F) 
FK506 did not alter the proportion of responses on the active versus inactive 
lever in adult mice with a prior history of alcohol (dark grey) or water (light 
grey) drinking.  
Effect of Intra-mPFC Calcineurin Inhibition on Operant Responding for Alcohol 
In contrast to the systemic experiments, this site-directed experiment was 
designed to determine the effects of calcineurin inhibition specifically within the 
mPFC on the reinforcing properties of alcohol in mice with or without a history of 
adolescent alcohol exposure. Owing to the advanced age of the mice in the adult 
exposure condition and the insensitivity to the systemic effects of FK506 in these 
groups, FK506 microinjection experiments were conducted in the adolescent alcohol 
and water exposure groups only. Among mice exposed to alcohol during 
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adolescence, 1µg of FK506 microinjected into the mPFC significantly increased 
operant responding for alcohol (t[3] = 4.70, p < 0.05; Figure 18A) and dose of 
alcohol achieved during the operant session (t[3] = 4.08, p < 0.05; Figure 18B). 
FK506 microinjection did not affect percent responding on the active lever, p > 0.05 
(Figure 18C).  
Among mice exposed to water during adolescence, 1µg of FK506 
microinjected into the mPFC did not alter operant responding for alcohol (Figure 
18D), dose of alcohol achieved during the operant session (Figure 18E), or percent 
responding on the active lever (Figure 18F; p > 0.05 for all comparisons). 
 
Discussion 
 
 The use of alcohol by adolescents is both widespread and associated 
with increased risk for alcoholism during adulthood, but the neurobiological 
mechanisms behind these related phenomena remain unclear. The present 
experiments were designed to identify differences between the adolescent and adult 
mPFC proteome response to voluntary alcohol drinking, and assess the functional 
relevance of alcohol-sensitive proteins in the risk for increased alcohol self-
administration in adulthood after alcohol drinking during adolescence. Here we 
provide evidence of qualitatively distinct responses of the adolescent and adult 
mPFC, respectively, to voluntary alcohol drinking. 
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Figure 18. Intra-mPFC calcineurin inhibition increases operant responding for 
alcohol selectively in mice with a history of adolescent alcohol, but not 
water, drinking. (A) FK506 (1µg) increased operant responding for alcohol in 
mice with prior history of alcohol drinking during adolescence. (B) FK506 
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increased the dose of alcohol consumed in mice with a prior history of alcohol 
drinking during adolescence. (C) FK506 did not alter percent responding on 
the active lever in mice with a prior history of alcohol drinking during 
adolescence. (D) FK506 did not alter operant responding for alcohol in mice 
with a prior history of water drinking during adolescence. (E) FK506 did not 
alter dose of alcohol cosumed in mice with a prior history of water drinking 
during adolescence. (F) FK506 did not alter percent responding on the active 
lever in mice with a prior history of alcohol drinking during adolescence. (* 
indicates p <0.05, ** indicates p < 0.01)  
 
In terms of the degree of protein expression impacted by alcohol and extent 
of functional protein networks altered by drinking, the adolescent mPFC appears to 
be more sensitive to the effects of alcohol than the adult mPFC. The protein 
calcineurin (PPP3) was chosen for functional assessment based on baseline age 
differences in expression and differential sensitivity to alcohol between adolescent 
and adult mice. When tested during the adolescent versus adult development 
periods, respectively, calcineurin inhibition more potently reduced alcohol intake in 
adolescent mice compared with adult mice. Next, we provide evidence that seven 
days of alcohol drinking in adolescence increases operant self-administration during 
adulthood, a model of findings reported in the human literature. In mice with a history 
of adolescent, but not adult, alcohol drinking, systemic calcineurin inhibition reduces 
operant alcohol self-administration. Lastly, inhibition of calcineurin in the mPFC 
increased operant alcohol self-administration in mice with a history of alcohol, but 
 
 
182 
 
not water, drinking during adolescence. Taken together, these findings suggest that 
acute age differences in the protein-level response of the mPFC to alcohol may have 
lasting effects that underlie the longitudinal vulnerability to AUDs observed after 
adolescent alcohol drinking. 
Proteomics  
 In the adolescent mPFC, 24 proteins were identified as alcohol-sensitive. Of 
these 24, two-thirds (16) were downregulated by alcohol drinking whereas the 
remainder (8) were upregulated by alcohol drinking (Table 1). Of the identified 
proteins, six have established roles in neurotransmitter signaling:  CRIP1A [18], 
CALR [19], TOLLIP [20], DCTN3 [21], NSFL1C [22] and PTGES3 [23]. An additional 
four proteins have explicit roles in neurotransmission related to synaptic plasticity: 
SNCB [24], PPP3R1 [25], CFL1 and CFL2 [26] and CPLX2 [27]. Three proteins have 
been shown to be involved in neuronal structure: ACTB [28], CLTA [29] and BRICK1 
[30]. The remaining proteins are mostly related to cellular metabolism. 
 In the adult mPFC, 16 proteins were identified as alcohol-sensitive. Of these, 
there was a roughly even split between proteins upregulated and downregulated by 
alcohol drinking (Table 2). Of the identified proteins, five were also identified in the 
adolescent mPFC: CLTA, CPLX2, COX6B1, DCTN3, NUDT2. Of the remaining 
seven unique proteins identified in the adult mPFC, two had discrete roles  in 
neurotransmitter signaling (ACP1 [31] and CALR [32]) while an additional two have 
specific functions in synaptic plasticity: CALM [33]  and NRGN [34]. One structural 
protein was unique to the adult mPFC (MYL6 [35]). The histone protein H4 was also 
identified, which plays a key role in gene regulation [36].     
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The design of the proteomics experiments directly compared mPFC tissue 
from alcohol and water drinking mice separately within each age group. As such, 
quantitative comparisons between adolescents and adults as to the amount of 
expression change at individual spots are not appropriate. However, qualitative 
comparisons between the two age groups reveal important differences in their 
respective responses to alcohol. In the protein expression experiment, about 75% of 
the identified proteins were unique to the adolescent mPFC, with only five proteins 
exhibiting alcohol sensitivity in both the adolescent and adult tissue. This result 
speaks to the markedly different impact that alcohol has on the mPFC between the 
two developmental stages. In the adolescent mPFC, a total of 24 proteins were 
identified as alcohol-sensitive, with three proteins appearing twice in the list for a 
total of 21 unique spots. These duplicates likely represent differing post-translational 
modifications of the identified proteins; as can be seen in Figure 2A, all three 
duplicates (actin, spots #3 and 5; calcineurin, spots #21 and 22; β-synuclein, 
spots#16 and 17) are in close proximity to one another and exhibit small shifts in IEF 
or molecular weight. In the adult mPFC, a total of 16 alcohol-sensitive proteins were 
identified, with two proteins appearing twice in the list (calmodulin, spots#5 and 6; 
clathrin light chain A, spots#2 and 3) and one protein appearing three times (myosin 
light polypeptide 6, spots#11, 12 and 13; Figure 3A) for a total of 12 unique spots. 
Accounting for duplicates, nearly twice as many proteins in the adolescent mPFC 
were alcohol-sensitive compared to the adult mPFC.  
 In the protein phosphorylation experiment, the opposite pattern of age 
differences was observed. In the adolescent mPFC, alcohol drinking altered the 
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phosphorylation of 14 unique proteins, all but two of which displayed increased 
phosphorylation in the alcohol drinking tissue. In the adult mPFC, alcohol drinking 
altered the phosphorylation of 34 proteins, including two proteins that appeared 
twice (actin, spots #33 and 34; Heat shock protein HSP 90-beta, spots #23 and 24) 
and one protein that appeared three times (calcium/calmodulin-dependent protein 
kinase II-α, spots G, H and I) for a total of 30 unique phosphoproteins. Similar to the 
adolescent phosphoproteins, approximately 75% of the identified phosphoproteins in 
the adult samples displayed increased phosphorylation in the alcohol-drinking tissue.  
Taken together, these findings may indicate one potential explanation for the 
increased sensitivity of the adolescent mPFC to the effects of alcohol. The mature 
adult mPFC appears to respond to alcohol drinking with widespread increases in 
protein phosphorylation and relatively limited changes in protein expression, which 
may represent a homeostatic mechanism that favors changes in activity (i.e. protein 
phosphorylation) over changes in protein quantity (i.e. protein expression changes) 
after alcohol exposure. The adolescent mPFC responds to alcohol with far fewer 
phosphorylation changes, and perhaps as a consequence goes on to display many 
more proteins with alcohol-induced expression changes than the adult mPFC.  
Bioinformatics  
Ingenuity Pathway Analysis (IPA) identified an array of biofunctions/disorders 
and canonical signaling pathways in the adolescent and adult mPFC, respectively 
that were disrupted by alcohol drinking. In both age groups, alcohol drinking 
appeared to significantly impact a variety of neuronal functions related to 
neurotransmitter signaling. In the adolescent and adult mPFC, vesicular transport 
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and exocytosis appear to be altered by alcohol exposure. Acute alcohol has been 
shown to alter extracellular concentrations of glutamate [13], GABA and dopamine 
[37] in the PFC in adolescent and adult rodents, which accords with the protein-level 
findings observed in the present study. IPA identified more disruption in 
neurotransmission-related biofunctions and canonical signaling pathways in the 
adolescent mPFC after alcohol drinking than the adult mPFC, in accordance with the 
more substantial effects of alcohol on protein expression seen in the adolescent 
mPFC. The increased number of alcohol-sensitive functions related to exocytosis in 
the adolescent experiment may relate to age differences in the effects of alcohol on 
neurotransmission in the PFC. Recent findings suggest that the adolescent PFC is 
more sensitive to alcohol-induced alterations in spontaneous glutamatergic 
neurotransmission than the adult mPFC as indexed by alcohol-evoked changes in 
glutamate transients [38]. Adolescent alcohol exposure has also been shown to 
cause lasting changes in GABAergic transmission in the PFC [39]. These findings, 
combined with the present data indicating substantial impact of adolescent drinking 
on neurotransmission-associated protein in the mPFC, may indicate one potential 
mediator of age differences in sensitivity to the acute and lasting effects of alcohol 
exposure. IPA indicated that adolescent, but not adult, alcohol drinking altered 
biofunctions related to behavior, and particularly learning. Previous research has 
shown that adolescents are more sensitive to the cognitive impairment induced by 
alcohol [40], and it has been suggested that these age differences are mediated by 
the relative immaturity of the adolescent PFC [12]. The present findings provide 
support for this hypothesis at the protein level, and suggest that calcineurin and 
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cofilin-1 may be in part responsible for the increased sensitivity of the adolescent to 
alcohol-induced cognitive impairment. Further assessment is necessary to confirm a 
functional relationship between these protein changes and memory impairment 
following alcohol drinking in adolescents.  
 IPA also identified two unique functional protein interaction networks in the 
adolescent and adult mPFC, respectively, that were predicted to be impacted by 
alcohol drinking. In the adolescent mPFC, a network related to behavior, cell-to-cell 
signaling/interaction and nervous system development/function was statistically 
predicted to have altered activity following alcohol drinking (Figure 4). The identified 
network contained several proteins that have previously been shown to regulate 
both the cellular and behavioral response of the rodent brain to alcohol, including 
subunits of the GABAA  and NMDA receptors [41], the adenosine 2A receptor [42], 
calcium/calmodulin-activated kinase II [43], mitogen-activated protein kinase [44] 
and fragile X mental retardation 1 [45]. Importantly, many of these same proteins 
have important roles in both neuronal development and learning/plasticity in the 
brain. The network therefore points towards a noxious interaction of increases in the 
expression/activity of these signaling systems during adolescence [15] and the 
sensitivity of these systems to alcohol.  
In adult tissue, voluntary alcohol drinking was associated with a functional 
protein interaction network involved in neurological disease, organismal 
injury/abnormality and cellular compromise. One of the predicted interaction 
proteins, brain-derived neurotropic factor (BDNF), has repeatedly been shown to 
play a role in the ceullular and behavioral response to alcohol [46]. Alcohol is a 
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physiological stressor that activates innate immune signaling in the rodent brain [47] 
and can induce brain damage in humans with chronic use [48]. Two of the 
interaction proteins identified by IPA, amyloid precursor protein (APP) and 
presenilin-1 (PSEN1), have well-established roles in other neurodegenerative 
disorders such as Alzheimer’s disease [49, 50], but to date the role of these proteins 
in alcohol-induced neurodegeneration has not be investigated. The adult interaction 
network therefore speaks to the impact of limited alcohol drinking on systems that 
underlie neurodegeneration, underscore the impact of alcohol drinking across the 
lifespan, and suggest some potential new avenues for research.  
Comparatively, the adolescent interaction network was comprised of five 
proteins identified in the proteomics screen and 23 proteins that were predicted to be 
functionally impacted by alcohol drinking. The adult network was comprised of three 
proteins identified in the proteomics screen and an additional seven proteins that 
were predicted to be functionally impacted by alcohol drinking. The adolescent 
network was thus more complex than the adult network and implicated alcohol 
impacting the activity of many more proteins downstream of the proteins that 
exhibited expression changes following alcohol drinking. These differences in 
functional interaction networks are a logical consequence of the greater number of 
alcohol-sensitive proteins identified in the adolescent mPFC, and illustrate the 
impact of relatively widespread protein expression changes in the developing brain 
and how short-term alcohol drinking may impact neural development. 
A limitation of the 2D-DIGE approach to proteomics is the difficulty in 
solubilizing membrane-bound proteins, particularly neurotransmitter receptors.  The 
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functional interaction networks identified by IPA give indications of receptors that 
were not detected in the proteomics screen that may nevertheless be affected by 
adolescent alcohol drinking in terms of their expression or activity, In particular, the 
adolescent interaction network identified the GABAA receptor, the adenosine 2A 
receptor, and the NMDA as being impacted by intermittent alcohol drinking. As all 
three of these proteins have well-established roles in alcohol drinking [51, 52], they 
represent useful targets for subsequent expression analysis using immoblotting or 
immunohistochemistry and functional assessment via pharmacological activation or 
inhibition of these receptors in adolescent and adult mice.  
Calcineurin  
 Of the proteins identified in the adolescent and adult alcohol proteomics 
experiments, calcineurin (PPP3R1) was selected for evaluation of a functional role in 
adolescent and adult alcohol drinking behavior. Calcineurin represented an attractive 
target for such assessment because it has previously been reported to exhibit 
increased expression in the adolescent relative to the adult mPFC [15] and was 
shown to be downregulated by alcohol drinking in the adolescent but not adult 
mPFC in the present study.  
Calcineurin is a protein phosphatase that plays an integral role in synaptic 
plasticity [25]. The only calcium-sensitive protein phosphatase identified to date, 
calcineurin dephosphorylates the GluA1 subunit of the glutamate AMPA receptor at 
Ser854, the phosphorylation site of protein kinase A (PKA) [53]. Dephosphorylation at 
this residue is associated with reductions in AMPA-mediated glutamatergic signaling 
and internalization of the receptor [54]. Accordingly, calcineurin overexpression has 
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been shown to block long-term potentiation (LTP) and long-term depression (LTD) of 
glutamatergic synapses [55], whereas forebrain-specific calcineurin inhibition has 
been shown to enhance LTP and improve memory function in rodents [56].  
To date, the role of calcineurin in alcohol drinking has received limited 
investigation. Observations from human alcoholics who undergo liver transplantation 
have suggested that the anti-rejection medication cyclosporine A (CSA), a 
calcineurin inhibitor, may be associated with reductions in alcohol drinking in this 
population. Two previous studies in rodent models have indicated that CSA and 
FK506 (another calcineurin inhibitor) reduce alcohol drinking in adults. However, age 
differences in sensitivity to calcineurin inhibition in the context of alcohol drinking 
have not be previously investigated.  
In the present experiments, pretreatment with FK506 prior to an intermittent 
two-bottle choice home cage drinking procedure reduced alcohol drinking in 
adolescent and adult mice (Figure 7), consistent with previous reports. However, 
both the 1 mg/kg and 3 mg/kg dose of FK506 reduced alcohol drinking in adolescent 
mice, whereas only the high dose produced a reduction in adult subjects. This 
finding suggests increased efficacy of calcineurin inhibition in adolescent mice. The 
proteomics findings indicated that alcohol drinking produces decreases in calcineurin 
expression in the adolescent, but not adult, mPFC. Adolescent-specific alcohol-
induced reductions in calcineurin during the initial week of alcohol drinking prior to 
drug testing may therefore have been responsible for the increased sensitivity of the 
adolescent mice to FK506. The 1 mg/kg dose did not significantly alter sucrose 
consumption in adolescent or adult mice, suggesting some degree of selectivity for 
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alcohol, and failed to alter open-field locomotor activity, indicating that the effects of 
FK506 were not due to nonspecific reductions in locomotor behavior.       
Modeling Long-term Risk for Increased Alcohol Consumption Following 
Adolescent Alcohol Exposure 
 The finding that adolescents were more sensitive to calcineurin regulation of 
alcohol drinking than adults was significant, but did not speak to the long-term risk 
for alcoholism following adolescent alcohol exposure. Therefore, a model of 
adolescent and adult alcohol drinking and subsequent operant responding for 
alcohol when all subjects had reached adulthood was developed. Mice in both age 
groups drank alcohol and water or water alone, respectively, in a two-bottle choice 
home-cage drinking procedure identical to the procedure used in both the 
proteomics experiments and the initial FK506 pharmacology experiments. Following 
two weeks of every-other-day alcohol drinking, alcohol access was removed for 6 
weeks, until adolescent subjects had reached adulthood (PND 90). Mice were next 
trained to operantly self-administer sweetened alcohol on an FR4 schedule.  
The use of both age-matched water control mice and groups that had been 
exposed during adolescence or adulthood enabled assessment of differences 
induced by type of fluid exposure and timing of fluid exposure on subsequent 
operant responding for alcohol. When adolescent alcohol exposure and adult alcohol 
exposure mice were directly compared during the first week of operant testing, the 
adolescent exposure group consumed significantly more alcohol than the adult 
exposure group across doses ranging from 3-15% alcohol by volume. When 
comparisons were made between water and alcohol exposure within age, mice with 
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adolescent alcohol exposure exhibited modest but significant increases in operant 
self-administration compared with adolescent water exposure mice. This effect was 
not evident between mice that received alcohol during adulthood when compared 
with mice who received water during adulthood. Together, these findings indicate 
that adolescent exposure to alcohol uniquely leads to a lasting increase in the 
reinforcing effects of alcohol as measured by operant self-administration.  
These results are particularly significant in light of the limited exposure to 
alcohol during adolescence in these experiments. Adolescent and adult mice drank 
alcohol in an intermittent (every-other-day) two-bottle choice procedure for the two-
week period conservatively estimated to comprise adolescence in rodents. This 
resulted in a total of only seven days of alcohol drinking, following by an extended 
period of abstinence. Nevertheless, this drinking procedure was sufficient to both 
cause extensive alterations in protein expression and predicted changes in 
interaction network function in the adolescent mPFC, and produce age differences in 
alcohol drinking following adolescent alcohol consumption that persisted for months. 
The results therefore indicate that even limited access to alcohol during adolescence 
may have lasting consequences for the adult brain.   
A significant limitation of the model is the use of the pause period between 
alcohol drinking and subsequent operant responding for alcohol. The current model 
was designed to isolate the effects of alcohol specifically during the adolescent 
period on subsequent operant responding. However, human adolescents experience 
no such pause in their consumption during late adolescence but rather regularly 
consume alcohol throughout the adolescent period and into adulthood. In this sense, 
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the model does not accurately reflect the drinking patterns typical amongst human 
adolescents. Continuing the drinking procedure throughout adolescence and into 
adulthood would most likely yield more significant changes in both brain protein 
expression and accompanying behaviors, and would therefore be predicted to 
produce more robust increases in operant self-administration during adulthood. For 
this initial assessment a more conservative approach was taken, but future studies 
to investigate the timing of the initiation of alcohol drinking will yield useful insights.    
Calcineurin Selectively Regulates Alcohol Self-Administration in Mice with a 
History of Adolescent Alcohol Drinking 
 The model of adolescent and adult alcohol exposure was next used to assess 
the effects of calcineurin inhibition on operant self-administration of alcohol. When 
injected systemically, FK506 reduced operant responding for alcohol only in mice 
with a prior history of alcohol drinking (Figure 16). Mice that consumed water during 
adolescence as well as mice that consumed alcohol during adulthood were 
insensitive to both doses of FK506 tested. The reduction in operant responding 
exhibited by the adolescent alcohol exposure group was accompanying by a 
reduction in alcohol dose achieved during the operant session, but no changes in 
percent responding on the active lever, indicating that the effects of FK506 were not 
due to nonspecific learning deficits. 
 To establish the relevance of calcineurin signaling in the prefrontal cortex on 
operant self-administration, cannulae aimed at the mPFC were implanted into mice 
in the adolescent alcohol exposure and adolescent water exposure groups. When 
1µg of FK506 was microinjected into the mPFC, it increased operant responding for 
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alcohol in mice with a history of adolescent alcohol drinking, but not in mice with a 
history of adolescent water drinking. This increase was accompanied by an increase 
in alcohol dose achieved during the operant session and no change in percent 
responding on the active lever, indicating that the effects of FK506 in the mPFC 
were not due to learning impairments.  
 The finding that systemic calcineurin inhibition reduces alcohol drinking and 
operant self-administration but intra-mPFC calcineurin inhibition increases alcohol 
self-administration speaks to the importance of assessing brain region-dependent 
effects of pharmacological manipulation of alcohol-related behaviors. In addition to 
the PFC, calcineurin expression is also dense within the nucleus accumbens, 
amygdala and ventral tegmental area, limbic regions associated with alcohol reward 
and reinforcement. As reductions in calcineurin expression and phosphorylation 
appear to be a drug effect of alcohol drinking in adolescents, systemic inhibition of 
calcineurin signaling may therefore be mimicking the effect of the alcohol, which 
would be expected to reduce the amount of alcohol necessary to achieve an 
intoxicating dose. This effect of systemic inhibition may be mediated not by the 
prefrontal cortex, but by the limbic reward-related brain regions detailed above. Adult 
animals are insensitive to this effect of alcohol on calcineurin expression as seen in 
the proteomics screen, which may explain why a higher dose was necessary to 
achieve reductions in alcohol drinking in the systemic alcohol drinking experiment. 
Such an explanation is consistent with behavioral reports from rodent models of 
adolescence and human studies which indicate that adolescents have increased 
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sensitivity to the rewarding effects of alcohol relative to adults. Calcineurin may be a 
molecular mechanism underlying these age-dependent behavioral manifestations. 
 Within the PFC, calcineurin inhibition would be expected to dephosphorylate 
the GluA1 subunit of the AMPA receptor, resulting in reduced glutamatergic 
signaling in this region. Importantly, the major glutamatergic projections of the mPFC 
terminate in the nucleus accumbens and amygdala, but synapse onto inhibitory 
interneurons in those regions. This network is believed to underlie the “executive 
control” exerted by the PFC over limbic regions, a feature that is relatively immature 
in the adolescent PFC relative to adults. In mice with a history of adolescent alcohol 
drinking, calcineurin inhibition in the PFC results in dysregulation of cortical output to 
limbic regions, which may increase responsivity to alcohol and related cues and 
motivate increased self-administration of alcohol. This effect of calcineurin inhibition 
appears to be blunted or absent in mice without a history of adolescent alcohol 
exposure, which is consistent with reports in humans and rodents of the persistence 
of an “adolescent phenotype” into adulthood following adolescent alcohol exposure.  
Overall, the dual findings that 1) alcohol drinking during adolescence downregulated 
calcineurin in the PFC, and 2) calcineurin inhibition in the PFC increased operant 
alcohol self-administration suggest that alcohol-induced downregulation of 
calcineurin in the PFC may increase the reinforcing effects of alcohol in this 
vulnerable population.     
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Limitations and Future Directions 
 Although the present findings provide an initial assessment, several questions 
remain as to the specific role of calcineurin in alcohol consumption across 
developmental stage. First, it would be informative to determine the longitudinal 
effects of alcohol exposure during adolescence on calcineurin expression during 
adulthood. Although the pharmacological data presented here indicate that 
adolescent alcohol exposure imparts lasting changes in calcineurin signaling, these 
effects could be due to adaptations in proteins or receptors downstream of 
calcineurin itself. It would also be valuable to assess the effects of this drinking 
procedure on GluA1, since it is a direct target of calcineurin activity and thought to 
mediate many of the effects of calcineurin. Additionally, since systemic and intra-
mPFC calcineurin inhibition created divergent effects on operant self-administration 
of alcohol, future studies will assess the effects of alcohol on calcineurin expression 
in other brain regions, particularly those known to be involved in alcohol reward such 
as the nucleus accumbens, amygdala and ventral tegmental area. Microinjection of 
FK506 into these additional brain regions would also help clarify the systemic 
findings. Lastly, although the home-cage drinking experiments suggested that the 
effects of calcineurin inhibition were selective for alcohol and not sucrose drinking, 
the selectivity of FK506 was not assessed in the operant experiments. The effects of 
adolescent alcohol exposure on subsequent operant responding for sucrose would 
indicate whether calcineurin signaling selectively alters alcohol-related pathways in 
the brain, or functions through pathways involved in reward more generally.      
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Conclusion     
Here we report that only seven days of voluntary alcohol drinking produced 
profound effects on the adolescent mPFC proteome. This limited adolescent alcohol 
exposure was further associated with long-term effects on the reinforcing properties 
of alcohol in adult mice. The results further provide initial evidence that calcineurin is 
selectively alcohol-sensitive in the adolescent mPFC and may mediate some of the 
long-term risk for increased alcohol self-administration observed following 
adolescent alcohol exposure. As personalized medicine gains prominence in the 
addiction field, these insights may be useful in developing treatments specifically for 
alcoholics with a history of heavy drinking during adolescence. One FDA-approved 
calcineurin inhibitor, cyclosporine A, has been suggested as a potential therapy for 
alcoholism, although significant side effects may pose a barrier to clinical evaluation. 
Additionally, this evidence for the unique vulnerability of the adolescent brain to the 
effects of alcohol may arm education and prevention efforts with more information 
about the harm of underage drinking.  
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CHAPTER FOUR: CaMKIIα-GluA1 ACTIVITY UNDERLIES VULERNABILITY TO 
ADOLESCENT BINGE ALCOHOL DRINKING2 
Introduction 
 
Adolescence is a distinct developmental period that in humans occurs from 
the early teens to the early twenties. This developmental stage is characterized by 
increased exploration and risk-taking, and is the time at which experimentation with 
drugs of abuse, including alcohol, is usually initiated [1].  Alarming data show that 25 
– 37% of U.S. high school students engage in heavy episodic or binge drinking [2] at 
more than twice the rate of adults [3], and a recent survey revealed that 
approximately 22% of 12th grade students had engaged in binge drinking in the last 
two weeks [4]. Binge drinking during adolescence is particularly troubling in light of 
evidence that individuals who initiate alcohol use during early adolescence are at 
substantially higher risk for the development of alcohol use disorders (AUDs) than 
those who initiate alcohol use as young adults [5, 6]. These data suggest that 
adolescent alcohol users are uniquely vulnerable to the development of AUDs, and 
indicate that a significant portion of the population is subject to this increased risk. 
However, the precise neurobiological mechanisms that mediate this effect have yet 
to be determined [7]. 
                                                          
2 This chapter previously appeared as an article in Alcoholism: Clinical and Experimental Research. 
The original citation is as follows: Agoglia AE, Holstein SE, Reid GT, Hodge CW (2015). CaMKIIα-
GluA1 activity underlies vulnerability to adolescent binge alcohol drinking. Alcoholism: Clinical and 
Experimental Research, 39(9) 1680-90. 
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In humans and in rodent models, adolescence is characterized by increased 
neuronal plasticity as the brain matures from childhood to adulthood [8]. This 
suggests that adolescents may be more vulnerable to the effects of alcohol on 
plasticity-linked cellular functions. Indeed, evidence indicates that adolescent 
rodents are more sensitive to alcohol-induced disruption of long-term potentiation 
[9], which is a cellular mechanism that underlies behavioral plasticity. Similarly, we 
have shown that adolescent mice are more sensitive than adults to acute alcohol-
induced changes in ERK MAP kinase activation in the amygdala [10] which is 
required for LTP in this region [11]. Further, alcohol exposure blunts LTP in the 
amygdala [12] where plasticity-linked proteins regulate alcohol-seeking behavior [13, 
14]. Thus, increased understanding of alcohol-induced changes in signaling systems 
that regulate cellular plasticity may be of interest to identify mechanisms underlying 
adolescent vulnerability to development of AUDs. 
 Glutamate is the primary excitatory neurotransmitter in the mammalian brain 
and its receptors and cellular signaling pathways are required for adaptive plasticity. 
Calcium/calmodulin-dependent protein kinase II (CaMKII) is a 12-subunit protein 
expressed primarily in glutamatergic synapses, where it has a well-established role 
in synaptic plasticity, learning and memory [15]. CaMKII has been shown to be 
involved in alcohol consumption and reward. Mice expressing autophosphorylation-
deficient CaMKIIα have been shown to drink less alcohol than wild type littermates 
[16] and display altered conditioned place preference for alcohol [17]. We have 
shown that voluntary alcohol drinking increases expression of the active 
(phosphorylated) form of CaMKIIαT286 (pCaMKIIαT286) in the mouse amygdala, and 
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that intra-amygdala inhibition of CaMKII activity reduces the positive reinforcing 
effects of alcohol [13]. CaMKII is activated upon phosphorylation, allowing it to 
phosphorylate several downstream targets including the GluA1S831 subunit of the 
AMPA subtype of glutamate receptors [18]. Phosphorylation of GluA1S831 
(pGluA1S831) is associated with increased stability of AMPARs in the synapse, which 
promotes synaptic plasticity and learning [19]. Our work also shows that AMPAR 
activity in the amygdala is required for the reinforcing effects of alcohol [13]. 
Together, these data suggest a critical role for CaMKIIα-GluA1 signaling in alcohol 
self-administration and reinforcement. However, age-dependent differences in 
sensitivity to alcohol-induced modifications of this system have not been explored. 
 To address this question, the present study was designed to test the 
hypothesis that adolescents are more sensitive to alcohol-induced changes in 
CaMKIIα and AMPAR GluA1protein phosphorylation and expression than adults. We 
chose to investigate protein changes in the amygdala and striatum based on our 
previous results as well as a wealth of literature indicating that these regions are 
functionally involved in alcohol self-administration and reinforcement [13, 20]. To 
evaluate the functional involvement of this system in adolescent and adult alcohol 
drinking, we used the drug tianeptine, a systemic upregulator of CaMKIIa-dependent 
GluA1 activation (e.g., phosphorylation). A binge-like model of alcohol access was 
utilized in these experiments in order to most closely mimic the drinking patterns 
exhibited by adolescents in the United States. 
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Materials and Methods 
Animals 
Male C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME) were individually 
housed in standard Plexiglass cages with a small PVC pipe for environmental 
enrichment. Adolescent mice were postnatal day 21 (PND 21) and adults were (PND 
63±2) upon arrival in our facility. Food and water were available ad libitum in home 
cages except where noted. The colony room was maintained on a 12-h light/dark 
cycle (lights on at 20:00 in the initial binge exposure experiment and lights on at 
19:00 in the pharmacology experiments) at 21°C. All experimental manipulations 
and testing occurred during the dark cycle. All procedures were carried out in 
accordance with the NIH Guide to Care and Use of Laboratory Animals [21] and 
approved by the Internal Review Board of the University of North Carolina, Chapel 
Hill. 
Experiment 1: Daily Binge Alcohol Exposure and Protein Changes in the 
Adolescent and Adult Mouse Brain 
Binge Alcohol Exposure Procedure 
 Adolescent and adult mice (N=40) were allowed one week (PND 21-27) or 
(PND 63-69) to habituate to our colony and acclimate to the light/dark cycle (Fig 
19A). During habituation, mice were handled and weighed daily. Mice were then 
brought to consume alcohol in a binge-like access procedure adapted from Rhodes 
et al. [22]. Beginning on PND 28 or PND 70, mice were weighed and home cage 
water bottles were removed at 11:00AM and replaced with a single drinking tube 
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containing either 20% (v/v) alcohol (alcohol treated animals) or water (water control 
animals) for four hours, n=10/treatment/age. The drinking tubes consisted of a 10mL 
serological pipette fitted with a ball-bearing sipper tube and fastened to the wire 
cage lid with a medium binder clip. This limited access procedure was repeated daily 
for two weeks, ending on PND 42 for adolescents or PND 84 for adults.  
Tissue Collection 
 Immediately after the cessation of drinking, on the last day of testing, mice 
were rapidly decapitated and blood alcohol concentration (BAC) was assessed. 
Approximately 20µL of trunk blood was centrifuged to obtain 5µL of plasma for use 
in an AM1 Alcohol Analyzer (Analox Instruments, Lunenburg, MA). The brains were 
extracted from the skulls and flash-frozen in -30°C isopentane. 
Western Blot Analysis 
Brain regions of interest were dissected from coronal brain sections (1mm 
slices) using a 1mm sterile tissue punch (Stoelting, Wood Dale, IL) and 
homogenized in buffer (10ml: 1.1g sucrose, 50µL 1M HEPES buffer, 1:100 
protease/phosphatase inhibitor cocktail, 1mL 10% SDS, 26.55mL ultra-pure water.) 
Protein concentration was measured using a calorimetric assay kit (Pierce 
Biotechnology, Rockford, IL). Protein (5µg) was diluted 4:1 with lithium dodecyl 
sulfate sample buffer (40–70% glycerol), 10:1 with sample reducing agent, vortexed, 
loaded onto a Nu-Page 4–15% Tris-glycine polyacrylamide gel (Invitrogen, Carlsbad, 
CA) for gel electrophoresis separation, and transferred to nitrocellulose membrane 
using an iBlot dry blotting system (Life Technologies, Grand Island, NY). Membranes 
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were blocked with 3% albumin bovine serum (Sigma-Aldrich, St. Louis, MO) before 
being incubated with primary antibodies [rabbit anti-pCaMKIIT286  (1:2 500; Abcam, 
Cambridge, MA), -pGluR1S831 (1:1 000, EMD Millipore, Billerica, MA) -tGluR1 (1:1 
000; Abcam) and mouse anti-tCaMKIIα (1:10 000; Millipore), in blocking solution at 
4°C overnight and β-actin (mouse monoclonal, 1:5 000; Sigma) in blocking solution 1 
h at room temperature] and washed before incubation with secondary antibodies 
(HRP-conjugated goat anti-rabbit and goat anti-mouse, 1:10 000; Jackson 
ImmunoResearch, West Grove, PA). Membranes were then visualized using 
enhanced chemiluminescence substrate (Pierce), and bands were quantified using 
optical density measurements (NIH/Scion Image).  
Experiment 2: Pharmacological Manipulation of Intermittent Binge Drinking 
Binge Alcohol or Sucrose Drinking Procedure 
 Mice (N=24/experiment) were allowed a one-week (PND 21-27) or (PND 63-
69) habituation period (Fig 4A). During habituation, mice were handled and weighed 
daily and given saline injections to habituate to the injection procedure. Beginning on 
PND 28 (adolescent) or PND 70 (adult), mice were weighed and the home cage 
water bottles were removed at 10:00AM and replaced with a drinking tube containing 
20% (v/v) alcohol (alcohol experiment) or 0.5% sucrose (sucrose experiment). Mice 
had access to alcohol or sucrose for four hours every other day. Beginning on PND 
36 or PND 80, mice were treated with 0, 3, 10 or 17 mg/kg tianeptine (i.p.) 30 
minutes prior to alcohol or sucrose tube access according to a Latin square dosing 
regimen. Drug pretreatment and drinking continued on PND 38, 40, and 42 
(adolescent) or PND 82, 84, and 86 (adult). Tianeptine dose range and pretreatment 
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time were determined from a study showing behavioral effects in alcohol-exposed 
rodents [23].   
Locomotor Testing 
 On PND 46 or PND 90, mice were pretreated with either saline or the 
effective dose of tianeptine (10 mg/kg for adolescents, 17 mg/kg for adults) for 2 
hours prior to a locomotor activity test (n=6/treatment/age). Open field activity was 
measured in Plexiglas activity monitor chambers (27.9 cm2; ENV-510, Med 
Associates, Georgia, VT). Two sets of 16 pulse-modulated infrared photobeams 
were located on opposite walls and recorded X–Y ambulatory movements. Distance 
traveled (in meters) throughout the session was quantified by assessing the mouse’s 
position in the open field every 100 miliseconds. Data from each chamber were 
collected by a computer. 
Blood Alcohol Clearance 
 On PND 47-48 or PND 91-92, adolescent (n=6) and adult (n=6) mice were 
pretreated with the effective dose of tianeptine (10 mg/kg for adolescents, 17 mg/kg 
for adults) or saline. Thirty minutes later, mice were injected with 4.0 g/kg alcohol 
(20% w/v) i.p. Beginning at 10 minutes post-alcohol injection, mice were confined in 
clear Plexiglas restraint tubes (Braintree Scientific, Braintree, MA), tail blood was 
collected using a heparinized microcapillary tube. Additional samples were collected 
at 30 minutes, 1 hour, 2 hours and 4 hours post-alcohol injection. Blood samples 
were analyzed as in Experiment 1.   
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Drugs 
 Alcohol solutions (v/v) were prepared by diluting 95% ethanol (Pharmco 
Products Inc., Brookfield, CT) with tap water (for drinking) or 0.9% saline (for 
injection). The GluA1 modulator tianeptine (Tocris Bioscience; Ellisville, MO) was 
freshly dissolved in saline before each day of testing. 
Data Analysis 
 All analyses were performed using Prism v. 6.0 (GraphPad, La Jolla, CA). For 
drinking experiments, alcohol intake data were reported as grams of intake per 
kilogram of body weight and water intake data were reported as milliliters of fluid 
consumed per kilogram of body weight. Intake of both solutions was analyzed via 
two-way repeated measures ANOVA (Age x Day). BAC was analyzed via t-test to 
compare adolescent and adult values.  
Western blot data were expressed as percent change from age-matched 
water drinking controls, and all protein levels were expressed as a ratio to β-Actin. 
Data were analyzed via independent t-tests comparing alcohol and water treated 
animals separately within each age group.  
In the two tianeptine pretreatment experiments, alcohol and sucrose intake 
were analyzed via two-way repeated measures ANOVA (Age x Dose) respectively. 
Tukey’s LSD test was used for all post-hoc analyses. BEC was analyzed via two-
way repeated measures ANOVA (Dose x Time) separately within each age. Open 
field locomotor data were collapsed into 20 minute time bins and activity was 
assessed via two-way repeated measures ANOVA (Dose x Time) separately within 
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each age. Locomotor data were further analyzed for potential age or drug-induced 
differences in anxiety-like behavior in an open-field test. Thigmotaxis was evaluated 
by comparing distance (cm) traveled in the center zone (inner 25% of the area) to 
distance traveled in the periphery (outer 75% of the area) as previously described 
[24]. α was set at 0.05 for all comparisons.    
Results 
 
Experiment 1 
Binge-like Alcohol Consumption 
 Adolescent and adult mice consumed equivalent amounts of alcohol and 
water over the two-week daily access period (adolescents averaged 5.01 ±.22 g/kg 
and adults averaged 5.09 ±.13 g/kg, Figures 19B and C). Alcohol drinking did not 
alter body weight in adolescents or adults (Figure 19D). Blood alcohol levels 
immediately after drinking on the last experimental day exceeded the NIAAA criteria 
for a binge drinking session (80 mg/dL), with no significant differences between the 
two age groups (Figure 19E) [25]. 
CaMKIIα Changes in the Amygdala 
 Western blot analysis of adolescent amygdala revealed that a two-week 
history of alcohol drinking significantly decreased the phosphorylation of 
CaMKIIαT286 by approximately 30%, t(17)= 1.916, p <0.05 (Figure 20A).   No 
differences in total CaMKIIα expression emerged in adolescents (Figure 20B). In 
contrast, neither pCaMKIIαT286 nor tCaMKIIα were affected by alcohol drinking in the 
adult amygdala (Figure 20C and D). 
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Figure 19. Adolescent and adult mice achieve binge levels of alcohol 
consumption in a daily limited access procedure. (A) Timeline of binge-
like drinking procedure. Adolescent and adult alcohol (B) and water (C) intake 
did not differ over two weeks of daily drinking sessions. (D) Alcohol drinking 
did not alter body weight in either adolescents or adults. (E) Blood ethanol 
concentration did not differ between alcohol-drinking adolescent and adult 
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mice immediately following the drinking session on the last drinking day. 
Dashed line indicates the NIAAA criteria for a binge drinking session (≥ 80 
mg/dL).  
CaMKIIα Changes in the Striatum 
Analysis of the adolescent and adult nucleus accumbens via Western blot 
showed no effect of alcohol exposure on pCaMKIIαT286 in either age (Table 9). 
Similarly, pCaMKIIαT286 levels were unaltered by alcohol drinking in both ages in the 
dorsal striatum. Total expression of CaMKIIα was also unaffected by alcohol 
exposure in adolescents and adults in both regions. 
GluA1 Changes in the Amygdala 
To examine a downstream target of phosphorylated CaMKII activity, the 
GluA1 subunit of the AMPAR receptor was analyzed in the adolescent and adult 
amygdala. Western blot analysis showed that in the adolescent amygdala, a two-
week history of alcohol drinking had a non-significant trend to decrease 
pGluA1Ser831, p= 0.11 (Figure 21A). In the adult amygdala, alcohol drinking 
significantly increased pGluA1Ser831 by approximately 65%, t(17)= 1.262, p =0.05 
(Figure 21C). No effect of alcohol drinking on total GluA1 expression emerged in 
either age (Figure 21B and D). 
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Figure 20. CaMKII phosphorylation is altered by two weeks of daily binge-like 
alcohol drinking in the adolescent but not adult amygdala. (A) Phospho-
CaMKIIαT286 (pCaMKIIαT286) was decreased in the amygdala of adolescent 
mice exposed to alcohol in the daily binge drinking procedure (*p <0.05). (B) 
Total CaMKIIα expression was not different between alcohol and water 
drinking adolescents. (C) pCaMKIIαT286 did not differ in the amygdala of adult 
mice exposed to alcohol or water in the daily binge drinking procedure. (D) 
tCaMKIIα expression was also not altered by alcohol treatment in adults. 
 
Experiment 2 
Effect of Tianeptine Pretreatment on Binge-like Alcohol Consumption 
 Prior to drug treatment, baseline 4-hour every-other-day alcohol intake was 
significantly greater among adolescents (5.6 g/kg ±0.69) than adults (3.7 g/kg ±0.69) 
[Main effect of Age, F(1, 22) = 8.896, p <0.01]. Over the course of the entire 
experiment, adolescent body weight increased steadily from an average of 14g on 
PND 28 to an average of 21g on PND42. The rate of body weight gain did not 
change following tianeptine pretreatment and is consistent with the published 
literature for mouse body weight at these ages [26]. 
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Table 9. Phospho-and total-CaMKIIα is unaffected by alcohol drinking in the 
adolescent and adult nucleus accumbens and dorsal striatum. Data are 
represented as the mean optical density/β-Actin for each age and treatment 
condition ±SEM. 
 
 pCaMKIIαT286 tCaMKIIα  
Brain region Water Alcohol  Water Alcohol   
ADOLESCENT 
 
Nucleus  
Accumbens 
100 
±5 
101 
±17 
 
 
100 
±8 
 
 
99 
±8 
  
Dorsal  
Striatum 
 
ADULT 
 
Nucleus  
Accumbens 
 
Dorsal  
Striatum 
 
100 
±9 
 
 
 
100 
±15 
 
100 
±18 
 
98 
±20 
 
 
 
82 
±14 
 
102 
±13 
 
100 
±3 
 
 
 
100 
±6 
 
100 
±3 
 
105 
±3 
 
 
 
99 
±4 
 
107 
±6 
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Figure 21. Differential effects of a two-week history of daily binge alcohol 
exposure on GluA1 phosphorylation in the adolescent and adult 
amygdala (A) Phospho-GluA1S831 (pGluA1S831) had a tendency to decrease 
in the amygdala of adolescent mice exposed to alcohol in the daily binge 
drinking procedure (#p <0.1). (B) Total GluA1 expression was not different 
between alcohol and water drinking adolescents. (C) pGluA1S831 was 
increased in the amygdala of adult mice exposed to alcohol in the daily binge 
drinking procedure (*p =0.05). (D) Total GluA1 expression was not different 
between alcohol and water drinking adults. 
Following 30 minute pretreatment with tianeptine, a Dose x Age interaction 
emerged, F(3, 66) = 5.062, p <0.001. Tukey’s multiple comparisons test revealed 
that among adolescent mice, the 10mg/kg dose of tianeptine significantly increased 
alcohol consumption relative to vehicle (p <0.05, Figure 22B). Adolescent alcohol 
intake increased from 5.4 g/kg to 6.6 g/kg (22%). In contrast, the 17mg/kg dose of 
tianeptine significantly decreased alcohol consumption relative to vehicle in adults (p 
<0.05). Adult alcohol intake decreased from 4.2 g/kg to 3.2 g/kg (25%). Dose effects 
were only apparent during the last two hours and total four-hour intake period (data 
not shown.) A main effect of Age also emerged [F(1, 22) = 45.37, p <0.0001] with 
adolescents consuming significantly more alcohol than adults. 
Selectivity of Tianeptine Effects 
To assess behavioral (alcohol) specificity, we evaluated effects of tianeptine 
pretreatment on binge-like consumption of sucrose, a non-drug solution that has 
rewarding properties. Analysis of 4-hour sucrose consumption following 30-minute 
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pretreatment with tianeptine revealed a main effect of Dose, F(3,63) =3.579, p 
<0.05, indicating that tianeptine decreased sucrose consumption similarly in 
adolescent and adult mice. No Age x Dose interaction emerged (p >0.05, Figure 
22C).  
To determine if tianeptine effects were associated with nonspecific locomotor 
effects, adolescent and adult mice were pretreated with either vehicle or the effective 
dose of tianeptine (10mg/kg for adolescents and 17mg/kg for adults) 2 hours prior to 
a 2 hour open-field locomotor activity test in order to correspond with the time 
interval during which tianeptine effects on alcohol drinking were observed. Analysis 
of cumulative locomotor activity in both adolescents and adults failed to detect any 
significant effect of tianeptine pretreatment (p >0.05, Figure 22D and E). 
To evaluate anxiety-like behavior, locomotor data were analyzed for time 
spent in the center versus perimeter of the chamber. A main effect of zone emerged, 
such that mice in both age groups spent more time in the perimeter of the chamber 
than in the center zone, F(1, 10) = 504.0, p < 0.0001. Under vehicle treatment 
conditions, both adolescents and adults spent approximately 80% of their time in the 
perimeter zone. No significant effect of tianeptine pretreatment or age emerged in 
either zone (p > 0.05, data not shown.) 
 To determine if tianeptine affected alcohol clearance, adolescent and adult 
mice were pretreated with tianeptine 30 minutes prior to a 4g/kg intraperitoneal 
injection of alcohol. Analysis of blood alcohol samples collected 10, 30, 60, 120, and 
240 minutes after the alcohol injection failed to reveal any significant effects of 
tianeptine pretreatment on BACs in either age (p >0.05, Figure 22F and G). 
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Figure 22. Tianeptine pretreatment alters alcohol, but not sucrose, intake in 
opposite directions in adolescent and adult male mice. (A) Timeline of 
tianeptine pretreatment binge drinking procedure. (B) Tianeptine dose-
dependently increased alcohol intake in adolescent mice but decreased 
alcohol intake in adult mice (*p <0.05). (C) Tianeptine comparably decreased 
sucrose intake in adolescent and adult mice. The open-field locomotor 
behavior of adolescent (D) and adult (E) mice injected with the effective dose 
of tianeptine in each age did not differ from age-matched controls injected 
with vehicle. Adolescent (F) and adult (G) mice pretreated with tianeptine did 
not differ in blood alcohol concentration following an acute alcohol injection.  
 
Discussion 
 
Although human [5, 6] and rodent studies [27-29] indicate that adolescent 
alcohol exposure increases the risk for lifetime AUDs, the neurobiological 
mechanisms of this age-specific vulnerability remain to be determined. To address 
this gap in knowledge, we first evaluated effects of voluntary binge-like alcohol 
drinking on protein expression and activation (e.g., phosphorylation) of CaMKIIαT286 
and the GluA1S831 subunit of AMPARs in adolescent and adult mice. To determine if 
CaMKIIα-GluA1 signaling mechanistically regulates age-dependent binge drinking, 
we next assessed the effects of systemic administration of the antidepressant 
Tianeptine, which potentiates AMPAR GluA1 activity via activation of CaMKIIα 
(Szegedi et al 2011), in adolescent and adult mice. Results indicate that voluntary 
binge-like alcohol drinking produces age-dependent differential effects on 
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pCaMKIIαT286 and pGluA1S831 in the amygdala. Accordingly, positive modulation of 
CaMKII-dependent AMPA signaling via systemic Tianeptine administration 
increased binge-like alcohol drinking specifically in adolescent mice and reduced 
drinking in adults. Together, these data indicate that binge drinking produces age-
dependent effects on CaMKIIα and GluA1 signaling that regulate the amount of 
alcohol consumed during binge drinking episodes.  
Effects of Binge-Drinking on CaMKIIα and GluA1 Expression and Phosphorylation 
 Adolescent and adult male C57BL/6J mice voluntarily consumed similar 
doses of alcohol during the two-week exposure period, each achieving blood alcohol 
levels consistent with binge exposure (e.g., > 80 mg/dL). Binge drinking produced no 
effects on overall health as indexed by body weight comparisons to parallel water-
only controls. The lack of age differences in alcohol intake in Experiment 1 was 
advantageous because it ruled out alcohol dose-dependent differences in protein 
expression, allowing us to more clearly interpret age-dependent differences (i.e., 
without the confound of differential alcohol dose). 
Adolescent. Binge-like alcohol drinking produced an age-dependent decrease 
in pCaMKIIαT286 in adolescent amygdala with no change in total protein expression. 
Since pCaMKIIαT286 is a primary molecular mechanism of synaptic plasticity that is 
required for associative learning and memory processes mediated by the amygdala 
(Lisman et al., 2002, Rodrigues et al., 2004), binge alcohol-induced downregulation 
of CaMKIIα activity in the adolescent amygdala may underlie age-dependent 
inhibition of memory processes as previously observed following alcohol exposure 
[10, 30, 31]. This observation is highly significant from a translational perspective 
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since estimates indicate that over 50% of college-age frequent binge drinkers have 
experienced significant associative memory loss, including complete  blackouts [32]. 
Moreover, emerging adults (age18-24) who have experienced binge-induced 
blackouts have lower levels of glutamate in the anterior cingulate cortex as 
compared to light drinkers [33]. Thus, binge drinking may produce adolescent-
specific cognitive deficits by disruption of basic molecular mechanisms of memory 
and plasticity in the amygdala.  
At the molecular and cellular level, alcohol-induced inhibition of pCaMKIIαT286 
expression in adolescents may disrupt numerous functions subserved by the kinase 
including regulation of membrane current, neurotransmitter synthesis and release, 
cytoskeletal organization, dendrite maturation, and gene expression [15, 34-36]. 
Further, a crucial function of CaMKIIα is to phosphorylate AMPARs at the GluA1S831 
site, which leads to potentiation of AMPA-mediated synaptic activity [37, 38], 
promotes AMPAR membrane insertion, and enhances their function [15, 34, 35]. 
Here, we observed a trend for decreased pGluA1S831 following adolescent binge-like 
alcohol intake. Binge drinking may disrupt a variety of critical neural and behavioral 
functions in the adolescent brain via inhibition of CaMKIIα activity and downstream 
mechanisms. This suggests that binge-induced changes in CaMKIIα activity may be 
associated with subtle changes in AMPAR signaling. 
Adult. In contrast to the adolescent, a two-week history of daily binge alcohol 
drinking specifically increased pGluA1S831 in adult amygdala with no change in 
pCaMKIIαT286 or total protein expression. These findings are consistent with previous 
evidence showing that pGluA1S831 is increased by voluntary 24-h home-cage 
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drinking or low-dose operant alcohol self-administration in adult mice [13], and by 
chronic intermittent high-dose alcohol vapor in adult rats [39]. Phosphorylation of the 
GluA1 subunit of the AMPAR results in increased single-channel conductance [18, 
40] and has been shown to be critical for the induction of LTP [19]. Recent work in 
our lab has demonstrated that CaMKII and GluA1 activity in the amygdala 
functionally regulate alcohol self-administration [13]. Thus, increased pGluA1S831 
may be indicative of increased activity of AMPARs in the adult amygdala after 
alcohol exposure, and may contribute to long-term plastic adaptations to alcohol. 
Since CaMKIIα phosphorylation was not increased in adults, it is plausible binge-like 
alcohol drinking does not specifically alter CaMKII signaling in this age group. Thus, 
GluA1S831 phosphorylation may have been mediated by another alcohol-sensitive 
kinase, such as PKC [41-44]. These results add weight to a growing body of 
evidence suggesting that glutamate signaling in the amygdala is a target of alcohol 
self-administration.  
Overall, these data show differential age-dependent effects of binge drinking 
on CaMKIIαT286 and GluA1S831 phosphorylation between adolescent and adult mice. 
Although the specific mechanism(s) for these effects are unknown, it is plausible that 
well-documented age-dependent maturation of the target systems is partly 
accountable. For instance, CaMKIIα expression increases linearly in rat forebrain by 
10-fold from PND 5 through 25 [45]. Similarly, CaMKIIα mRNA increases 10-fold 
between PND 1 and 21 with an additional 5-fold increase by PND 90, which spans 
the adolescent and early adult periods examined in the present study. Additionally, 
the subcellular distribution of CaMKII shifts from primarily cytosolic to membrane 
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localization during development [46, 47]. Developmentally regulated protein 
concentration and localization in neural tissue may influence the effects of alcohol on 
CaMKIIα phosphorylation. 
Tissue for these experiments was collected immediately following the last 
drinking session, when mice had achieved a binge-level of alcohol consumption. 
Therefore, the results should be considered in the context of alcohol-induced brain 
protein changes in the presence of alcohol. The present findings were also selective 
for the amygdala, with no changes in pCaMKIIaT286 or pGluA1S831 observed in the 
nucleus accumbens or the dorsal striatum. Therefore, glutamatergic signaling in the 
striatum may be less relevant than in the amygdala in terms of the regulation of 
binge-like alcohol self-administration. The amygdala is a complex region comprised 
of several subnuclei, including the central, basolateral and lateral subregions, and 
these nuclei may play different roles in the regulation of alcohol drinking behavior 
[48, 49]. The current experiment is limited by the use of whole amygdala tissue, 
making it difficult to establish the relevance of different sub-nuclei in these findings. 
Future studies utilizing immunohistochemistry would clarify the contributions of 
different subregions of the amygdala to the effects observed in the present study. 
Effects of the pGluA1S831 Upregulator Tianeptine on Binge-Drinking  
In Experiment 2, adolescent animals consumed more alcohol than adult 
animals both at baseline and during drug treatment under vehicle conditions. This 
result is in contrast to Experiment 1, where adolescent and adult alcohol intake was 
equivalent. Although adolescents have been reported to consume more alcohol than 
adults in some studies [50, 51], other reports have failed to find differences in 
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adolescent and adult intake [52, 53]. Procedural differences between experiments 
are likely to account for discrepancies in age differences across studies. 
Interestingly, the studies above that failed to find age differences in alcohol self-
administration utilized daily or continuous access procedures (as in Experiment 1) 
whereas the studies that demonstrated increased alcohol consumption during 
adolescence made use of intermittent drinking protocols (as in Experiment 2). These 
findings suggest that intermittent drinking procedures may be advantageous for 
experiments in which age differences in alcohol consumption are under 
investigation, whereas daily drinking procedures may be useful when dose 
differences between ages represent a confounding variable. 
Binge alcohol consumption increased pGluA1S831 in the adult amygdala. 
Mimicking this effect via systemic pretreatment with the AMPAR positive modulator 
Tianeptine dose-dependently decreased binge-like alcohol consumption in adult 
mice. Since Tianeptine increases pGluA1S831 in a CaMKII-dependent manner [54], it 
may have substituted for a pharmacological effect of alcohol in adult mice, leading to 
decreased alcohol consumption. This finding is consistent with previous studies 
which have shown that tianeptine pretreatment decreases alcohol intake [55] and 
attenuates alcohol withdrawal symptoms in adult rats [23]. Moreover, alcohol self-
administration increases pGluA1S831 expression in adult mouse amygdala where 
AMPAR activity is required for the positive reinforcing effects of alcohol [13] and 
increased non-NMDA glutamatergic signaling in the amygdala is associated with 
alcohol conditioned reward [56]. Importantly, tianeptine pretreatment also decreased 
sucrose consumption in adult mice, suggesting that tianeptine may globally reduce 
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the consumption of palatable solutions. These findings add growing evidence that 
AMPAR activity is critical for the reinforcing effects of alcohol and other palatable 
solutions in adults.  
In contrast to adults, binge-like alcohol drinking resulted in a trend for 
decreased pGluA1S831 in the adolescent amygdala. Opposing this alcohol-induced 
effect via systemic pretreatment with tianeptine increased binge-like alcohol 
consumption in this age group. Tianeptine may therefore have blocked a 
pharmacological effect of alcohol at AMPARs in adolescent mice, leading to a 
compensatory increase in alcohol drinking. The effects of tianeptine on adolescent 
binge drinking formed an inverted U-shaped dose-response curve, with an 
intermediate dose leading to increased alcohol consumption and a high dose 
returning to baseline. It is possible that testing a higher dose would reveal decreased 
alcohol consumption in adolescents, indicating a rightward shift of the dose-
response curve in adolescents corresponding to the effect in adults. Significantly, 
tianeptine pretreatment produced comparable decreases in sucrose consumption in 
adolescent and adult mice, indicating that the increase in alcohol drinking seen after 
tianeptine pretreatment in adolescents is selective for alcohol and not generalized to 
other reinforcing solutions. The alterations in glutamate signaling reported here in 
the adolescent mouse may therefore be both selective for the adolescent brain and 
specific for alcohol. Together, these data provide evidence that CaMKIIα-GluA1 
signaling differentially regulates binge-like drinking by adolescent and adult mice. 
Upregulation of AMPAR activity in the amygdala may promote increased drinking 
during adolescence but inhibit this behavioral pathology during adulthood. Future 
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studies that target AMPAR activity specifically in the amygdala would clarify the 
anatomical basis of this age-dependent differential response. 
Tianeptine pretreatment failed to significantly alter open-field activity in both 
adolescents and adults, and blood alcohol clearance was similarly unaffected by 
tianeptine pretreatment in both ages, indicating a lack of effect of tianeptine on gross 
locomotor activity and alcohol metabolism. It is possible that tianeptine and alcohol 
may interact to alter locomotor behavior in adolescent and adult mice. While no 
obvious locomotor effects were observed during drinking, this possibility limits the 
interpretation of the locomotor results. Tianeptine may alter the metabolism of lower 
doses of alcohol but not the higher doses tested here, limiting the interpretation of 
the blood alcohol clearance experiments. Additionally, the injections administered in 
these experiments may have represented a significant stressor in the experimental 
design, potentially contributing to the age differences observed in alcohol drinking. 
However, zone analysis of adolescent and adult locomotor behavior under vehicle 
conditions revealed no evidence for anxiety-like behavior in either age, and 
tianeptine pretreatment did not alter time spent in the center or perimeter of the open 
field. Therefore, stress-related explanations for these findings are unlikely. 
A potential limitation of these findings is the possibility for tianeptine activity at 
targets other than CaMKII/GluA1 signaling. Unlike most antidepressants, tianeptine 
has very low affinity for monoamine receptors or transporters [57] and the drug has 
not been found to interact directly with NMDA receptors [58]. However, activation of 
CaMKII also prompts the protein to bind with the NR2B subunit of the NMDA 
receptor [59]. Therefore, activation of CaMKII via tianeptine pretreatment could alter 
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NMDA receptor activity as well as GluA1Ser831 phosphorylation. Additionally, a recent 
report suggests that tianeptine may have some affinity for the µ-opioid receptor [60], 
which could represent another mechanism for tianeptine’s effects on alcohol 
drinking. However, activation of µ-opioid receptors has been shown to be an 
upstream trigger of the signaling cascade that stimulates CaMKII activation [61], and 
therefore may be part of the pGluASer831 potentiation seen after tianeptine treatment.  
In conclusion, the findings from this study indicate that binge-like alcohol 
drinking impacts amygdala glutamate signaling systems of adolescent and adult 
animals in very different ways. Glutamate signaling in the amygdala, as indexed by 
CaMKIIα and GluA1 phosphorylation, appears to be downregulated by alcohol in 
adolescence and upregulated in adulthood. Results from this study suggest that 
CaMKIIα-GluA1 signaling in the adolescent amygdala is especially vulnerable to 
binge-induced insult. Understanding the age-dependent differences in the impact of 
binge alcohol drinking on glutamate signaling and how these systems, in turn, 
regulate intake is critical to understanding adolescent vulnerability to alcohol 
addiction.   
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CHAPTER FIVE: GENERAL DISCUSSION 
 Adolescent alcohol drinking is both extremely prevalent and particularly 
dangerous, as it is associated with nearly a 50% increase in lifetime risk for 
developing an alcohol use disorder (AUD). Insights from research in alcoholic 
populations [2] and preclinical findings from rodent models [3] have suggested that 
the same process of synaptic plasticity that ushers the adolescent brain into maturity 
may also be responsible for the unique vulnerability of this age group to the lasting 
deleterious effects of alcohol use. However, the specific molecular mechanisms that 
mediate this developmental risk have not been completely elucidated.  Thus, the 
overarching goals of this dissertation were to first identify novel targets of alcohol 
drinking in the adolescent brain and then to validate their involvement in behavioral 
processes that underlie vulnerability to alcohol addiction in adulthood. 
 In the present study, unbiased high-throughput proteomics and hypothesis-
driven pharmacological assessments were combined to provide insight into 
developmental differences between the adolescent and adult brain that play a role in 
alcohol-related behaviors. First, a proteomics screen of the adolescent and adult 
medial prefrontal cortex (mPFC) in the absence of alcohol revealed substantial age-
related alterations in protein expression and implicated functional protein networks 
involved in behavior and neurological disease as being affected by the immaturity 
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of the adolescent brain. The results of this study provide further evidence that 
adolescence is distinct from both childhood and adulthood and represents a period 
of significant protein-level change in the Second, a proteomics screen of the 
adolescent and adult mPFC following two weeks of intermittent home-cage alcohol 
drinking pointed to the increased vulnerability  of the adolescent mPFC to the effects 
of alcohol drinking on protein expression. Alcohol drinking in adolescent mice was 
associated with profound alterations in proteins and interaction networks associated 
with learning and synaptic plasticity, in support of the hypothesis that the heightened 
plasticity during adolescent brain development confers some of the vulnerability to 
alcoholism observed following adolescent alcohol exposure. The protein calcineurin 
was chosen for functional assessment due to its identification in both the 
developmental and alcohol drinking proteomics experiments (downregulated by 
alcohol in adolescent mPFC) and its central role in regulating the plasticity of 
glutamatergic synapses. Initial behavioral pharmacology studies showed that 
adolescent mice were more sensitive than adult mice to reductions in alcohol 
drinking induced by the calcineurin inhibitor FK506, which is consistent with alcohol-
induced downregulation of total calcineurin protein by alcohol drinking in this 
vulnerable age group. To assess the effects of calcineurin activity on the long-term 
risk for increased alcohol consumption following adolescent alcohol exposure, a 
model of adolescent alcohol drinking and subsequent operant responding for alcohol 
in adulthood was developed. Mice exposed to alcohol during adolescence exhibited 
increased operant self-administration compared with mice exposed to water during 
adolescence and mice exposed to alcohol during adulthood, indicating that 
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adolescent drinking increases the positive reinforcing effects of alcohol later in life. 
Mice with a history of adolescent alcohol drinking were also sensitive to FK506-
induced decreases in operant responding for alcohol whereas mice with a history of 
adolescent water drinking and mice with a history of adult alcohol or water drinking 
were all insensitive to the effects of calcineurin inhibition.  To establish the role of the 
mPFC in mediating some of the effects of calcineurin inhibition on operant 
responding for alcohol, FK506 was infused directly into the mPFC. Results showed 
that inhibition of calcineurin specifically in the mPFC increased the positive 
reinforcing effects of alcohol only in mice with a history of adolescent alcohol, but not 
water, consumption. As a whole, these findings indicate that calcineurin activity in 
the mPFC selectively regulates the reinforcing effects of alcohol during adulthood 
following adolescent alcohol exposure.  
Lastly, the synaptic plasticity-associated protein calcium/calmodulin-
dependent protein kinase II (CaMKII) was evaluated for sensitivity to binge-like 
alcohol drinking in adolescent and adult mice. CaMKIIα phosphorylation was 
decreased in adolescent but not adult mice selectively within the amygdala, whereas 
phosphorylation of the GluA1 subunit of the AMPA receptor was enhanced in adult 
mice but trended towards suppression in adolescent mice. To establish a functional 
role for CaMKII-GluA1 signaling in adolescent binge-like alcohol drinking, adolescent 
and adult mice were pretreated with the CaMKII-dependent pGluA1 enhancer 
tianeptine. Tianeptine increased binge drinking in adolescent mice but decreased 
binge drinking in adults, an effect that was selective for alcohol but not sucrose 
drinking. These findings provide a separate line of evidence that suggests 
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mechanisms of synaptic plasticity play a critical role in mediating immediate age 
differences between adolescent and adult alcohol drinking. 
The experiments described above made use of three different procedures for 
modeling alcohol consumption in rodents: binge-like limited access single bottle 
alcohol drinking, 24-hour intermittent two-bottle choice alcohol drinking, and operant 
alcohol self-administration. Each of these procedures presents advantages and 
disadvantages in terms of their ability to replicate differing aspects of human alcohol 
use. Binge-like limited access drinking arguably provides the best model of 
adolescent-typical alcohol consumption available in mice. Binge drinking is 
extremely widespread amongst human adolescents who consume alcohol [4], and 
indeed has been reported to be the preferred method of alcohol consumption among 
this age group [5]. Every-other-day binge drinking has reliably modeled increased 
alcohol drinking in adolescent versus adult mice both in the present findings and in 
previous reports [6-9], further validating it as an accurate reflection of adolescent-
typical drinking patterns observed in the human literature. The disadvantage of 
limited-access binge drinking is the limited access; although mice readily consume 
intoxicating quantities of alcohol during the binge drinking session, the total dose of 
alcohol achieved by each mouse is artificially limited by the experimenter. In the two-
bottle choice 24-hour access model, mice receive one tube containing alcohol and 
one tube containing water for 24-hours every other day. This procedure is 
advantageous when higher alcohol consumption is desirable; in the present 
experiments, mice routinely achieved alcohol consumption in excess of 20 g/kg 
during 24-hour drinking sessions, whereas the limited access binge-drinking model 
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produced alcohol consumption of 4-6 g/kg over four hours. Both an advantage and 
disadvantage of the two-bottle choice 24-hour access procedure is the lack of age 
differences in alcohol drinking observed in this model in the present studies. 
Although this procedure does not recapitulate the age differences in alcohol 
consumption observed in humans, the similar alcohol consumption of adolescent 
and adult mice removes dose as a variable from the experiment, allowing brain and 
behavior changes to be attributed directly to developmental stage and not to merely 
increased or decreased intake between the two ages. Although this model is a less 
accurate reflection of the drinking patterns of a typical human adolescent, 24-hour 
drinking sessions are not unheard of in the human literature and the model does 
offer insight into what high-dose alcohol exposure may do to the adolescent brain, a 
topic that has gained additional relevance as extreme alcohol drinking continues to 
increase among adolescents in the US [10]. Operant self-administration of alcohol 
offers several advantages over home-cage drinking models. Operant behavior is far 
more quantitative than home cage drinking and affords the experimenter the ability 
to measure not just consumption, but motivation to consume alcohol (indexed via 
responding for alcohol), alcohol seeking (indexed via head entries into the reward 
trough) and a proxy measure of learning (indexed via the accuracy of responding on 
the active versus inactive lever) [11]. Operant behavior is also exquisitely sensitive 
to pharmacological manipulation as compared with home-cage drinking, making it a 
particularly attractive model for use in assessing the molecular mechanisms that 
regulate alcohol intake. The disadvantage of operant models is the limited amount of 
alcohol animals are able to self-administer; in the present experiments, mice 
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achieved doses of 1-2 g/kg over the course of a one-hour operant session, making 
this procedure even more limited than the limited-access binge-like alcohol drinking 
model.  
The choice of which drinking model to use for a given experiment was 
predicated on the experimental question at hand. Thus, acute age differences in 
alcohol drinking were best assessed in a limited-access binge model in which those 
differences were most prominent, the effects of alcohol drinking on protein 
expression in the adolescent and adult brain benefitted from the highest dose of 
alcohol voluntarily consumed by the mice (i.e. 24-hour two-bottle choice drinking), 
and the pharmacological assessment of the longitudinal increased risk for alcohol 
consumption in adulthood following adolescent alcohol exposure called for the most 
sensitive method of quantitating intake possible, i.e. operant self-administration. 
However, it would be useful to conduct some of these same assessments in different 
models of alcohol drinking to clarify the effect of alcohol dose/access procedure on 
brain and behavioral actions of alcohol in the adolescent mouse. Of particular 
interest would be determining whether the protein-level changes observed in the 
high-dose 24-hour two-bottle choice experiments would also be observed in lower-
dose drinking procedures that more accurately reflect adolescent alcohol drinking in 
humans, i.e. the binge-like limited-access procedure.  
An important caveat about the interpretation of the present experiments in 
terms of alcoholism is that none of the three models used in these studies attempted 
to reflect alcohol dependence, withdrawal or relapse, three key characteristics of 
alcoholism in humans.  The current results identified initial effects of alcoholism 
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during adolescence and long-term effects on adult alcohol consumption following 
adolescent exposure, but did not continue to the predicted outcome of alcohol 
dependence following adolescent exposure. Thus, important questions remain as to 
the mechanisms that translate escalated alcohol drinking following adolescent 
alcohol exposure into full-blown alcohol dependence. The model developed here 
could readily be adapted to address this question. In the adolescent exposure-adult 
operant model, a pause period was build into the procedure to isolate the effects of 
alcohol exposure during adolescence. To assess the effects of adolescent alcohol 
drinking on subsequent alcohol exposure, the pause period could be removed in 
favor of continuous access to alcohol throughout adolescence and into adulthood. 
Previous studies have demonstrated that intermittent two-bottle choice alcohol 
drinking produces physiological dependence upon alcohol (as indexed by tolerance 
and withdrawal) [12], making this procedure appropriate for assessments that more 
directly concern “alcoholism” in rodents. Alternatively, repeatedly cycles of 
intermittent binge alcohol exposure have similarly been shown to produce increased 
alcohol intake over time in a way that may reflect the early transition from use to 
dependence [13]. Such a procedure could be used to introduce age differences 
evident in binge-like alcohol drinking into the model to more accurately reflect the 
human condition. After dependence upon alcohol had been established, operant 
self-administration could be used as a model for relapse to alcohol seeking if mice 
were trained to self-administer alcohol, taken through extinction of operant 
responding, and then presented with an alcohol-associated cue to induce 
reinstatement of alcohol seeking. This procedure has been successfully used to 
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model relapse in previous studies [14, 15] and would be particularly appropriate to 
address this aspect of human alcoholism.  
The experiments in this dissertation focused primarily on two brain regions: 
the prefrontal cortex (PFC) and the amygdala. The PFC was a major focus of this 
work because of its dual-role in the neurobiology of alcohol addiction and the 
neurobiology of adolescence. In both humans and rodents, the PFC has been 
shown to be critical for executive function; that is, learning and memory, decision 
making, and regulation of emotional reactivity and related behaviors [16]. The PFC 
exerts this regulatory control via projections to downstream brain regions involved in 
emotionally relevant stimuli and behavioral responses to them, most notably the 
nucleus accumbens, amygdala, ventral tegmental area, and the thalamus. Within the 
PFC, differing subregions have varying projections and associated functions. 
Generally, in humans the lateral PFC contains projections that extend to other 
cortical areas, the medial PFC (mPFC) contains dense connections to the thalamus, 
hippocampus and striatum, and the orbitofrontal cortex contains reciprocal 
connections with the amygdala, basal ganglia and other prefrontal subregions [17]. 
Rodents also have a PFC as defined by both structural projections similar those 
seen in primates and the functional impact of lesions to this same area on executive 
function [18]. The rodent PFC has similar subdivisions as the primate PFC, including 
a mPFC with similar projections to limbic brain areas that can be divided in the 
dorsal pre-limbic and ventral infra-limbic regions [19]. The topography of the rodent 
mPFC connections roughly matches the primate mPFC, with more dorsal regions 
(PL-mPFC) projecting to dorsal portions of the striatum and ventral regions (IL-
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mPFC) projecting to ventral striatum, although fiber tracts in both subdivisions can 
project throughout the striatum [17]. (It should be noted that the present experiments 
did not differentiate the subregions of the mPFC.) Although the major projection 
neurons of the PFC are excitatory glutamatergic neurons, many of these projections 
terminate onto GABAergic interneurons within the striatum and amygdala [20]. In 
this way, excitatory output from the PFC inhibits the activity of limbic regions, 
underlying cortical regulation of emotional behavior.  
Alcohol has direct effects on neurotransmission in the PFC. In vitro studies 
have demonstrated that acute alcohol reduces spontaneous spiking and upstates of 
glutamatergic neurons within the PFC [21]. In vivo animal studies have indicated that 
alcohol induces widespread alterations in neurotransmitter receptors within the PFC, 
including opioid [22], serotonin [23] and endocannabinoid receptors [24], as well as 
direct effects on glutamate concentration and receptors . Further, alcohol 
consumption-related behaviors can be manipulated with intra-PFC infusion of 
several neuromodulatory drugs [25, 26]. In studies with human participants, acute 
alcohol has been shown to inhibit several PFC-dependent behavioral tasks, 
including memory and decision making [17]. Acute alcohol also increases blood flow 
to the PFC at low doses but reduces blood flow at high doses [27]. Additionally, 
trans-magnetic cranial stimulation (TMS)-evoked PFC activity is reduced by acute 
alcohol [28]. In studies with alcoholic participants, reductions in PFC gray matter 
have been noted alongside reductions in white matter volume [29].  Together, these 
findings indicate that the PFC is both a site of the actions of acute alcohol as well as 
a regulator of some of the effects of acute alcohol on behavior. 
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As discussed in Chapter One, the PFC is one of the last brain regions to 
mature during adolescent development, and the delay in PFC maturation is thought 
to underlie some of the adolescent-typical behaviors exhibited during this epoch [30]. 
Thus, the effects of adolescence and alcohol on the brain would seem to converge 
on the PFC, making it an attractive target for housing cellular and molecular 
mechanisms of age differences in alcohol drinking and vulnerability to alcoholism 
following adolescent alcohol intake. Indeed, in Chapter Three significant qualitative 
differences in the response of the adolescent and adult mPFC to alcohol drinking 
were observed. Notably, many of these protein changes (including the focus protein 
calcineurin) were related to synaptic plasticity and learning and memory, both key 
features of cortical regulation of limbic brain regions and hallmarks of adolescent 
brain maturation. Previous evidence has indicated that alcoholics exhibit cognitive 
deficits as well as abnormalities in emotional processing which have been suggested 
to represent a persistence of the adolescence phenotype into adulthood induced by 
alcohol exposure [31]. The present findings accord with this view and suggest that 
the PFC may play a role in this phenomenon.  
The amygdala, like much of the limbic system, develops earlier in 
adolescence than the PFC [32], but remains immature in terms of its functional 
connectivity to cortical brain regions throughout adolescence. Importantly, it has 
been demonstrated that PFC input from reward-associated brain regions such as the 
nucleus accumbens matures more rapidly than input from the aversion-associated 
amygdala, which may underlie the increased sensitivity to the rewarding effects of 
drugs of abuse but blunted sensitivity to the aversive properties observed in 
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adolescent rodents and humans [33]. Such a view of the relationship between the 
PFC and amygdala may be overly simplistic, since the amygdala (particularly the 
CeA and BLA) also mediates some of the reinforcing effects of drugs of abuse [34] 
and may indeed be a “salience detector” rather than an aversion response system 
(with regions in the extended amygdala such as the bed nucleus of the stria 
terminalis applying negative emotional valence to aversive stimuli) [35, 36]. What is 
clear is that across the course of adolescent brain development, functional 
connectivity between the PFC and amygdala shifts from a positive to a negative 
correlation; that is, in children increased activity of the PFC is associated with 
increased amygdala activity, but in adults increased PFC activity is associated with 
decreased amygdala activity [37]. Thus, even though the amygdala may be 
structurally mature during early adolescence, it remains immature in terms of its 
network-wide signaling until adulthood.     
The present findings characterized the role of two synaptic plasticity-
regulating enzymes in the effects of adolescent alcohol drinking. First, in the PFC 
calcineurin was found to be increased in adolscents relative to adults, to be sensitive 
to alcohol drinking in adolescents but not adults, and to regulate both acute alcohol 
drinking in adolescence and the long-term increases in alcohol drinking following 
adolescent alcohol exposure. Calcineurin is a negative regulator of synaptic 
plasticity; activation of this protein phosphatase prompts dephosphorylation of the 
GluA1 subunit of the AMPA receptor, reduced AMAP-mediated currents, and 
reductions in the magnitude of the postsynaptic response to glutamate. Thus, in the 
adolescent cortex alcohol drinking would be predicted to have a net effect of 
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enhanced AMAPA receptor signaling (via reductions in calcineurin expression and 
activity), and potentially increase glutamatergic output of the PFC onto downstream 
limbic brain regions. 
In the amygdala, alcohol drinking reduced the phosphorylation of CaMKIIα in 
adolescent but not adult mice; accordingly, alcohol drinking was associated with 
increases in GluA1 phosphorylation in the adult but not adolescent amygdala. Taken 
together with the findings in the PFC, the results of these experiments suggest that 
increased excitatory output of the PFC onto inhibitory interneurons within the 
amygdala may reduce alcohol-associated activity in that region. As amygdala 
glutamate signaling has been shown to be involved in alcohol self-administration in 
adult rodents, this inhibition of a pharmacological effect of alcohol may drive 
adolescent mice to consume more alcohol in order to achieve an intoxicating dose. 
Adolescent rodents and humans have repeatedly been shown to be less sensitive to 
the acute effects of alcohol than their adult counterparts [38], and the present 
findings provide a hypothesis as to the molecular mechanisms behind this 
behavioral phenotype. Thus, systemic enhancement of CaMKII-GluA1 signaling may 
drive increased alcohol self-administration in adolescents by blocking a direct 
pharmacological effect of alcohol (i.e. reductions in CaMKII-GluA1 activity) in the 
amygdala, whereas mPFC-specific calcineurin inhibition increases alcohol self-
administration via indirect blockade of this pharmacological effect via increased PFC 
inhibition of amygdala activity. This hypothetical model is illustrated in Figure 23. 
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Figure 23. Proposed model of effects of alcohol on synaptic plasticity in the 
adolescent brain. (A) At baseline, calcineurin (PPP3) activity in the PFC 
(left) and CaMKII activity in the amygdala (right) maintain normal balance of 
PFC glutamatergic output onto inhibitory GABAergic interneurons in the 
amygdala (center). (B) Under the influence of alcohol, both calcineurin and 
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CaMKII activity are blunted in the PFC and amygdala, respectively, leading to 
net reductions in GluA1 phosphorylation and related activity in the adolescent 
amygdala. These features may lead to a blunted response of the adolescent 
amygdala to the presence of alcohol, requiring adolescents to consume a 
higher dose in order to achieve subjective intoxication. 
Although the present findings support this hypothesis, several additional 
experiments would more concretely establish a role for PFC regulation of amygdala 
responses to alcohol in adolescent alcohol drinking. First, additional assessments of 
the protein-level changes in the PFC and amygdala induced by adolescent alcohol 
drinking are necessary. In Chapter Two, CaMKII was shown to exhibit reduced 
phosphorylation in the adult but not adolescent PFC. Reductions in CaMKII activity 
would reduce glutamatergic activity in the PFC, and could therefore be a 
compensatory response to avoid the inordinate glutamatergic output to limbic 
regions that has been hypothesized to go awry in the adolescent brain. However, the 
effects of alcohol on calcineurin expression and activity in the amygdala have not 
been assessed in these experiments. Immunoblotting or immunohistochemistry 
would provide important insight into the response of calcineurin to alcohol in the 
adolescent amygdala.  
     Secondly, the changes in protein expression observed in the present work have 
been predicted to alter glutamatergic neurotransmission in the PFC and amygdala, 
respectively, but assessment of AMPA signaling in both regions using 
electrophysiology would directly test that hypothesis. Based on the protein-level and 
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pharmacological findings, adolescent alcohol exposure would be predicted to 
enhance AMPA currents in the PFC and reduce AMAPA currents in the amygdala.  
Thirdly, the net effect of adolescent alcohol is herein proposed to blunt 
glutamate signaling in the amygdala, thereby necessitating more alcohol 
consumption to achieve intoxicating effects in adolescent versus adult mice. 
Reductions in the subjective effects of alcohol have been previously associated with 
increases in alcohol consumption [39], and glutamate activity specifically within the 
amygdala has been shown to underlie some of the discriminative-stimulus properties 
of alcohol [40]. Additionally, adolescent rats have been shown to display blunted 
sensitivity to the discriminative stimulus effects of alcohol [41]. Although all of these 
findings provide additional support for the proposed hypothesis, a direct assessment 
of the role of glutamate signaling in adolescent alcohol discrimination would be 
better evidence. Adolescent and adult mice could be trained to discriminate injected 
alcohol from saline, then administered tianeptine systemically as in Chapter Four to 
test for age differences in sensitivity to the effect of enhanced CaMKII-GluA1 
signaling on the interoceptive effects of alcohol. Enhancement of amygdalar CaMKII-
GluA1 signaling would be predicted to restore adult-typical enhancement of this 
activity following alcohol consumption and would therefore most likely confer 
sensitivity to the interoceptive effects of lower doses of alcohol in adolescent mice. 
Further, discrimination training of adult mice with a history of adolescent alcohol or 
water drinking would determine whether any evident age differences in glutamate 
regulation of the subjective effects of alcohol persist following adolescent alcohol 
exposure. Microinjection of tianeptine into the amygdala could then be assessed in 
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the discrimination procedure, and would be predicted to restore sensitivity to the 
interoceptive effects of lower dose alcohol in mice with a history of adolescent 
alcohol drinking. 
Lastly, the proposed hypothesis involves signaling changes between the PFC 
and amygdala mediated by glutamatergic transmission. To conclusively demonstrate 
the relevance of this circuitry in adolescent alcohol drinking, an ideal experiment 
would be to utilize chemo- or optogenetic enhancement of PFC-amygdala projection 
neurons in adolescent and adult mice. Based on the present findings, excitation of 
PFC-amygdala glutamatergic projection neurons would be predicted to increase 
alcohol consumption in adolescents but not adults. Unfortunately, due to the limited 
period of adolescence in rodent models (approximately two-four weeks), time for 
viral transfection and surgical recovery are insurmountable obstacles. However, 
such an experiment would be more feasible in adult mice with a history of 
adolescent alcohol or water drinking, respectively, where enhanced PFC-amygdala 
excitation would be expected to increase alcohol consumption selectively in subjects 
with a history of adolescent alcohol drinking. 
Age differences in adolescent behavior and brain function have been well-
characterized in the literature, but the connections between these phenomena and 
the degree to which they relate to increased risk for alcoholism following adolescent 
exposure have been difficult to establish. As the results of the age comparison 
experiments show, the adolescent brain is in a unique developmental stage that is 
completely distinct from the adult state at the protein level in the PFC.  Alcohol 
induces widespread alterations in protein networks within the adolescent PFC, 
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including the synaptic plasticity-associated proteins CaMKII and calcineurin, and 
seems to produce more lasting alterations in the adolescent cortex versus the adult 
cortex. Pharmacological manipulation of CaMKII and calcineurin point to a regulatory 
role for these proteins in mediating some of the acute age differences in adolescent 
and adult alcohol drinking as well as the long-term risk for increased alcohol drinking 
following adolescent alcohol exposure. These findings support the hypothesis that 
the increased activity and expression of plasticity-associated proteins in the 
adolescent brain may underlie adolescent vulnerability to addiction during adulthood. 
The results also suggest that such changes may persist into the adult organism, 
leading to calcineurin regulation of alcohol drinking selectively in individuals with a 
history of adolescent alcohol exposure. This finding points to age of drinking onset 
as a potential means of distinguishing different types of alcoholics for targeted 
prevention and treatment efforts. Problem drinking that begins during adolescence 
may impact distinct neurotransmitter systems from problem drinking that develops in 
midlife, and patients with adolescent alcohol exposure may respond differently to 
medications for alcoholism treatment. This type of analysis may help retrospective 
reviews of published clinical trials make sense of individual differences in drug 
efficacy as well as guide the analysis of future studies in humans. Finally, the current 
experiments provide further justification for the continued development of 
pharmacological and neurobehavioral treatments for alcoholism based on altering 
glutamatergic plasticity. Both the field at large and these results specifically strongly 
caution against underage drinking. However, they also offer hope that the lasting 
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effects of adolescent alcohol drinking may still be sensitive to therapeutic 
intervention in adulthood.  
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